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RESUMEN 
 
El objetivo general del trabajo presentado es investigar nuevas metodologías para la 
síntesis de: a) nectrisina, un  inhibidor de α-glucosidasas y α-mannosidasas, b) del 
fragmento oligosacarídico del antibiótico AT2433-A1, un antibiótico utilizado en el 
tratamiento de numerosos tipos de cánceres y, c) de análogos del cidofovir o HPMPC, 
nucleósido acíclico que incorpora una unidad de fosfonato, y que se utiliza en el 
tratamiento del citomegalovirus (CMV) en pacientes con SIDA. 
 
 
Figura 1. Estructuras del antibiótico AT2433-A1, de la Nectrisina y de análogos del 
Cidofovir 
 
Síntesis enantioselectiva de nectrisina  
 
Retrosintéticamente la síntesis de la nectrisina puede llevarse a cabo por ciclación del 
aminoaldehído 2 (R4=CHO), el cual puede proceder del alqueno trans 3 mediante una 
reacción de dihidroxilación estereoselectiva. La síntesis de 3 puede llevarse a cabo a 
partir de 4 mediante elongación de la cadena utilizando la reacción de metatesis cruzada 
catalizada por rutenio. Finalmente, el intermedio clave 4 procede de una aminación 
alílica asimétrica catalizada por Pd del monepóxido de butadieno racémico 5, reacción 
ya descrita por Trost. 
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Esquema 1. Retrosíntesis de la nectrisina. 
 
La aminación alílica asimétrica del monepóxido de butadieno racémico catalizada por 
Pd (η3-C3H5)PdCl/DACH-naftilo transcurrió con elevado rendimiento y 
enantioselectividad para dar el compuesto 4. La elongación de la cadena de 4 se realizó 
mediante una metatesis cruzada catalizada por  el catalizador de Grubbs-Hoveyda  con 
diferentes alquenos como acroleína, 2-vinil-1,3-dioxolano, y con  acrilato de etilo. Sólo 
en este último caso se obtuvieron resultados relevantes del compuesto 3 (R4=COOEt) 
como para continuar la síntesis. La reacción de dihidroxilación estereoselectiva del 
alqueno trans 3 (R4=COOEt) condujo al diol deseado 2 (R4=COOEt) con buena 
selectividad utilizando OsO4/TMEDA. La hidrólisis del benzoato con LiOH y la 
ciclación in situ condujo a la lactama, a partir de la cual se siguió una secuencia 
sintética descrita en la bibliografía, consistente en la sililación de los grupos hidroxilo, 
protección del grupo amino en forma de terc-butil carbamato, reducción del carbonilo y 
eliminación con desprotección concomitante de los grupo sililo para dar la imina, que en 
nuestras manos no logró llevarse a fin debido a problemas en la última etapa de 
eliminación para dar la imina. 
 
Síntesis enantioselectiva de análogos de Cidofovir HPMPC 
 
La síntesis de los análogos del cidofovir se planteó siguiendo un esquema sintético 
similar al de la nectrisina, en el que la síntesis del intermedio 7 se llevó a cabo mediante 
la aminación alílica asimétrica del monoepóxido del butadieno y posterior reacción de 
metátesis cruzada como pasos clave.  
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                                                    Esquema 2. Retrosíntesis de 7 
 
En primer lugar se realizó la aminación alílica asimétrica catalizada por Pd (η3-
C3H5)PdCl/DACH-naftil del monepóxido de butadieno racémico, con adenina y citosina 
la cual se optimizó hasta conseguir rendimientos y excesos enantioméricos superiores al 
90%. Seguidamente se optimizó la reacción de metátesis cruzada de los compuestos 
obtenidos (6) con un alil fosfonato convenientemente protegido, obteniendo 7 con buen 
rendimiento. La síntesis de los análogos de cidofovir insaturados 8 y 9 se completó tras 
la desprotección de todos los grupos protectores con TMSBr. La síntesis del derivado 
saturado 10 se realizó mediante la hydrogenación (3 bares de hidrógeno, Pd/C durante 
5h) y la eliminación de los grupos protectores.  
 
Síntesis enantioselectiva del fragmento oligosacarídico del antibiótico AT2433-A1 
 
La retrosíntesis de 18 se planteó por ciclación electrófila inducida por yodo de 15, 
donde X debiera ser un grupo activador del doble enlace que a su vez se pudiera 
comportar como grupo saliente en la subsiguiente reacción de glicosilación a partir de 
15. La síntesis del intermedio 15 se planteó por diferentes procedimientos y en 
particular a partir del sulfato 14, el cual provendría del diol 13, que a su vez provendría 
de la dihidroxilación de 12. El compuesto 12 debería poder obtenerse a partir de 5 por la 
secuencia clásica de DYKAT y metatesis cruzada. Así, a partir del compuesto 11 
(R=Boc) se realizó la metatesis cruzada con diferentes alquenos y en particular con el 
alil fenil tioéter. Las limitaciones se encontraron en la reacción de dihidroxilación, ya 
que en casi todos los casos ensayados se produjo la oxidación del azufre, lo que 
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conduciría al cambio de la selectividad en posteriores etapas como la ciclación. Se 
consiguió evitar la oxidación utilizando ligandos quirales en la dihidroxilación, pero con 
rendimientos muy bajos no compatibles con un esquema de síntesis por etapas. 
Alternativamente se exploró otra vía de síntesis a partir del aldehído 17, pero la síntesis 
del intermedio 16 tampoco pudo culminarse con éxito. 
 
Esquema 3. Retrosíntesis  de 18. 
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1.1. Introduction 
The present thesis deals with the development of methodology for the syntheses of 
several organic molecules that were selected by their interesting biological properties: 
the antibiotic AT2433-A1, the glycosidase inhibidor nectrisine and analogs of the anti-
viral Cidofovir (Figure 1.1) . Although apparently structurally unrelated, they were 
envisaged to be synthesized through common high-efficient key steps that involve 
metal-catalyzed process. 
On this section, a brief overview on the target molecules will be presented, 
leaving for the corresponding chapters a more detailed examination. In addition, the key 
issues of the metal-catalyzed processes involved in the syntheses will be discussed. 
 
Figure 1.1. Structures of AT2433-A1, nectrisine and cidofovir analogues 
1.1.1. Azasugars 
Polyhydroxylated nitrogen heterocycle aza-sugars may be considered to be 
mimics of sugars in which the ring oxygen has been substituted for a nitrogen atom.F1F 
The often potent inhibitory activity of many of these compounds toward carbohydrate-
processing enzymes has suggested their use in a wide range of potential therapeutic 
                                                 
1  a) Winchester, B.; Fleet, G. W. J. Glycobiology 1992, 2, 199-210. b) O’Hagan, D. Nat. Prod. Rep.  
 1997, 14, 637-651. c) Asano, N.; Nash, R. J.; Molyneux, R. J.; Fleet, G. W. J. Tetrahedron: Asymmetry  
 2000, 11, 1645-1680 
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strategies including the treatment of viral infections,F2F cancer,F3F diabetes,F4F tuberculosis,F5F 
lysosomal storage diseases,F6F and parasitic protozoa.F7F  
 
Nectrisine is an azasugar isolated from a strain of the fungus Nectricine lucida 
(Figure 1.1) as immunomodulator FR-900483F8F and found to exhibit inhibitory activity 
on α–glycosidases.Moreover, nectrisine is involved in the prevention of different 
diseases such as Newcastle disease virus. Due to this important biological activity many 
organic chemists are focused on the development of new methods to synthesize 
nectrisine. 
1.1.2. Acyclic Nucleoside phosphonates 
In the last few years the ever-growing interest in the field of nucleosides and 
nucleotides has led to renewed efforts in the synthesis of analogues. Nucleosides are 
fundamental building blocks of biological systems and show a wide range of biological 
activity. They are sequentially phosphorylated by kinases into their mono-, di- and tri-
phosphates and the resultant nucleotides are processed into nucleic acids by 
polymerases. F9F,F10F Modifications in the sugar moiety are one of the most important kind 
                                                 
2   Karpas, A.; Fleet, G. W. J.; Dwek, R. A.; Petursson, S.; Namgoong, S. K.; Ramsden, N. G.;  
 Jacob, G. S.; Rademacher, T. W. Proc. Natl. Acad. Sci., U.S.A. 1988, 85, 9229-9233.  
3    Goss, P. E.; Baker, M. A.; Carver J. P.; Dennis, J. W. Clin. Cancer Res. 1995, 1, 935-944 
4    Watson, K. A.; Mitchell, E. P.; Johnson, L. N.; Son, J. C.; Bichard, C. J. F.; Orchard, M. G.; Fleet,  
            G. W. J.; Oikonomakos, N. G.; Leonidas, D. D.; Kontou, M.; Papageorgiou, A. C. Biochemistry  
 1994, 33, 5745-5758. 
5     a) Davis, B. G.; Brandstetter, T. W.; Hackett, L.; Winchester, B. G.; Nash, R. J.; Watson, A. A.;  
 Griffiths, R. C.; Smith, C.; Fleet, G. W. J.; Tetrahedron 1999, 55, 4489-4500. b) Shilvock, J. P.;   
 Wheatley, J. R.; Nash, R. J.; Watson, A. A.; Griffiths, R. C.; Butters, T. D.; Muller, M.; Watkin,  
 D. J.; Winkler, D. A.; Fleet, G. W. J. J. Chem. Soc., Perkin Trans. 1 1999, 2735-2745. 
6          Fan, J. Q.; Ishii, S.; Asano N.; Suzuki, Y. Nat. Med. 1999, 5, 112-115. 
7          a) Li, C. M.; Tyler, P. C.; Furneaux, R. H.;. Kicska, G.; Xu, Y. M.; Grubmeyer, C.; Girvin, M. E.;  
 Schramm, V. L. Nat. Struct. Biol. 1999, 6, 582-587. b) Miles, R. W.; Tyler, P. C.; Evans, G. B.;  
 Furneaux, R. H.; Parkin, D. W.; Schramm, V. L. Biochemistry 1999, 38, 13147-13154. 
8         Shibata, T.; Nakayama, O.; Tsurumi, Y.; Okuhara, M.; Terano, H.; Kohsaka, M. J. Antibiot. 1988,  
 41, 296–301. 
9  Chu, C. K., Baker, D. C., Eds.; Nucleosides and Nucleotides as Antitumor andAntiviral Agents;. Plenum  
             Press: New York, 1993. 
10  Townsend, L. B., Ed., Chemistry of Nucleosides and Nucleotides. Plenum Press:New York, 1988. 
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of nucleoside derivatives that can lead to promising chemotherapeutic agents.F11F These 
compounds have attracted much attention as potential antiviral and anticancer agents.F12F  
 
Since the latter part of the 1980s, nucleoside analogs have been investigated with 
renewed urgency in the search for effective agents against the human immunodeficiency 
virus (HIV), the causative agent of the AIDS epidemic, in addition to more effective 
treatment for other viral infections which can prove lethal to AIDS patients and other 
immuno-compromised individuals.F13F,F14 
 
Acyclic nucleosides consist of a familly of nucleosides with a disconnected chain 
resulting from the omission of bonds from the pentose or cyclopentane rings. 
Acyclic nucleoside phosphonatesF15F possess a phosphonate group attached to the 
acyclic nucleoside moiety through a stable P-C bond. In contrast to the phosphate group 
(which is attached through a P-O-C bond), a phosphonate group (P-C bound) cannot be 
cleaved off by cellular hydrolases (esterases). Foremost among the acyclic nucleoside 
phosphonates that have been pursued as antiviral agents are cidofovir (HPMPC) [(S)-1-
(3-hydroxy-2-phosphonylmethoxypropyl)cytosine], adefovir (PMEA) [9-(2-
phosphonylmethoxyethyl)adenine], and tenofovir (PMPA) [(R)-9-(2-
phosphonylmethoxypropyl) adenine] (Figure 1.2). 
                                                 
11  a) Ferrero, M.; Gotor, V. Chem. Rev. 2000, 100, 4319–4347.b) Kool, E. T. Chem. Rev. 1997, 97, 1473– 
       1487. 
12  a) Vince, R.; Hua, M. J. Med. Chem. 1990, 33, 17–21. b) Ozaki, S.; Akiyama, T.; Ike, Y.; Mori, H.; Hoshi,  
 A. Chem. Pharm. Bull. 1990, 37, 3405–3417. 
13  a) Pannecouque, C.; Busson, R.; Balzarini, J.; Claes, P.; De Clercq, E.; Herdewijn, P. Tetrahedron 1995, 51,  
 5369–5380. b) Pannecouque, C.; Van Poppel, K.; Balzarini, J.; Claes, P.; De Clercq, E.; Herdewijn, P.  
 Nucleos. Nucleot. 1995, 14, 541–544. c) Herdewijn, P.; Balzarini, J.; Pauwels, R.; Janssen, G.; Van  
 Aerschot, A.; De Clercq, E. Nucleos. Nucleot. 1989, 8, 1231–1257. d) Lin, T.; Zhou, R.-X.; Scanlon, K. J.;  
 Brubaker, W. F., Jr.; Lee, J. J. S.; Woods, K.; Humphreys, C.; Prusoff, W. H. J. Med. Chem. 1986, 29, 681– 
 686. e) Lin, T.-S.; Prusoff, W. H. J. Med. Chem. 1978, 21, 109–112. 
14  Lavandera, I.; Fernández, S.; Ferrero, M.; Gotor, V. J. Org. Chem. 2001, 66, 4079–4082. 
15  De Clercq, E. Biochem. Pharmacol. 1991, 42, 963–972. 
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Figure 1.2. Structures of some acyclic nucleoside phosphonates 
1.1.3. Deoxyglycosides 
Glycoconjugates form a complex group of biomolecules with an unsurpassed 
structural diversity, performing a variety of biological functions. They play thereby a 
fundamental role in the development, growth, and functioning of cells and living 
organisms.F16F Their almost omnipresent occurrence has generated great interest in 
biology and chemistry. Thus, development of carbohydrate-based therapies has 
increased the demand for plenty quantities of pure oligosaccharides. However, their 
isolation from natural sources is very difficult, involving tedious purifications, and it 
only provides small quantities of material that often lacks the required degree of purity 
for detailed biochemical studies. Therefore, the synthesis of polysaccharides having 
defined structures has become an important field of research.F17 
Glycoproteins with N-glycans found on cell surfaces and in the blood serum play 
important roles in many biological events such as cell-cell adhesion, immune system 
modulation, and signal transduction. Subtle changes of the carbohydrate moieties may 
result in completely altered functionality of the glycoproteins. Therefore, asparagine 
linked N-glycans have gained intensive investigations.F18FActually, only a few of these 
oligosaccharides can be isolated from natural sources due to their microheterogeneity.F19F 
                                                 
16   Varki, A. Glycobiology, 1993, 3, 97–130.   
17  a) Weijers, C. A. G. M.; Franssen, M. C. R.; Visser, G. M. Biotech. Adv. 2008, 26, 436–456. b) Pukin, A. V.;  
 Weijers, C. A. G. M.; van Lagen, B.; Wechselberger, R.; Sun, B.; Gilbert, M.; Karwaski, M. F.; Florack, D.  
 E. A.; Jacobs, B. C.; Tio-Gillen, A. P.; van Belkum, A. F.; Endtz, H. P.; Visser, G. M.; Zuilhof, H.  
 Carbohydr. Res. 2008, 343, 636–650. (c) Hölemann, A.; Seeberger P. H. Curr. Opin. Biotechnol. 2004, 15,  
 615–622. d) Koeller, K. M.; Wong. C. H. Glycobiology, 2000, 10, 1157–1169.   
18  Varki, A.; Cummings, R. D.; Esko, J. D.; Freeze, H. H.; Stanley, P.; Bertozzi, C. R.; Hart, G. W.; Etzler, M.  
 E.; Eds. Essentials of Glycobiology, 2nd ed.; Cold Spring Harbor Laboratory Press: NY, 2009.   
19      a) Endo, T. J. Chromatogr. A. 1996, 720, 251–261. b) Rice, K. G. Anal. Biochem. 2000, 283, 10–16.   
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These circumstances have stimulated the chemical synthesis of N-glycans as a method 
to provide sufficient quantities for further research.F20 
2-Deoxy- and 2,6-dideoxyglycosides are structural units present in many natural 
products. Deoxysugars are defined carbohydrates with a substitution of one or more of 
the hydroxylic groups by another heteroatom or hydrogen. These compounds present 
varied interesting biological properties, among which we hightlight that as antitumor 
agents (anthracyclines like Cyclamycine 0, angucyclines like Landomycine A and 
indolocarbazole glycosides like the antibiotic AT2433-A1 (Figure 1.3).F21F Although the 
pharmacological effect of these compounds is associated to the aglycone moiety, the 
oligosaccharidic part is essential for the biological activity because it influences the 
pharmacokinetic properties, and participates in the molecular recognition. Removing 
deoxysugars from these clinically important molecules often severely decreases their 
efficiency and/or specificity.F22F Due to this biological relevance, the development of 
methods for the efficient, chemo- and stereoselective construction of glycosidic linkages 
in deoxyglycosides has useful applications in medicinal and bioorganic chemistry by 
further understanding the biological mechanisms and elaborate new and less toxic 
drugs. 
                                                 
20      a) Ogawa, T.; Sugimoto, M.; Kitajima, T.; Sadozai, K. K.; Nukada, T. Tetrahedron Lett. 1986, 27, 5739– 
 5742. b) Nukada, T.; Kitajima, T.; Nakahara, Y.; Ogawa, T. Carbohydr. Res. 1992, 228, 157–170.   
21      Chisholm, J.D.; Van Vranken, D.L.  J. Org. Chem. 2000, 65, 7541–7553. 
22     Kren, V.; Martínková, L. Curr. Med. Chem. 2001, 8, 1313–1338.   
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Figure 1.3.. Examples of natural compounds with 2,6-dideoxyoligosaccharide units. 
1.2. Background 
1.2.1. Synthesis of Allyl Amines by Pd-catalyzed Asymmetric Allylic Alkylation 
Transition metal-catalyzed Asymmetric Allylic Alkylation (AAA) reactions have 
proven to be extremely useful and versatile synthetic transformations. Transition metals 
such as iron, cobalt, nickel, molybdenum, ruthenium, rhodium, tungsten and platinum 
have been used for this purpose.F23F However, iridium,F24F palladiumF25F and copperF26F have 
                                                 
23  For selected publications see : a) Trost, B. M. J. Org. Chem. 2004, 69, 5813–5837. b) Mori, M. Chem. Pharm.  
 Bull. 2005, 53, 457-470. c) Trost, B. M.; Crawley. Chem. Rev. 2003, 103, 2921-2943. d) Belda, O.; Moberg,  
 C. Acc. Chem. Res. 2004, 37, 159–167. e) Sawamura, M.; Ito, Y. Chem. Rev. 1992, 92, 857-871. f) Trost, B.  
 M. Pure. Appl. Chem. 1996, 68, 779–784.  
24  For selected publications see: a) Ohmura, T.; Hartwig, J. F. J. Am. Chem. Soc. 2002, 124, 15164–15165.  
 b) Takeuchi, R.; Ue, N.; Tanabe, K.; Yamashita, K.; Shiga, N. J. Am. Chem. Soc. 2001, 123, 9525–9534. c)  
 Kiener, C. A.; Shu, C. T.; Incarvito, C.; Hartwig, J. F. J. Am. Chem. Soc. 2003, 125, 14272-14273. d) Janssen,  
J. P.; Helmchen, G. Tetrahedron Lett. 1997, 38, 8025–8026. e) Garcia-Yebra, C.; Janssen, J. P.; Rominger, 
F.; Helmchen, G. Organometallics 2004, 23, 5459–5470. f) Lipowsky, G.; Miller, N.; Helmchen, G. Angew.  
 Chem., Int. Ed. 2004, 43, 4595–4597. 
25   For selected publications see: a) Trost, B. M.; Machacek, M. R.; Aponick, A. Acc. Chem. Res. 2006, 39, 747– 
 760. b). Trost, B. M.; Horne, D. B., Woltering, M. J. Chem. Eur. J. 2006, 12, 6607–6620.  
 2006, 45, 5246-5248. d) Hirakawa, T.; Ikeda, K.; Ogasa, H.; Kawatsura, M.; Itoh, T. Synlett 2010, 19, 2887– 
 2890. e) Shi, C.; Chein, C.-W.; Ojima, I. Chem. Asian J. 2011, 6, 674–680.  
26  For selected publications see: a) Falciola, C. A.; Alxakis, A. Eur. J. Org. Chem. 2008, 3765–3780. b) Geurts,  
 K.; Fletcher, S. P.; Van Zijl, A. W.; Minnaard, A. J.; Feringa, B. L. Pure Appl. Chem. 2008, 80, 1025–1037. 
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been more extensively used. Among them, palladium has so far proven to be the most 
versatile metal catalyst for these transformations because its easy manipulation, high 
catalytic activity and high enantioselectivity. Scheme 1.1 shows the catalytic cycle 
accepted for the Pd-catalyzed allylic alkylation. 
 
Scheme 1.1. Catalytic cycle of the Pd-catalyzed allylic alkylation 
 
Catalytic asymmetric allylic alkylation differs from virtually all other catalytic 
processes in two important ways. In the first, there are many enantiodiscriminating 
mechanisms, not just one. As shown in Scheme 1.2, there are at least five such 
mechanisms.F27F As in most other catalytic asymmetric reactions, differentiating the 
enantiotopic faces of a π-unsaturation is one mechanism (Scheme 1.2, A). A second 
mechanism is differentiating enantiopic leaving groups (Figure 1.5, B). Mechanism C 
involves differentiating enantiotopic termini of a π-allylmetal intermediate. Since this 
intermediate derives from a chiral racemic precursor in which the chirality of the 
substrate is lost, this deracemization constitutes a dynamic kinetic asymmetric 
transformation (DYKAT). Mechanism D is a variant of mechanism A wherein the π-
allylmetal intermediates interconvert faster than they are attacked by a nucleophile and 
asymmetric induction derives from differential rates of reaction of the two 
diastereomeric intermediates. This mechanism allows employment of either an achiral 
precursor or a racemic chiral precursor, the latter then corresponding to a DYKAT. All 
of the foregoing involves creation of chirality at the π-allyl fragment. Mechanism E 
involves discriminating between the enantiotopic faces of the nucleophile. 
                                                 
27         Trost, B. M. Chem. Pharm. Bull. 2002, 50, 1–14 
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Scheme 1.2. Various Enantiodiscriminating Events in AAA27 
DYKAT through rapid π−σ−π interconversion of intermediatesF28 
This process relies on the rapid interfacial exchange of the allyl ligand through a 
π−σ−π interconversion. Oxidative addition with inversion of each substrate enantiomer 
initially forms two diastereomeric π-allyl-Pd(II) intermediates (Scheme 1.3). With a 
                                                 
28  a) Trost, B. M.; Fandrick, D. R. Aldrichimica Acta 2007, 40, 59–72. b) Trost, B. M.; Bunt, R. C.; Lemoine, 
R. C.; Calkins, T. L. J. Am. Chem. Soc. 2000, 122, 5968–5976. c) Eliel, E. L.; Wilen, S. H. Stereochemistry 
of organic compounds. Wiley Interscience. 1992. 
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chiral catalyst, a rate difference in the oxidative addition is expected, and a DYKAT 
occurs with complete comsumption of the mismatched substrate. Asymmetric induction 
results from the preferential alkylation of one diastereomer intermediate over the other. 
Accordingly, high enantioselectivity is achieved when, in addition to a selective 
alkylation (k1>>>k2), a Curtin-Hammett condition is established wherein 
interconversion is rapid and succesfully competes with nucleophilic addition. Another 
requirement for this type of DYKAT is the existence of identical geminal substituents 
on one side of the allyl ligand. If one of the terminus of the allyl ligand is substituted 
with diferent geminal groups, then the π−σ−π interconversion will result in a 
geometrical isomerization of the allyl ligand. These π-allylPd(II) intermediates cannot 
“racemize” through a π−σ−π mechanism. Further complicating the alkylation with 
unsymmetrical substrates is alkylation at the diferent termini, which leads to 
regioisomers. Regioselectivity in the AAA has been achieved by both substrate and 
catalyst control. Although the chiral catalyst provides a significant preference for a 
regioselective alkylation of one diastereomeric intermediate, optimization of the 
reaction conditions is often necessary to establish the Curtin-Hammett situation for 
asymmetric induction. 
 
Scheme 1.3. DYKAT through a π−σ−π-interconversion 
 
A versatil substrate for the palladium-catalyzed dynamic kinetic alkylation AAA 
is vinyl epoxide, which, due to the ring strain, promotes the oxidative addition and 
consumption of the mismatched enantiomer required for a DYKAT. Suitable vinyl 
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epoxides have geminal hydrogens or other identical geminal substituents on the olefin 
terminus, enabling a Curtin-Hammett condition to be established through a rapid π−σ−π 
interconversion. In the π−allylPd(II) intermediates, the alcohol or alkoxide can direct 
the alkylation for the branced products typically through hydrogen bonding or other 
convalent interaction with the incoming nucleophile (Scheme 1.4). 
 
Scheme 1.4. Regioselectivity of the AAA by substrate control using vinyl epoxide 
Vinyl epoxides have shown a broad utility in Pd-catalyzed DYKAT with 
oxygenF29F, carbonF30F and some nitrogenF31F  nucleophiles. As far as the reactant is 
concerned, nitrogen nucleophiles have generally presented challenges in several aspects. 
First, double alkylation frequently occurs with primary amines since the product, a 
secondary amine, is more nucleophilic than the starting material, leading to mixtures of 
products. Second, regioselectivity of the substitution with unsymmetrical allyl systems 
can be a significant problem and frequently mixtures of products are obtained. 
In the palladium-catalyzed process of butadiene monoepoxide, Trost and co-
workers studied different nucleophiles that could coordinate to the leaving group in 
order to improve the regioselectivity. In this sense, sulfonamide and imide  nucleophiles 
have been effectively employed, in particular, phthalimide, an excellent primary amine 
surrogate, has shown to provide more enantioselection than other imido nucleophiles.  
                                                 
29  Trost, B. M.; McEachern, E. J.; Toste, F. D. J. Am. Chem. Soc. 1998, 120, 12702–12703. 
30   Trost, B. M.; Jiang, C. J. Am. Chem. Soc. 2001, 123, 12907–12908. 
31   A) Trost, B. M.; Bunt, R.C.; Lemoine, R.C.; Calkins, T.L. J. Am. Chem. Soc. 2000, 122, 5968–5976. b) 
Trost, B. M.; Calkins, T. L.; Oertelt, C.; Zambrano, J. Tetrahedron Lett. 1998, 39, 1713–1716. 
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Figure 1.4. Chiral ligands developed by Trost for asymmetric allylic transformations 
 
As for the chiral ligand used in these processes, although BINAP-based ligands 
have been examined for the DYKAT of vinyl epoxides,F32F high enantioselectivities for 
the intermolecular addition of nucleophiles to vinyl epoxides typically required the use 
of diphenylphosphinobenzoic acid (DPPBA) derived ligands. Thus, the ligands studied 
by Trost and col. (Figure 1.4) in order to effect this transformation were designed taking 
into account the following issues: i) creating a chiral space with an array of groups 
whose conformational bais originate from primary stereogenic centers; ii) electronic 
desymmetrization on the donor atoms of the ligand where different bond lengths on 
each side of the chiral space promote different reactivity at each terminus. These 
reactions allowed the use of a broad range of nucleophiles and enabled application of 
this approach to numerous total syntheses. The AAA of butadiene monoepoxide (1.13) 
with phthalimide 1.14 provided 2-(S)-N-phthalimido-3-buten-1-ol (1.15) (Scheme 1.5) 
in high regioselectivity, enantioselectivity (>98%) and yield (99%).F33F The obtained 
                                                 
32  a) Hayashi, T.; Yamamoto, a.; Ito, Y. Tetrahedron Lett. 1988, 29, 99. b) Larksarp, C.; Alper, H. J. Am. Chem. 
Soc. 1997, 119, 3709-3715. 
33   a) Trost, B. M.; Horne, D. B.; Woltering, M. J. Angew. Chem. Int.  Ed. 2003, 42, 5987–5990. b) Harris, M. C.  
 J.; Jackson, M.; Lennon, I. C.; Ramsden, J. A.; Samuel, H. Tetrahedron Lett. 2000, 41, 3187–3191. c) Trost,  
 B. M.; O’Boyle, B. M. Org. Lett. 2008, 10, 1369-1372. d) Trost, B. M.; Lemoine, R. C. Tertrahedron 1996,  
 37, 9161–9164.  
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intermediate 1.15 is a useful starting material in the synthesis of different natural 
products.X27X  
 
  
 Scheme 1.5. Synthesis of 2-(S)-N-phthalimido-3-buten-1-ol (1.15) 
 
Vinylglycinol 1.17 was obtained directly via palladium-catalyzed allylic 
substitution from butadiene monoepoxide (1.13) using 2 mol% of [(η3-C3H5)PdCl]2, 6% 
of (R,R)-DACH-Naphtyl using the corresponding imide 1.16 to afford the desired 
compound in an 98% yield and 97% ee (Scheme 1.6).F34 
N
H
O
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O N
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H
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NHHN
O O
PPh2 Ph2P
1.17
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1.10
6 mol % (R, R)
2 mol% [( 3-C3H5)PdCl]2
DCM, 35ºC, 18h
1.16
 
Scheme 1.6. Synthesis of (S) –ter-butyl-1-benzoyloxybut-3-ene-2-yl-carbamate (1.19) 
The initial proposal by Trost was that a hydrogen-bonding interaction between the 
alkoxide of the π-allylPd(II) intermediate and the nucleophile would direct the 
alkylation. Reactions with triphenylphosphine still favored the branched product with a 
slightly lower regioselectivity (4:1 branched/linear). Without directing effects, the linear 
product is favored due to alkylation at the least sterically hindered position. Therefore, 
both the substrate and catalyst contribute to the high regioselectivity observed in the 
DYKAT. 
                                                 
34   Trost, B. M.; Fandrick, D. R.; Brodmann, T.; Stilles, D. T. Angew. Chem. Int. Ed. 2007, 46, 6123–6125. 
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The asymmetric induction obtained in the allylic alkylations with DPPBA ligands 
is rationalized by the preferential ionization and alkylation occurring under a flap in the 
“nun’s hat” model (Scheme 1.7).F35F In this model, the walls represent the chiral space 
created by the propeller-like array of the phenyl rings; the raised flaps represent the 
phenyls which lie in a plane approximately parallel to the allyl, while the lowered flaps 
represent the phenyls which are somewhat perpendicular to the allyl. Minimizing any 
steric interactions between the approaching nucleophile and the chiral ligand also 
directs it to approach from the front left quadrant. On the other hand, the ligand must 
afford a chiral environement in which one of the diastereomeric π-allyl complex is 
favoured, being both diastereomeric species equilibrated faster than nucleophilic attack 
to achieve a dynamic kinetic asymmetric transformation. The matched alkylation of the 
mismatched intermediate would favor the linear product, and the matched-intermediate 
matched alkylation would favor the branched product (Scheme 1.7). Halide additives 
increase the rate of the necessary interconversion,F36F and improve the regioselectivity by 
promoting the necessary Curtin-Hammett condition, thus allowing for the prefrerred 
matched alkylation of the matched intermediate. 
 
Scheme 1.7. Rationalization of the Regioselectivity in the alkylation with DPPBA 
ligands 
 
 
                                                 
35    a) Trost, B. M.; Toste, F. D. J. Am. Chem. Soc. 1999, 121, 4545–4554. b) Hayashi, T.; Kawatsumura, M.;  
 Uozumi, Y. J. Am. Chem. Soc. 1998, 120, 1681–1687.  
36  Burckhardt, U.; Baumnann, M.; Togni, A. Tetrahedron: Asymmetry 1997, 8, 155-159. 
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1.2.2. Cross-metathesis reaction  
Olefin metathesis transformation entails a redistribution of alkylidene fragments 
by the scission of carbon-carbon double bonds in two olefin moieties. It can be used in 
five closely related types of reactions: cross metathesis (CM), ring-opening metathesis 
polymeration (ROMP), ring-closing metathesis (RCM), acyclic diene metathesis 
polymerization (ADMET) and ring-opening metathesis (ROM) (Scheme 1.8). 
CM
RCM
ROMP
R
R'
R
R'
+
n
+
+
n
n +
ADMET
ROM
R'
+
R'
 
 
Scheme 1.8. Types of olefin metathesis 
Over the years, olefin cross metathesis (CM) has become a powerful method for 
the formation of carbon-carbon double bondsF37F while reducing formation of undesired 
self metathesis product. In comparison with the classical olefination Wittig reaction, 
cross metathesis reaction is an economical atom reaction since ethylene is the secondary 
product. Moreover, contrary to other cross-coupling processes, such as Stille or the 
Miyaura-Suzuki reactions, in cross-metathesis no sophisticated coupling partners need 
to be prepared.F38F  
The first metallic systems used in metathesis reactions consisted on transition 
metal salts combined with main group alkylating agents or deposited on solid supports. 
The classic combinations include WCl6/Bu4Sn, WOCl4/EtAlCl2, MoO3/SiO2 and 
Re2O7/Al2O3, among many others. The utility of these catalysts were limited by the 
harsh conditions and the strong Lewis acids required. Many mechanistic proposals have 
                                                 
37   Cossy, J.; Arseniyadis, S.; Meyer, C. Metathesis in Natural Product Synthesis, 2010, Willey-VCH,  
 Weinheim. 
38  Grubbs, R. H. Handbook of Metathesis 2, 2009, Willey-VCH, Weinheim.  
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been suggested for this reaction over the years, but the one proposed by Chauvin was 
found to be the most consistent with the experimental evidences and it remains the 
generally accepted mechanism. Chauvin proposed that olefin metathesis involves the 
interconversion of an olefin and a metal alkylidene. This process is believed to occur via 
a metallacyclobutane intermediate by alternating [2+2] cycloadditions and 
cycloreversions (Scheme 1.9).F39F  
 
 
Scheme 1.9. Mechanism of olefin metathesis proposed by Chauvin 
The first single-component homogeneous catalyst for olefin metathesis was 
developed during the late 1970s and early 1980s and involved alkoxide-alkylidene 
tungsten complexes. These new catalysts included [(CO)5W=CPh2],F40F 
bis(cyclopentadienyl)titanocyclobutanesF41F and various dihalo-alkoxide-alkylidene 
complexes of tungsten.F42F,F43F As well-defined complexes, these catalysts exhibited better 
initiation times and higher activity under milder conditions than ever before. The 
molybdenum and tungsten alkylidenes with the general formula (NAr)(OR’)2M=CHR 
were the first of these catalysts to become widely used, in particular the molybdenum 
complex 1.18 or the more active 1.19 (Figure 1.6) developed by Schrock and co-
workers.F44F,F45F These catalysts and others based on the early transition metals are highly 
                                                 
39  Hérrison, J. L.; Chauvin, Y. Makromol. Chem. 1971, 141, 161–176 
40   a) Katz, T. J.; Sivavec, T. M. J. Am. Chem. Soc. 1985, 107, 737–738. b) Katz, T. J.; Lee, S. J.; Acton, N.  
 Tetrahedron Lett. 1976, 47, 4247–4250. 
41   Grubbs, R. H.; Tumas, W. Science 1989, 243, 907–915 
42   Wallace, K. C.; Liu, A. H.; Dewan, J. C.; Schrock, R. R. J. Am. Chem. Soc. 1988, 110, 4964–4977. 
43   a) Kress, J.; Osborn, J. A.; Greene, R. M. E.; Ivin, K. J.; Rooney, J. J.  J.Am. Chem. Soc. 1987, 109, 899–901.  
 b) Kress, J.; Aguero, A.; Osborn, J. A. J. Mol. Catal. 1986, 36, 1–12. c) Quignard, F.; Leconte, M.; Basset, J.- 
 M. J. Chem. Soc., Chem. Commun. 1985, 1816–1817. 
44  a) Bazan, G. C.; Oskam, J. H.; Cho, H.-N.; Park, L. Y.; Schrock, R.R. J. Am. Chem. Soc. 1991, 113, 6899– 
 6907. b) Bazan, G. C.; Khosravi, E.; Schrock, R. R.; Feast, W. J.; Gibson, V. C.; O’Regan, M. B.; Thomas, J.  
 K.; Davis, W. M. J. Am. Chem. Soc. 1990, 112, 8378–8387. c) Schrock, R. R.; Murdzek, J. S.; Bazan, G. C.;  
 Robbins, J.; DiMare, M.; O’Regan, M. J. Am. Chem. Soc. 1990, 112, 3875–3886. d) Schrock, R. R.; Feldman,  
 J.; Cannizzo, L. F.; Grubbs, R. H. Macromolecules 1987, 20, 1169–1172. 
45  For reviews of this area, see: (a) Schrock, R. R. Tetrahedron 1999, 55, 8141-8153. (b) Schrock, R. R. Acc.  
 Chem. Res. 1990, 23, 158–165. 
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active, long-lived catalyst systems and do not require Lewis acidic co-catalyst or 
promoters. However, they show moderate to poor functional group tolerance, high 
sensibility to air and moisture or even to trace impurities present in solvents, thermal 
instability on storage and they suffer from expensive preparation.  
The ruthenium vinylidene complex (PCy3)2(Cl)2Ru=CHPh (1.20) (Figure 1.5) has 
been used extensively in organic chemistry due to its high reactivity with olefinic 
substrates in the presence of most common functional groups.F46F  
 
Figure 1.5. Schrock, Grubbs and Hoveyda-Grubbs catalysts  
The mechanism of olefin metathesis reactions catalyzed by ruthenium complex 
1.24 and its analogues has been the subject of an intense experimental and theoretical 
investigation, with the ultimate goal of facilitating the rational design of new catalysts 
displaying higher activity, stability and selectivity.  
As illustrated in Scheme 1.10, the first step involves olefin coordination to the 
metal center, presumably cis to the alkylidene and concominant phosphine dissociation. 
In one possible pathway (Scheme 1.10, A), alkylidene rotation occurs in order to 
generate the intermediate, in which the olefin remains cis to the alkylidene. This 
intermediate then undergoes metallocyclobutane formation cis to the bound phosphine, 
followed by cleavage to release the metathesis products. An alternative pathway 
(Scheme 1.10, B) involves phosphine dissociation and rearrangement of the olefin trans 
                                                 
46  Trnka, T. M.; Grubbs, R. H. Acc. Chem. Res. 2001, 34, 18–29.  
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to the remaining phosphine. Then, this intermediate 1.26 undergoes metallacyclobutane 
formation trans to the phosphine 1.27.  
Ru
PCy3
Cl
PCy3
RCl
Ru
Cl
PCy3
RCl
R'
Ru
Cl
PCy3
Cl
R
Ru
Cl
PCy3
RCl
R'
Ru
Cl
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Cl R
products
products
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1.24 1.25
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Pathway B
1.26 1.27
R
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Scheme 1.10. Proposed mechanism of olefin metathesis for (PCy3)2Cl2Ru=CHR   
Early mechanistic studies of the catalyst established that phosphine dissociation is 
a critical step along the olefin metathesis reaction. Catalysts containing sterically bulky 
and electron-donating phosphine ligands have been demostrated led to display the 
highest catalytic activity. This trend was explained on the basis of the increased trans-
effect of larger and more basic/donating phosphines. One of the contributions of the 
phosphine ligands is σ-donation to the metal center, which promotes the formation of 
the mono-(phosphine) olefin complex by facilitating phosphine dissociation and 
stabilizing the vacant trans site. Even more importantly, σ-donation helps to stabilize 
the 14-electron metallacyclobutane intermediate. The steric bulk of the ligands may also 
contribute to phosphine dissociation by destabilizing the crowded bis(phosphine) olefin 
complex. 
On the basis of these important studies, a new class of ruthenium alkylidenes 
containing N-heterocyclic carbenes ligands (NHC) (1.21-1.22) has been developed 
(Figure 1.5), which are significantly larger and more electron donating than 
trialkylphosphines. This second generation of ruthenium olefin metathesis catalysts 
exhibit dramatically increased reactivity with olefin substrates. The high activity of the 
N-heterocyclic carbene has previously been attributed to its ability to promote 
phosphine dissociation.F47F, F48 
                                                 
47  Sanford, M. S.; Ulman, M.; Grubbs, R. H. J. Am. Chem. Soc. 2001, 123, 749–750. 
48  Khan, R. K. M.; O´Brien, R. V.; Li. B.; Hoveyda, A. H. J. Am. Chem. Soc. 2012, 134, 12774–12779. 
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Olefin metathesis has become a standard synthetic method because of the wide 
variety of applications. The activity and functional group tolerance of ruthenium 
catalyst is now sufficiently high for olefin metathesis to compete with more traditional 
carbon-carbon bond-forming methods. Unfortunately, ruthenium catalysts are limited 
by incompatibility with basic functional groups, notably nitriles and amines.  
In particular, attractive features of ruthenium-catalyzed cross metathesis 
olefination are: i) high E/Z-selectivity with good yield in the product, ii) functional 
group tolerance, iii) high activity providing high yields under mild conditions and iv) 
reasonable ability in the presence of amino functionality.F49F Minimization of 
unproductive alkenes from self-metathesis and consequently maximization of 
productive cross metathesis is a crucial issue to be optimized.  
This reaction has recently attracted widespread attention as a versatile and 
powerful tool for the construction of complex biologically active natural products.F50F In 
this context, E-selective cross-metathesis olefination has been used to synthesize 
compound 1.29, which has an E double bond in its skeleton (Scheme 1.11). Grubbs and 
co-workers observed that cross-metathesis between compounds like esters, aldehydes, 
and ketones and simple terminal olefins in the presence of Ru-catalyst proceeded in 
good to excellent yields with impressive E selectivity. The compound 1.28 afforded the 
desired  product  1.29 under cross-metathesis raction using Ru-catalyst.F51F  In spite of 
impressive advances accomplished during the past two decades, a number of unresolved 
issues limited the utility of catalytic olefin metathesis reactions,F52F among which a 
notable shortcoming was the lack of methods that selectively furnish Z alkenes.F53F 
Nearly all ring-opening/ cross-metathesis (ROCM) reactions catalyzed by Mo or Ru 
complexes afford E olefins exclusively or predominantly.F54F,F55F Only when the cross 
                                                 
49  Grubbs, R. H.; Chang, S. Tetrahedron 1998, 54, 4413–4450. 
50    Prunet, J. Curr. Topics Med. Chem. 2005, 5, 1559–1577. 
51    a) Chatterjee, A. K.; Choi. T. L.; Sanders, D. P.; Grubbs, R. H. J. Am. Chem. Soc. 2003, 125, 11360–11370.  
 b) Chatterjee, A. K. Morgan, J. P. Scholl, M. Grubbs, R. H . J. Am. Chem. Soc. 2000, 122, 3783–3784. 
52          Hoveyda, A. H.; Zhugralin, A. R. Nature 2007, 450, 243–251. 
53          Randall, M. L.; Tallarico, J. A.; Snapper, M. L. J. Am. Chem. Soc. 1995, 117, 9610–9611. 
54  Schrader, T. O.; Snapper, M. L. In Handbook of Metathesis; Grubbs, R. H., Ed.; Wiley-VCH: Weinheim,  
 Germany, 2003; 2, 205–245. 
55  a) La, D. S.; Sattely, E. S.; Ford, J. G.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2001, 123, 7767– 
 7778. b) Van Veldhuizen, J. J.; Gillingham, D. G.; Garber, S. B.; Kataoka, O.; Hoveyda, A. H. J. Am. Chem.  
UNIVERSITAT ROVIRA I VIRGILI 
ENANTISELECTIVE SYNTHESIS OF NATURAL PRODUCTS 
Mariam Azzouz 
General Introduction 
 
25 
 
partner bears an sp-hybridized substituent (acrylonitrile or an enyne) are Z alkenes, at 
times, favored.F56F Effective solution to the above critical problem reactions was recently 
provided in enantioselective ROCM reactions and required the development of 
structurally distinct catalysts based on an adamantyl-tetrahydroaryloxide-Mo 
complex,F57F which delivered Z olefins with selectivities that were previously entirely out 
of reach. These stereogenic-at-Mo monaryloxypyrrolides were also sucesfully used in 
the more challenging Z-selective olefin cross-metathesis reactions and applied to the 
syntheses of a variety of natural products.F58 
 
Scheme 1.11. Synthesis of compound (1.29) by a cross-metathesis reaction  
1.2.3. Dihydroxylation reaction 
Osmium-mediated dihydroxylation reaction is a widely used method in organic 
synthesis for the transformation of alkenes to 1,2-diols.F59F The asymmetric version 
expands this powerful reaction to the synthesis of chiral 1,2-diols.F60F A number of 
features have turned the osmium-catalyzed asymmetric dihydroxylation process into a 
powerful method for the asymmetric synthesis: i) the reaction is stereospecific leading 
to 1,2-cis-addition of two OH groups to the olefin, ii) it proceeds with high 
chemoselectivity, iii) the facial selectivity is readily predicted using a simple mnemonic 
device and exceptions are very rare, iv) it tolerates the presence of most organic 
functional groups, v) the diols are always derived from cis-addition and, side products, 
                                                                                                                                               
 Soc. 2003, 125, 12502–12508. c) Gillingham, D. G.; Kataoka, O.; Garber, S. B. J. Am. Chem. Soc. 2004, 126,  
 12288–12290. (d) Funk, T. W.; Berlin, J. M.; Grubbs,R. H. J. Am. Chem. Soc. 2006, 128, 1840–1846.  
 e) Cortez, G. A.; Baxter,C. A.; Schrock, R. R.; Hoveyda, A. H. Org. Lett. 2007, 9, 2871–2874. f) Gillingham,  
 D.  G.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2007, 46, 3860–3864. 
56  a) Crowe, W. E. Goldberg, D. R. J. Am. Chem. Soc. 1995, 117, 5162–5163. b) Randl, S. Gessler, S.  
 Wakamatsu, H. Blechert, S. Synlett 2001, 430–432. c) Hansen, E. C. Lee, D. Org. Lett. 2004, 6, 2035–2038. 
57          Ibrahem, I.; Yu, M.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 4592– 3844. 
58  Meek, S.J.; O’Brien, B.V.; Llaveria, J.; Schrock, R. R.; Hoveyda, A. H. Nature 2011, 471, 461 
59   a) Kolb, H. C.; VanNieuwenhze, M. S.; Sharpless, K. B. Chem. Rev. 1994, 94, 2483–2547. b) Français, A.;  
 Bedel, O.; Haudrechy, A. Tetrahedron 2008, 64, 2495–2524. 
60    Hentges, S. G.; Sharpless, K. B. J. Am. Chem. Soc. 1980, 102, 4263–4265. 
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such as epoxides or trans-diols are never observed, and vi) it usually exhibits a high 
catalytic turnover, allowing low catalyst loading and good yields.F61 
Chiral alkaloid derivatives coordinate to osmium tetraoxide through the nitrogen 
moiety providing a reaction acceleration and asymmetric induction.F62F In addition, the 
efficiency of the usually employed stoichiometric reoxidant such as N-methyl-
morpholine-N-oxide (NMO),F63F potassium ferricyanide (K3FeCN6),F64F or tert-butyl 
hydroperoxide (tBuOH)F65F favours the metal regeneration. The use of water as a solvent 
is necessary to facilitate the cleavage of the intermediate osmate esters 1.32, which is 
the determining step of the reaction and also CH3SO2NH2 leads to shorter reaction 
times.F66F  
Much effort has been made to envision the mechanistic features of this reactionF67F 
and two distinct reaction pathways were proposed to account for the formation of 
osmium glycolate 1.32.F68F i) a concerted reaction mechanism involving a pericyclic 
[3+2] transition state 1.30 (Scheme 1.12, pathway A) F69F and, ii) a stepwise route 
involving formation of an osmaoxetane 1.31 from formal [2+2] addition of the alkene to 
OsO4 followed by expansion of the metallacycle (Scheme 1.12, pathway B).F70F In this 
regard, computational studies support the metallaoxetane mechanism because of the 
minimum energy in that intermediate. F71 
 
                                                 
61   Beller, M.; Bolm, C. Transition Metals for Organic Synthesis, 2004, Wiley-CVH, 2, Weinheim.Kolb, H. C.;  
 Sharpless, K. B. 
62   a) Jacobsen, E. N.; Marko, I.; Mungall, W. S.; Schröder, G.; Sharpless, K. B. J. Am. Chem. Soc. 1988, 110,  
 1968–1970. b) Jacobsen, E. N.; Marko, I.; France, M. B.; Svendsen, J. S.; Sharpless, K. B. J. Am. Chem. Soc.  
 1989, 111, 737–739. 
63    VanRheenen, V.; Kelly, R. C.; Cha, D. Y. Tetrahedron Lett. 1976, 17, 1973–1976. 
64    Minato, M.; Yamamoto, K.; Tsujo, J. J. Org. Chem. 1990, 55, 766–768. 
65    Sharpless, K. B.; Akashi, K. J. Am. Chem. Soc. 1976, 98, 1986–1987. 
66    Sharpless, K. B.; Amberg, W.; Bennani, Y. L.; Crispino, G. A.; Hartung, J.; Jeong, K.-S.; Kwong, H.-L.;  
 Morikawa, K.; Wang, Z.-M.; Xu, D.; Zhang, X.-L. J. Org. Chem. 1992, 57, 2768–2771. 
67   Nelson, D. W.; Gypser, A.; Ho, P. T.; Kolb, H. C.; Kondo, T.; Kwong, H. L.; McGrath, D. V.; Rubin, A. E.;  
 Norrby, P.-O.; Gable, K. P.; Sharpless, K. B. J. Am. Chem. Soc. 1997, 119, 1840–1858. 
68    a) Ojima, I. Catalytic Asymmetric Synthesis, 2000, 402-406. Willey-VCH, 2nd edition, Canada. 
69    Corey, E. J.; Noe, M. C. J. Am. Chem. Soc. 1996, 118, 319–329. 
70    Norrby, P.-O.; Becker, H.; Sharpless, K. B. J. Am. Chem. Soc. 1996, 118, 35–42. 
71    Veldkamp, A.; Frenking, G. J. Am. Chem. Soc. 1994, 116, 4937–4946.  
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Scheme 1.12. Schematic representation of the concerted [3+2] mechanism (Path A)  
and the stepwise osmaoxetane mechanism (Path B) 
 
Dihydroquinine and dihydroquinidine, two pseudoenantiomeric alkaloids from 
cinchona, in combination with different spacers are the ligands of choice for this 
process.F72F The enantioselectivity is mainly influenced by the nature of the C9 
substituent. Initially, CLB (1.35) (p-chlorobenzoate), MEQ (4-methyl-2-quinolil) (1.36) 
and PHN (phenanthryl ether) (1.37) were used as spacers (first generation), however, 
second generation spacers which are bonded to two chiral ligands such as PHAL (1.38) 
(phthalazine), Pyr (pyrimidine) (1.39) and AQN (anthraquinone) (1.40) are preferently 
used (Figure 1.6).  
 
                                                 
72  (a) Sharpless, K. B.; Amberg, W.; Bennani, Y. L.; Crispino, G. A.; Hartung, J.; Jeong, K.-S.; Kwong, H. L.;  
 Morikawa, K.; Wang, Z.-M.; Xu, D.; Zhang, X.-L. J. Org. Chem. 1992, 57, 2768–2771. (b) Sharpless, K. B.;  
 Amberg, W.; Beller, M.; Chen, H.; Hartung, J.; Kawanami, Y.; Lübben, D.; Manoury, E.; Ogino, Y.; Shibata,  
 T.; Ukita, T. J. Org. Chem. 1991, 56, 4585–4588. (c) Crispino, G. A.; Jeong, K.-S.; Kolb, H. C.; Wang, Z.- 
 M.; Xu, D.; Sharpless, K. B. J. Org. Chem. 1993, 58, 3785–3786. 
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Figure 1.6. Cinchone ligands 
 
Mechanistic studies revealed the presence of a secondary catalytic system as the 
culprit of the low enantioselectivities found in osmium-catalyzed dihydroxylation. This 
secondary cycle proceeds with poor-to-no face selectivity, since it does not involve the 
chiral ligand (Scheme 1.13).  The desired path involves the hydrolysis of 1.42 to OsO4 
and the optically active 1,2-diol, whereas the undesired cycle is entered when 1.42 
reacts instead with a second molecule of olefin, yielding the osmium (VI) bisglycolate 
1.44 and thence 1,2-diol of low enantiopurity.F73F The use of K3Fe(CN)6 in combination 
with heterogeneous solvent systems, typically tert-butanol/water, allows an olefin 
osmylation and osmium re-oxidation steps uncoupled, since they occur in different 
phases. The osmylation takes place in the organic layer, giving rise to the osmium (VI) 
glycolate 1.42. This osmium(VI) complex cannot be oxidized to an osmium(VIII) 
glycolate, because of the absence of the inorganic stoichiometric oxidant K3Fe(CN)6 in 
the organic layer. Consequently, the second catalytic cycle cannot occur. This reaction 
requires hydrolysis of the osmium (VI) glycolate 1.43 to the 1,2-diol and a water 
soluble inorganic osmium(VI) species, which enters to the basic aqueous layer ready to 
be oxidized by K3Fe(CN)6 to OsO4. 
 
                                                 
73    Wai, J. S. M.; Markó, I.; Svendsen, J. S.; Finn, M. G.; Jacobsen, E. N.; Sharpless, K. B. J. Am. Chem. Soc.  
 1989, 111, 1123–1125.  
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Scheme 1.13. Proposed catalytic cycle in osmium-catalyzed dihydroxylation 
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2. Objectives 
 
The research described in this thesis aims to investigate new methods for the 
stereoselective synthesis of antibiotic  AT-2433-A1, Nectrisine and analogues of  
Cidofovir  based on new enantio-, stereo- and diastereoselective methods catalyzed by 
transition metal complexes (Scheme 2.1).  
 
Figure 2.1. Structures of AT2433-A1, nectrisine and cidofovir analogues 
In this context, the specific objectives of the present work are the following: 
2.1. Enantioselective synthesis of the glycosidic moiety of AT-2433-A1, 
Nectrisine and analogues of Cidofovir based on the following key reactions: 
          -Enantioselective synthesis of the key synthon allylamine by asymmetric 
palladium-catalyzed allylic amination of racemic vinyloxirane with different imido 
nucleophiles through a Dynamic Kinetic Asymmetric Transformation (DYKAT). 
         - Study of the ruthenium-catalyzed cross-metathesis reaction of the 
previously prepared allyl amines with alkenes, in order to obtain different synthetic 
precursors of target natural products.  
        - Optimization of the dihydroxylation reaction as one of the key steps in the 
proposed synthesis of antibiotic AT-2433-A1 and Nectrisine. 
In addition, the following issues will be addressed: 
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2.2. Study of the deprotection and cyclization reaction conditions of the allylic 
amine intermediate in order to complete the synthesis of the Nectrisine. 
2.3. To study hydrogenation reaction for obtaining acyclic nucleoside 
phosphonates analogues. 
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3.1. Introduction 
 
Oligosaccharides have been shown to play important roles in a large number of 
biological recognition events that range from cell–cell communication, fertilization, and 
cell differentiation, to pathological processes including cancer metastasis, and 
inflammation.F74F Iminoanalogues of sugars (also known as azasugars) are known to 
behave as glycosidaseF75F or glycosyltransferaseF76F inhibitors by acting as transition state 
mimics, where the flattened pyrrolidine ring and protonated nitrogen mimic the 
distorted structure of the glycosyl cation intermediate (Figure 3.1).F7787 
 
Figure 3.1. Structure of the glycosyl cation intermediate 
 
Hence, this class of sugar mimetics offers therapeutic potential in areas such as 
inflammatory diseases, lysosomal storage disorders, and cancer.F78F Two of these 
iminosugars are the pyrrolidine 1,4-dideoxyimino-D-arabinitol (DAB-1) (3.1)F79F and the 
polyhydroxylated dihydropyrrole nectrisine (FR 900483) (3.2)F80F (Figure 3.2). These 
compounds are extremely potent α-glucosidase inhibitors [IC50 1.8×10−7 and 4.8×10−8 
M, respectively (yeast α-glucosidase)] (Figure 3.2).F81  87 
 
                                                 
74  a) Bertozzi, C. R.; Kiessling, L. L. Science 2001, 291, 2357–2364. b) Yarema, K. J.; Bertozzi, C. R. Curr.   
 Opin. Chem. Biol. 1998, 2, 49–61. c) Dwek, R. A. Chem. Rev. 1996, 96, 683–720. 
75   Legler, G. In Iminosugars as Glycosidase Inhibitors; Stutz, A. E., Ed.; Wiley-VCH: New York, 1998;  
 Chapter 3. 
76     Compain, P.; Martin, O. R. Curr. Top. Med. Chem. 2003, 3, 541–560. 
77       McGarvey, G. J.; Wong, C.H. Liebigs Ann./Rec. 1997, 1059–1074.  
78     a) Asano, N. Curr. Top. Med. Chem. 2003, 3, 471–484. b) Butters, T. D.; Dwek, R. A.; Platt, F. M. Chem.    
 Rev.2000, 100, 4683–4696. c) Nangia-Makker, P.; Conklin, J.; Hogan, V.; Raz, A. Trends Mol. Med. 2002,  
 8, 187–192. 
79     a) Furukawa, J.; Okuda, S.; Saito, K.; Hatanaka, S. I. Phytochemistry. 1985, 24, 593–594. b) Nash, R. J.;  
 Bell, E. A.;  Williams, J. M. Phytochemistry. 1985, 24, 1620–1622. 
80    a) Shibata, T.; Nakayama, O.; Tsurumi, Y.; Okuhara,M.; Terano, H.; Kohsaka, M. J. Antibiot. 1988, 41,  
 296–301. b) Kayakiri, H.; Takase, S.; Setoi, H.; Uchida, I.; Terano, H.; Hashimoto, M. Tetrahedron Lett.  
 1988, 29, 1725–1728. 
81    a) DAB-1: Fleet, G. W. J.; Nicholas, S. J.; Smith, P. W.; Evans, S. V.; Fellows, L. E.; Nash, R. J.  
 Tetrahedron Lett. 1985, 26, 3127–3130. b) nectrisine: Tsujii, E.; Muroi, M.; Shiragami, N.; Takatsuki, A.  
 Biochem. Biophys. Res. Commun. 1996, 220, 459–466. 
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Figure 3.2. Structures of DAB-1 (3.1) and Nectrisine (3.2) 
 
Nectrisine (3.2) is an azasugar that was isolated from a strain of the fungus 
Nectricine lucida (Figure 3.3) as FR-900483 immunomodulator X80Xa,X81 Xb and found to 
exhibit inhibitory activity on α–glycosidases.F82F Moreover, nectrisine is involved in the 
prevention of different diseases such as Newcastle disease virus.X81 Xb Due to this 
important biological activity many organic chemists are focused on the development of 
new methods to synthesize nectrisine. 
 
 
 
Figure 3.3. Microphotograph of anamorph of strain F-449080a 
    
3.1.1. Physico-chemical Properties80a 
 
Nectrisine is a colorless powder (m.p.= 75ºC,  [α]D23= +22° (c 0.55, H2O)) soluble 
in water, slightly soluble in methanol and ethanol and substantially insoluble in acetone, 
chloroform and ethyl acetate. 
 
3.1.2. Biological activities80a 
 
The biological activities of Nectrisine are: 
                                                 
82     a) Ganem B., Acc. Chem. Res. 1996, 29, 340–347. b) Compain, P.; Martin, O.R. Bioorg. Med. Chem. 2001,  
 9, 3077–3092. (c) Asano, N. Glycobiology.  2003, 13, 93R–104R. 
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            -  Competitive effect of Nectrisine against immunosuppressive factor obtained 
from tumor bearing mice serum.X80 a,F83 
            -  Effect of Nectrisine on antibody formation to SRBC (Sheep Red Blood Cells) 
in the immuno-defecient mice: The administration of FR-900483 reversed the 
suppressed immuneresponse.X80aX,X83 X,F84 
             -  Antimicrobial activity: antimicrobial activity of Nectrisine was determined by 
a serial broth dilution method in bouillon media for Gram-positive and Gramnegative 
bacteria and Sabouraud media for fungi and yeast. Nectrisine was devoid of 
antimicrobial activity when tested versus the following microorganisms at 100 μg/ml; 
Escherichia coli, Pseudomonas aeruginosa, Bacillus, Staphylococcus aureus, Candida 
albicans, Aureobasidium pullulans and Aspergillus niger.X80 Xa 
 
In addition, Nectrisine exhibited potent inhibitory activity against α-glycoside 
hydrolase isolated from yeast, gastrointestinal tract of rat or porcine small intestine. 
Further studies on biological activities of FR-900483 are now in progress.80a 
 
3.1.3. Nectrisine as glycosidase inhibitior81b 
 
Nectrisine has the structure of 4-amino-4-deoxy-D-arabinose, and previous works 
have demonstrated its inhibitory activity against α -glucosidase and α -mannosidase as 
expected from its structure.X80 Xa To extend this finding, various commercially available 
glycosidases were tested for their sensitivity to nectrisine. As shown in (Figure 3.4), α-
glucosidase was the most sensitive to nectrisine, and the concentration required for the 
50% inhibition (IC50) was calculated to be 4.8 × 10−8 M. At higher concentrations, 
nectrisine inhibited the activities of α-mannosidase, β-mannosidase, β-glucosidase and 
β-N-acetylhexosaminidase, with decreasing sensitivity in that order, and the respective 
IC50 values were 2.0 × 10−6 M, 1.2 × 10−5 M, 4.1 × 10−5 M and >5.0 × 10−4 M.X81 Xb 
 
 
                                                 
83   Hino, M.; O. Nakayama, Y. Tsurumi, K. Adachi, T. Shibata, H. Terano, M. Kohsaka, H. Aoki.; H. Imanaka.  
 J. Antibiotics. 1985, 38, 926–935. 
84    Cunningham, A. J.;  Szenberg , A. Immunology, 1968, 14, 599–600 
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Figure 3.4. Dose dependency of the inhibition of glycosidases by nectrisine. Enzyme solutions 
were treated with designated concentrations of nectrisine. The amounts of enzymes were as 
follows: 1 U/ml α-glucosidase (●), 0.5 U/ml, β-glucosidase (○), 0.5 U/ml α-mannosidase (■), 
0.1 U/ml β -mannosidase (□), and 0.5 U/ml β -N-acetylglucosaminidase (∆).X81Xb 
 
3.1.4. Syntheses of Nectrisine. Background  
 
Nectrisine has been conveniently prepared starting from compounds of the chiral 
pool like diethyl tartrate (path a),F85F,F86F aminoacids (path b),F87F Garner aldehyde (path c),F88F 
and carbohydrates (path d) F89F,F90F (Scheme 3.1).  
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Scheme 3.1. Nectrisine synthesis. Reported procedures 
 
 
 
                                                 
85  Kim, Y. J.; Takatsuki, A.; Kogoshi, N.; Kitahara, T. Tetrahedron 1999, 55, 8353–8364.  
86    Kim, Y. J.; Kitaraha, T. Tetrahedron Lett. 1997, 38, 3423–3426.  
87    Hulme, A. N.; Montgomery, C.H. Tetrahedron Lett. 2003, 44, 7649–7653.  
88    Ribes, C.; Falomir, E.; Carda, M.; Marco, J. A. J. Org. Chem. 2008, 73, 7779–7782. 
89    Merino, P.;  Delso, I.; Tejero, T.; Cardona, F.; Marradi, M.; Faggi, E.; Parmeggiani, C.; Goti, A.  
 Eur. Org. Chem. 2008, 2929–2947. 
90  Bosco, M.; Bisseret, P.; Bouix-Peter C.; Eustache, J. Tetrahedron Lett. 2001, 42, 7949–7952.  
UNIVERSITAT ROVIRA I VIRGILI 
ENANTISELECTIVE SYNTHESIS OF NATURAL PRODUCTS 
Mariam Azzouz 
Enantioselective Synthesis of nectrisine 
 
41 
 
Path a X85X,X86 
 
D-(-)-Diethyl tartrate was used as starting material in a synthesis that initially had 
as objective the preparation of aldehyde intermediate 3.3. A modified Strecker 
reactionF91F of the aldehyde 3.3,F92F with 2.4 eq. of p-methoxybenzylamine and 1.2 eq. of 
diethyl phosphorocyanidate (DEPC) in THF gave aminonitrile 3.4 (2 steps, 96%, 
Scheme 3.2). The aminonitrile 3.4 was subsequently deprotected with tetra-n-
butylammonium fluoride (TBAF) in THF to afford the corresponding amino alcohol 3.5 
in 87% yield. 
 
 The amino alcohol 3.5 was oxidized by reaction with tetra-n-propylammonium 
perruthenate (TPAP)F93F and N-methylmorpholine-N-oxide (NMO), and cyclized to give 
the lactam 3.6. This lactam was treated, without purification, with 3 eq. of sodium 
methoxide in methanol at room temperature to give the methyl ester 3.7 (2 steps, 71%), 
which was reduced with LiBH4 (lithium borohydride) in THF to form an alcohol as a 
chromatographically separable mixture of two diastereomers trans-lactam 3.8 and cis-
lactam 3.9, in 87% yield, and a ratio of (56:44). 
 
 
 
 
Scheme 3.2. Synthesis of compounds 3.8 and 3.9 
 
                                                 
91    Harusawa, S.; Hamada, Y.; Shioiri, T. Tetrahedron Lett. 1979, 20, 4663–4666. 
92   a) Iida, H.; Yamazaki, N.; Kibayashi, C. J. Org. Chem. 1987, 52, 3337–3342. b) Kuwahara, S.; Moriguchi, 
 M.; Miyagawa, K.; Konno, M.; Kodama, O. Tetrahedron 1995, 51, 8809–8814 . 
93   Griffith, W.P.; Ley, S.V.; Whitcombe, G.P.; White, A.D.J. Chem. Soc., Chem. Commun. 1987, 1625–1627.5. 
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Protection of the primary alcohol of trans-lactam 3.8 with t-butyldiphenylsilyl 
chloride (TPSCl) and Et3N gave the silyl ether 3.10 in 96% yield (Scheme 3.3). 
Treatment of 3.10 with ceric ammonium nitrate (CAN)F94F in CH3CN-H2O (9:1) at 0ºC 
afforded lactam 3.11 in 84% yield. The key step in this synthesis is the reduction of the 
lactam to the amino alcohol. The reduction of 3.11 with various reducing reagents 
(DIBAL-H, LiEt3BH, NaBH4 etc) did not afford the desired product. To face this 
problem, N-protecting group, PMB, was replaced with the more electron-withdrawing 
and easily removable Boc group. Thus lactam 3.11 was treated with di-t-butyl 
dicarbonate (Boc)2O and Et3N in CH2Cl2 to give an imide 3.12 in quantitative yield. 
Reduction of the imide 3.12 with LiEt3BH (Super Hydride ®) in THF at -78ºC cleanly 
afforded the amino alcohol 3.13 in 93% yield. The final task was the removal of the 
protecting groups. This was accomplished by treatment of 6N HCI in THF at 50ºC for 
2h to give the amino sugar precursor F95F (>80% yield), followed by ion exchange column 
chromatography (Dowex resin, OH-form) which afforded nectrisine 3.2 in 90% yield. 
 
 
 
Scheme 3.3. Synthesis of Nectrisine 3.2 
 
 
 
 
 
                                                 
94    Kronenthal, D.R.; Han, C.Y.; Taylor, M.K. J. Org. Chem. 1982, 47, 2765–2768. 
95    Naleway, J.J.; Raetz, C.R.H.; Anderson, L. Carbohydr. Res. 1988, 179, 199–209. 
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Path b X87 
 
D-Serine was the starting material in the synthesis of aldehyde intermediate 3.14, 
which was achieved in five steps with 88% overall yield using a previously reported 
procedure.F96F, F97F  This aldehyde was found to be stable to racemisation on storage at 4°C 
for up to 48 h. Aldehyde 3.14 was converted to the α,β-unsaturated ester 3.15 in 
excellent yield (95%) under Horner–Wadsworth–Emmons conditions using the mild 
base Ba(OH)2 (Scheme 3.4).F98F Osmium tetroxide-catalysed dihydroxylation resulted in 
a moderate yield (59%) of diols 3.16 and 3.17 in a 65:35 diastereomeric ratio, favouring 
the undesired all-syn diol 3.16. The use of AD-mix-α resulted in a very sluggish 
reaction and only a modest improvement in yield (65% based on unrecovered starting 
material) and no apparent increase in diastereoselectivity. However, the 
diastereoselectivity could be overturned in favour of the desired syn diol 3.17 by use of 
AD-mix-β, but again the reaction rate was very slow (7 days) and the 
diastereoselectivity modest (32:68, 3.16:3.17). Separation of the desired syn 
diastereomer 3.17, conversion to the corresponding Weinreb amide and removal of the 
N-benzyl protecting groups using Pearlman’s catalyst Pd(OH)2/C resulted in conversion 
in situ to the previously reported lactam 3.18.X96 X  
 
 
 
Scheme 3.4. Synthesis of compound 3.18 
                                                 
96    Hulme, A. N.; Montgomery, C. H.; Henderson, D. K. J.Chem. Soc., Perkin Trans. 1 2000, 1837–1841.  
97    Hulme, A. N.; Curley, K. S. J. Chem. Soc., Perkin Trans. 1 2002, 1083–1091. 
98   Paterson, I.; Yeung. K. S.; Smail, J. B. Synlett 1993, 774–776. 
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Sequential protection in the hydroxyl functions and then in the amino function 
afforded 3.20 (Scheme 3.5). The increased carbonyl electrophilicity resulting from N-
Boc protection facilitated the smooth reduction of the lactam with Super Hydride® even 
at −78°C to give 3.21. Heating the amino alcohol 3.21 with 6N HCl at 50°C for 2h led 
to the clean removal of all of the protecting groups and the formation of an intermediate 
aminosugar 3.22.X85X Neutralisation and purification by ion-exchange chromatography 
[Dowex 1X2 (HO−)] provided nectrisine 3.2 in excellent yield. 
 
H
N O
OHHO
TBDPSO
3.18
H
N O
OTBSTBSO
TBDPSO
3.19
N
OTBSTBSO
TBDPSO
3.20
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HO
N
OHHO
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3.2 3.22
TBSOTf, 2,6-lutidine,
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N O
OTBSTBSO
TBDPSO
Boc2O, Et3N, DMAP (cat.),
CH2Cl2, rt, 1.5 h, 96%
Boc
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3.21
LiEt3BH, THF,
-78°C, 15 min , 96%
6N HCl (aq.), THF,
50°C, 2 h
Dowex 1X2 (HO-),
H2O (80%).
 
 
Scheme 3.5. Synthesis of Nectrisine 3.2 
 
Path c X88 
 
Dihydroxy ester 3.23 was obtained   from Garner,s (R)-aldehyde F99F via olefination 
and dihydroxylation. Acid treatment of 3.23 caused cleavage of the Boc and acetonide 
groups, followed by in situ spontaneous formation of the lactam ring (Scheme 3.6). This 
gave a crude triol which was then subjected to selective silylation of the primary alcohol 
group to yield pyrrolidinone 3.24 in 67% yield. Since 3.24 was a late intermediate in 
Hulme,s synthesis of 3.2X87X,X96 X this constitutes a formal synthesis of this natural 
compound. 
 
                                                 
99  a) Campbell, A. D.; Raynham, T. M.; Taylor, R. J. K. Synthesis 1998, 1707–1709. b) Liang, X.; Andersch, J.;  
 Bols, M. J. Chem. Soc., Perkin Trans. 1 2001, 2136–2157. 
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Scheme 3.6. Formal Synthesis of Nectrisine 3.2 
 
 
Path d.1 X89 
 
The starting nitrones 3.25F100F used for this study were prepared from D-arabinose 
(Scheme 3.7). Deoxygenation of nitrone 3.25 to provide imine 3.26 was achieved by a 
modification of a reported procedure.F101F Addition of triphenylphosphine (10 mol-%) 
and trimethylphosphite in triethylamine allowed 3.26X90 X to be afforded in good yield. 
Debenzylation of 3.26 with BCl3,X90 X  in order to preserve the imine functionality, gave 
nectrisine 3.2, which was found to be unstable in D2O solution,F102F affording hydrated 
derivatives. On the other hand, 13C NMR spectroscopic data of the crude compound 
were in agreement with those reported in the literature.X85 
 
D-Arabinose
N+
O-
OBnBnO
BnO
ref 100 (MeO)3P Ph3P, 
Et3N, reflux, 62% N
OBnBnO
BnO
BCl3, CH2Cl2
       67% N
OHHO
HO
3.25 3.26 3.2  
 
Scheme 3.7. Synthesis of Nectrisine 3.2 
 
 Product 3.25 was prepared from D-arabinose through three steps. D-Arabinose 
acytalyzation, benzylation of the hydroxyl function using BnCl/KOH and hydrolysis of 
acetal by acid treatement gave the desired product 3.27 in an 50% yield. The reaction of 
compound 3.27 with hydroxylamine in pyridine at room temperature and protection of 
alcohol with TBDPSCl afforded compound 3.28 (100%). Substitution of the OH in 3.28 
was then achieved using PPh3/imidazole/I2 in hot toluene to furnish the iodo-derivative 
                                                 
100    Cardona, F.; Faggi, E.; Liguori, F.; Cacciarini, M.; Goti, A. Tetrahedron Lett. 2003, 44, 2315–2318; 
101    Milliet, P.; Lusinchi, X. Tetrahedron 1979, 35, 43–49. 
102    Otero, J. M.; Soengas, R. G.; Estevez, J. C.; Estevez, R. J.; Watkin, D. J.; Evinson, E. L.; Nash, R. J.; Fleet,  
 G. W.   J. Org. Lett. 2007, 9, 623–626. 
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3.29 in 48 % yield. Deprotection of silyl group was effected by TBAF, which was 
converted to the desired nitrone 3.25 (91%). 
 
 
Scheme 3.8. Synthesis of Nitrone 3.25 
 
Path d.2 X90 
 
This synthesis commenced with a Wittig olefinationF103F of the commercially 
available 2,3,5-tri-O-benzyl-D-arabinofuranose 3.27. Two successive Mitsunobu 
reactions, first with p-nitrobenzoic acid, then with phthalimide, afforded 
3.30.Hydrazinolysis of phthalimide 3.30F104F (Scheme 3.9) and treatment of the crude 
amine thus obtained with trifluoroacetic anhydride provided the trifluoroacetamide 3.31. 
Dihydroxylation (OsO4/NMO) of the olefinic bond and oxidative cleavage (NaIO4) of 
the resulting diol led to an aldehyde which cyclised to the protected aminal 3.32 upon 
standing. Initial attempts to remove the benzyl groups in 3.32 by hydrogenolysis, using 
a variety of conditions, were disappointing as the desired deprotected product 3.33 was 
obtained only in low yield, always accompanied by substantial amounts of the 
aminoalcohol arising from reduction of the latent aldehyde function in 3.33. Hydrolysis 
of the trifluoroacetamide with dilute NaOH and concomitant dehydration, followed by 
ion-exchange chromatography (Sephadex® CM-C-25 (NH4+), elution with 2% aqueous 
                                                 
103   Freeman, F.; Robarge, R.D. Carbohydr. Res. 1986,  154, 270–274.  
104   Bouix, C.; Bisseret, P.; Eustache, J. Tetrahedron Lett. 1998, 39, 825–828. 
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ammonia) completed our synthesis of nectrisine, thus obtained in nine steps and 18% 
overall yield starting from commercially available 2,3,5-tri-O-benzyl-(D)-arabinose.X104 
1) N2H4·H2O, ethanol, reflux, 1.5 h;
2) (CF3C=O)2O, NEt3, 0°C–rt, 2 h,
72% (two steps)
NH
OBn
OBn
BnO
O
F3C OsO4 (cat.), NMO,THF/acetone/H2O 4/4/1,
rt, 48 h;
NaIO4, THF/acetone/H2O (4/4/1), rt, 1.5 h,
98% (two steps)
N
OBnBnO
OH
OF3C
BnO
N
OHHO
OH
OF3C
HO
BCl3, CH2Cl2, -78°C, 2 h,
then -40°C, 16 h, 96%
N
OHHO
HONaOH (0.5 M), rt, 30 min, then
AcOH to pH 4, 96%
3.31
3.32 3.33
3.2
O
OBnBnO
BnO
OH
1) n-BuLi, CH3PPh3 Br , THF, 0°C to RT, 85%
2) p-NO2PhCOOH, PPh 3, DEAD, toluene, 0°C to RT,
then KOH (2M) in water, reflux, 67%
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Scheme 3.9. Synthesis of Nectrisine 3.2 
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3.2. Retrosynthesis  
 
We recently described that Trost’s DYKAT process based on Pd-catalyzed 
asymmetric allylic amination in combination with cross-metathesis and dihydroxylation 
reactions is an efficient strategy for accessing important natural products such as 
sphingosineF105F and Jaspine.F106F Here we explore an enantioselective synthesis of 
nectrisine based on Pd-catalyzed asymmetric allylic amination, cross-metathesis and 
dihydroxylation as key steps. Scheme 3.10 shows the retrosynthesis proposed, where 
the key synthon is the allylamine 3.36 which is obtained in high enantiomeric purity by 
a deracemization process using Pd/DACH as a catalytic system.X33 X,X34 XCross-metathesis 
with acrolein will allow increasing the chain length, and at the same time would provide 
the aldehyde functionality necessary for formation of the cyclic imine moiety in the 
final nectrisine. The high reactivity of the aldehyde function would, though, pose some 
problems, which would advise the use of an aldehyde surrogate that might be 
compatible with the cross metathesis reaction and cyclization process, such as a 
dioxolane or an ester group.  
 
Besides, configuration of double bond resulting from cross-metathesis must be E 
in order to provide the correct configuration of hydroxyl groups in 3.34 after the 
dihydroxylation reaction. The stereoselectivity of this reaction will be controlled by the 
stereocenter in the molecule, which could be also be enhanced by chiral ligands in a 
matched double stereodifferentiation process. 
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HO OH
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R1O
N
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Scheme 3.10. Retrosynthesis of nectrisine 3.2 
 
                                                 
105   Llaveria, J.; Díaz, Y.; Matheu, M. I.; Castillón, S. Org. Lett. 2009, 11, 205–208.  
106   Llaveria, J.; Díaz, Y.; Matheu, M. I.; Castillón, S. Eur. J. Org. Chem. 2011, 1514–1519. 
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3.3. Results and discussion  
3.3.1. Synthesis of allyl amines by asymmetric Pd-catalyzed allylic amination of 
butadiene monoepoxide. 
For our prupose, we focused on the preparation of enantioenriched 2-amino-3-
butenol by means of an asymmetric transformation (DYKAT) consisting in the 
deracemization of butadiene monoepoxide by means of an asymmetric Pd-catalyzed 
allylic amination. Thus, reaction of butadiene monoepoxide (3.37) with 2 mol% of [(η3-
C3H5)PdCl]2, 6 mol% of (R,R)-DACH ligand 3.39 and  imide 3.38 afforded allyl amine 
3.40 with 98% yield and  97% e.e.X34X Compound 3.40 was subsequently treated with di-t-
butyl dicarbonate  and  DMAP to give allyl imide 3.41 in excellent yield (92%) 
(Scheme 3.11).  
N
H
O
OtBu
O
O N
Boc
BzO
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3.37
N
Boc
BzO
Boc
3.41
NHHN
O O
PPh2 Ph2P
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98% yield, 97% ee 92% yield
3.39
6 mol % (R, R)
2 mol% [(η3-C3H5)PdCl]2
DCM, 35ºC, 18h
   (Boc)2O
DMAP, Et3N
3.38
 
                            Scheme 3.11. Synthesis of compounds 3.40 and 3.40 
2-(S)-N-phthalimido-3-buten-1-ol 3.43 was prepared under the conditions 
optimized by Trost.X33 XThus, when 3.37 was treated with phthalimide 3.42 using 0.4 
mol% of [(η3-C3H5)PdCl]2, 1.2 mol% of (R,R)-DACH-Naphtyl 3.39, and Na2CO3 in 
dichloromethane for 14h, allylic amine 3.43 was obtained in an excellent yield (98%) 
and 96% ee (Scheme 3.12). 
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3.39
 
Scheme 3.12. Synthesis of compound 3.43 
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3.3.2. Synthesis of 1,2-disubstituted allyl amines by Ru-catalyzed cross-metathesis 
Among the many types of transition-metal-catalyzed C-C bond forming reactions, 
olefin methatesis has come to the fore in recent years owing to the wide range of 
transformations that are possible with commercially available and easily handled 
catalyst. Consequently, olefin metathesis is now widely considered as one of the most 
powerful synthetic tools in organic chemistry. Until recently the intermolecular variant 
of this reaction, cross-metathesis had been neglected despite its potential. With the 
evolution of new catalysts, the selectivity, efficiency, and functional-group 
compatibility of this reaction have improved to a level that was unimaginable just a few 
years ago. 
The second generation Grubbs catalyst is compatible with a wide range of 
functionalities,F107F the generation of olefins with electron-withdrawing functional 
groups, such as α,β-unsaturated aldehydes, ketones and esters, remains a difficult task 
in organic synthesis. Other π-conjugated functional groups compatible with alkylidene 
Schrock catalyst failed to react with first generation of Grubbs catalyst. However, 
second generation of ruthenium catalyst and, Hoveyda-Grubbs catalyst were found to be 
very efficient in the reaction with α,β-unsaturated carbonyl compounds. X51 
As mentioned in the retrosynthesis (Scheme 3.10), three different alkenes were 
considered for the metathesis reaction, acrolein, vinyldioxolane and ethyl acrylate, 
which were tested in the reaction with allylimides 3.41 and 3.43. An initial essay with 
the di-boc derivative 3.41 and acrolein 3.44 did not proceed when the reaction was 
carried out in toluene at 80ºC for 12h in the presence of catalyst 3.48 (5 mol%) (Table 
3.1, Entry 1). When the reaction was performed in dichloromethane at room 
temperature in the presence of catalysts 3.47 (5 mol%) and 3.48 (5 mol%) the result was 
also negative (Table 3.1, Entries 2, 6). By contrast, cross-coupling product 3.45 was 
obtained in the presence of catalyst 3.48 (5 mol%) when the reaction was performed at 
55ºC, although conversion was moderate 34% (Table 3.1, Entry 3). The Hoveyda-
Grubbs catalyst 3.49 (5 mol%) also provided poor conversion, affording product 3.45 
                                                 
107  a) Yamamoto, T.; Hasegawa, H.; Hakogi, T.; Katsumura, S. Org. Lett. 2006, 8, 5569–5572. b) Chaudhari, V.  
 D.; Kumar, K. S. A.; Dhavale, D. D. Org. Lett. 2005, 7, 5805–5807. c) Morales-Serna, J. A.; Llaveria, J.;  
 Díaz, Y.; Matheu, M. I.; Castillón, S. Org. Biomol. Chem. 2008, 6, 4502-4504. d) Torsell, S.; Somfai, P. Org.  
 Biomol. Chem. 2004, 2, 1643–1646.     
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with 13-17% conversion at rt-55ºC (Table 3.1, Entries 4, 5). The best result was 
obtained by cross-metatesis reaction between phthalimido derivative 3.43 and acrolein 
3.44 in the presence of the Hoveyda-Grubbs catalyst 3.49 (5 mol%), under these 
conditions 3.46 was obtained in 78% yield (Table 3.1, Entry 7). 
 
Table 3.1. Cross-metathesis of allylimides 3.41 and 3.43 with acrolein 3.44.[a] 
Ru
PCy3
Cl
Cl
Ph
NNMes Mes
3.48
CHO
N
R1O
R2 R3
3.41 R1=Bz, R2=R3=Boc
3.43 R1=H, R2=R3=phthalimido
N
R1O
R2 R3
CHO
Ru
PrOi
Cl
Cl
NNMes Mes
4.49
Mo
O
O
N
Ph
F3C
CF3
F3C
CF3
3.47
3.45 R1=Bz, R2= R3=Boc
3.46 R1=H, R2=R3=phthalimido
[cat]
[cat]=
3.44
 
 
Entry Allylamine Cat. Solvent Temp. 
(ºC) 
Product Conv[b] (Yield) [c]   
(%) 
1 3.41 3.48 Toluene 80 3.45 <2 
2 3.41 3.48 CH2Cl2 rt 3.45 <2 
3 3.41 3.48 CH2Cl2 reflux 3.45 34 
4 3.41 3.49 CH2Cl2 reflux 3.45 13 
5 3.41 3.49 CH2Cl2 rt 3.45 17 
6[d] 3.41 3.47 CH2Cl2 rt 3.45 <2 
7 3.43 3.49 CH2Cl2 reflux 3.46 (78) 
[a]conditions: mixture of allyl imide (1 equiv) , alkene (5 equiv) and catalyst ( 5 mol%) were stirred for 
12h in 0.5M solution. [b] Determined by 1H NMR spectroscopy. [c] Isolated yield. [d] Reaction in Dry 
box.  
We studied then the cross-metathesis reaction using vinyldioxolane 3.50 instead 
of acrolein. In all cases the results obtained were better than with acrolein. When the 
reaction between the di-boc derivative 3.41 and vinyldioxolane 3.50 was carried out 
under similar reaction conditions to those optimized previously, dichloromethane as 
solvent and 55ºC, using the second generation Grubbs 3.48 (5 mol%) or Hoveyda-
Grubbs 3.49 (5 mol%) catalysts, product 3.51 was obtained in 55-54% yields, 
respectively (Table 3.2, entries 1 and 4). The replacement of solvent by toluene and 
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performing the reaction at 80ºC in the presence of the second generation Grubbs 3.48 (5 
mol%) catalyst allowed the product 3.51 to be obtained as the E-isomer in 30% yield 
(Table 3.2, Entry 2). Increasing the number of equivalents of vinyldioxolane 3.50 and 
working under similar conditions, the yield of compound 3.51 raised to 78% (Table 3.2, 
Entry 3). Indeed, cross-metathesis reaction of vinyl dioxolane with the phthalimido 
derivative 3.43 afforded the best results and compound 3.52 was obtained in 81% yield 
(Table 3.2, Entry 5). 
Table 3.2. Cross-metathesis of allylimides 3.41 and 3.43 with vinyldioxolane 3.50.[a] 
 
N
R1O
R2 R3
3.41 R1=Bz, R2=R3=Boc
3.43 R1=H, R2=R3=phthalimido
N
R1O
R2 R3
3.51 R1=Bz, R2= R3=Boc
3.52 R1=H, R2=R3=phthalimido
[cat]
O
O
O
O
3.50
 
 
Entry Allylamine Cat. Solvent Temp. 
(ºC) 
Product Conv[b] (Yield) [c]   
(%) 
1 3.41 3.48 CH2Cl2 reflux 3.51 64(55) 
2 3.41 3.48 Toluene 80 3.51 50(30) 
3[d] 3.41 3.48 CH2Cl2 reflux 3.51 82(78) 
4 3.41 3.49 CH2Cl2 reflux 3.51 64(54) 
5 3.43 3.48 CH2Cl2 reflux 3.52 (81) 
[a]conditions: mixture of allyl imide (1 equiv), alkene (5 equiv) and catalyst (5 mol%) were stirred for 
12h in 0.5M  solution. [b] Determined by 1H NMR spectroscopy. [c] Isolated yield. [d] (7 equiv) of alkene 
3.50 were added. 
 
The cross-metathesis reaction of allylimides 3.40, 3.41 and 3.43 with ethylacrylate 
was studied under the conditions optimized previously for acrolein and vinyldioxolane. 
Yields were moderate to excellent with both allylimides 3.41 and 3.43 when the Grubbs 
catalyst was used. Thus, cross-metathesis reactions between 3.41 and ethylacrylate 3.53 
in the presence of catalyst 3.48 (5 mol%) afforded the cross-product 3.55 with 22% 
conversion (Table 3.3, Entry 2). Similarly to that reported in Tables 3.1 and 3.2, the 
reaction with allylimide 3.43 using the same catalyst provides a better yield of 71% 
(Table 3.3, Entry 4).  However, when the reactions of compounds 3.40, 3.41 and 3.43 
were run in the presence of catalyst 3.49, products 3.54, 3.55 and 3.56 were obtained in 
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excellent 96, 98 and 98% yields (Table 3.3, Entries 1, 3 and 5) respectively. Thus, it can 
be concluded that the cross-metathesis reaction with ethylacrylate affords excellent 
yields with the allylimides tested and that the Hoveyda-Grubbs catalyst 3.49 (5 mol%) 
is the catalyst of choice for this reaction. 
 
Table 3.3. Cross-metathesis of allylimides 3.40, 3.41 and 3.43 with ethyl acrylate 3.53. 
[a]  
COOEt
N
R1O
R2 R3
3.40 R1=Bz, R2=H, R3=Boc
3.41 R1=Bz, R2=R3=Boc
3.43 R1=H, R2=R3=phthalimido
N
R1O
R1 R3
COOEt
3.54 R1=Bz, R2=H,  R3=Boc
3.55 R1=Bz, R2= R3=Boc
3.56 R1=H, R2=R3=phthalimido
[cat]
3.53
 
 
Entry Allylamine Cat. Solvent Temp. 
(ºC) 
Product Conv[b] (Yield) [c]   
(%) 
1 [d] 3.40 3.49 CH2Cl2 reflux 3.54 <99(96) 
2 3.41 3.48 CH2Cl2 reflux 3.55 22 
3[d] 3.41 3.49 CH2Cl2 reflux 3.55 <99(98) 
4 3.43 3.48 CH2Cl2 reflux 3.56 (71) 
5 3.43 3.49 CH2Cl2 reflux 3.56 (98) 
[a]conditions: mixture of allyl imide (1 equiv) , alkene (5 equiv) and catalyst (5 mol%) were stirred for 
12h in 0.5M solution. [b] Determined by 1H NMR spectroscopy. [c] Isolated yield. [d] (10 equiv) of 
alkene 3.53 were added. 
3.3.3. Dihydroxylation of allyl imides 
Syn dihydroxylation was the next challenge in our synthetic plan. Dihydroxylation 
assays of related structurally allyl amides by our group and othersX105X,F108F had showed that 
the reaction proceeds under substrate control using achiral catalysts leading to moderate 
diastereoselectivities, which can be improved if chiral ligands are used in double 
differentiation process.     
Thus, we initially tried the diastereoselective dihydroxylation of di-boc derivative 
3.51 bearing a dioxolane ring using AD-mix-β affording a mixture of two products 3.58 
                                                 
108  Jeon, J.;  Shin, M.;    Won Yoo, J.;  Seok Oh, J.; Gwang, B. J.; Jung, H. S.;  Kim, Y.G. Tetrahedron Lett. 
2007, 48, 1105–1108. 
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and 3.59 with 33% conversion in a 4:1 ratio (Table 3.4, Entry 1). Unexpectedly, the 
ethyl carboxylate derivatives bearing N-boc protecting group with the alcohol protected 
3.54 or unprotected 3.57, as well as the N-di-boc derivative 3.55 afforded no 
dihydroxylated products in the presence commercial chiral ligands AD-mix-α and AD-
mix-β, or even with the catalytic systems prepared in situ such as (DHQD)2PYR, 
(DHQ)2PYR or (DHQ)2AQN (Table 3.4, Entries 2-10). 
 
Table 3.4. Catalytic Dihydroxylation assays of alkenes 3.51, 3.54, 3.55 and 3.57 using 
chiral ligands.X105 X,X108 X,F109 
 
Entry Allyl Chiral  ligand Tem 
(ºC) 
Time 
 
Product Ratio[a] Conversion 
(%)[a] 
1 3.51 AD-mix β rt 30h 3.58:3.59 4:1 33 
2 3.54 AD-mix α rt 10d 3.60:3.61 - <2 
3 3.54 AD-mix β rt 10d 3.60:3.61 - <2 
4 3.55 AD-mix α rt 10d 3.62:3.63 - <2 
5 3.55 AD-mix β rt 10d 3.62:3.63 - <2  
6 [b] 3.55 AD-mix β rt 10d 3.62:3.63 - <2 
7[c] 3.55 (DHQD)2PYR rt 5d 3.62:3.63 - <2 
8[c] 3.55 (DHQ)2PYR rt 5d 3.62:3.63 - <2 
9[c] 3.55 (DHQ)2 AQN rt 5d 3.62:3.63 - <2 
10 3.57 AD-MIX β rt 24h 3.64:3.65 - <2 
[a] Determined by 1H NMR. [b] (DHQD)2PYR ligand was added. [c] Ligand (0.03 equiv), CH3SO2NH2 (1.1 equiv), 
K2CO3 (0.3 equiv), NaHCO3 (0.3 equiv), K3Fe(CN)6 (3equiv), K2OsO2(OH)4 (0.02 equiv). 
 
On the other hand, dihydroxylation assays of N-di-boc derivatives 3.51 and 3.55, 
bearing a dioxolane and a carboxyethyl groups, with OsO4 and NMO afforded the 
desired products with total conversion but with unsatisfactory selectivity, 1:1 and 2:1, 
                                                 
109  Ritsuo, I.; Skurai, O.; Yamashita, T.; Horikawa. H. Tetrahedron 1998, 54, 10657–10670.  
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respectively (Table 3.5, Entries 1 and 5). A similar result was obtained from the N-Boc 
protected derivative 3.54, since a 1:1 diastereomeric mixture was also obtained (Table 
3.5, Entry 4). However, when diastereoselective dihydroxylation of compound 3.51 
with OsO4/NMO was tested in water, the desired product 3.58 was isolated in good 
yield, together with a minor amount of the partially deprotected derivative 3.59 (Table 
3.5, Entry 2). Interestingly, in this case the phthalimido derivative 3.52 afforded total 
conversion and good stereoselectivities under the standard reaction conditions (Table 
3.5, Entry 3). 
 
Table 3.5. Dihydroxylation reaction of alkenes 3.51, 3.52 and 3.54, 3.55 using 
OsO4/NMO. X105X,X108X  
N
R3
R1O
R2
R4
N
R3
R1O
R2
R4
OH
OHN
R3
R1O
R2
R4
OH
OH
3.51 R1=Bz, R2= R3=Boc, R4= CH(OCH2)2
3.52 R1=H, R2= R3=Phth, R4= CH(OCH2)2
3.54 R1=Bz, R2=H,  R3=Boc, R4= COOEt
3.55 R1=Bz, R2= R3=Boc, R4= COOEt
3.58 R1=Bz, R2= R3=Boc, R4=  CH(OCH2)2
3.66 R1=H, R2= R3=Phth, R4= CH(OCH2)2
3.60 R1=Bz, R2=H,  R3=Boc, R4= COOEt
3.62 R1=Bz, R2= R3=Boc, R4= COOEt
3.59 R1=Bz, R2= H, R3=Boc, R4= CH(OCH2)2
3.67 R1=H, R2= R3=Phth, R4= CH(OCH2)2
3.61 R1=Bz, R2=H,  R3=Boc, R4= COOEt
3.63 R1=Bz, R2= H, R3=Boc, R4= COOEt
 
Enty Substrate T(ºC) t(h) 
 
Product Ratio[b] Conv 
(%)[b] 
Yield 
(%)[c] 
1 3.51 rt 24 3.58:3.59 1:1 <99 - 
  2[c] 3.51 rt 24 3.58:3.59 5.5:1 <99 70:25 
    3 3.52 rt 24 3.66:3.67 5:1 <99 75:20 
4 3.54 rt 24 3.60:3.61 1:1 <99 - 
  5[c] 3.55 rt 24 3.62:3.63 2:1 <99 60:36 
[a] Conditions: all reaction were stirred in the presence of OsO4 (0.1 equiv).[ and NMO (2.5 equiv).[b] Determined by 
1H NMR.[b] Isolated yield. [c] (2.5 mol%)  of OsO4 in water were used . 
 
Stoichiometric dihydroxylation using 1 eq of OsO4 in the presence of TMEDA at 
low temperature has been described in many examples to improve diastereoselectivities 
compared to those of catalytic OsO4/MNO system.F110F With this prupose, the reaction of 
3.55 with stoichiommetric OsO4 and TMEDA promoted osmylation in excellent yield 
(98%) and in significantly improved selectivity (20:1) to give, however, the osmate 
3.68, which resulted inert to hydrolysis under the reaction conditions. Subsequent 
                                                 
110  Donohoe,  T . J.; Blades,  K..; Helliwell, M.; Moore , P. R.; Winter, J. J. G. J. Org. Chem. 1999, 64, 2980–
2981.  
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hydrolysis in the presence of HCl and MeOH rendered the desired diol product 3.62 
(Scheme 3.13).  
 
N
Boc
BzO
Boc
COOEt
O
O
Os
N
N
OsO4, TMEDA
CH2Cl2, -78ºC to rt
98%, 20:1
3.68
BzO
COOEt
N
Boc Boc
3.55
BzO
COOEt
N
Boc Boc
OH
OH   HCl (con)
MeOH, 2h, 90%
3.62  
 
Scheme 3.13. Synthesis of compounds 3.68 and 3.62 
 
3.3.4. Phthalimido and Boc deprotection 
           
- Boc deprotection 
           Boc-cleavage in the dihydroxylation products was attempted under acidic 
conditions. Hydrolysis of ethyl ester 3.62 with HCl/EtOHF111Fafforded 3.71 with 
moderate 50% yield (Table 3.6, Entry 5). The use of trifluoroacetic acid proved more 
efficient, increasing the yield of 3.71 to an excellent 98% yield (Table 3.6, Entry 4). 
Hydrolysis starting from the diastereomeric mixture 3.62/3.63 rendered amines 
3.71/3.72 in 70% yield (Table 3.6, Entry 3). 
 
         Boc-group removal from pure dioxolane derivative 3.58 or the diastereomeric 
mixture 3.59/3.60 with TFAX88 X gave either mixture 3.69/3.70 or 3.69 with 60% and 50% 
yields (Table 3.6, Entries 1 and 2) respectively. The low efficiency compared to those of 
the ester derivatives 3.62/3.63 could be attributed to acetalyzation/hydrolysis processes 
due to the dioxolane moiety, but no aldehyde product was observed in the reaction 
crude. 
 
      It is worth to point out that no lactamization product was observed, as could be 
expected from reaction of the amino and the ester groups in the molecule in acidic 
medium. 
 
 
 
                                                 
111  Bimalendu, R.;  Kausikisankar, P.; Balaram, M, Glycoconj. J . 2008, 25, 157–166. 
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Table 3.6. Boc deprotection.X87X,X88 
 
N
Boc
BzO
Boc
R4
OH
OH
3.58 R4=  CH(OCH2)2
3.62 R4= COOEt
3.69 R4=  CH(OCH2)2
3.71 R4= COOEt
N
Boc
BzO
H
R4
OH
OH NH2
BzO
R4
OH
OH NH2
BzO
R4
OH
OH
3.59 R4=  CH(OCH2)2
3.63 R4= COOEt
3.70 R4=  CH(OCH2)2
3.72 R4= COOEt  
 
Entry Substrate Reagents Solvent Temp. 
(ºC) 
Product Yield 
(%)  
1[a] 3.58/3.59 TFA CH2Cl2 0 3.69/3.70 60 
2[b] 3.58 TFA CH2Cl2 0 3.69 50 
3[a] 3.62/6.63 TFA CH2Cl2 0 3.71/3.72 70 
4[b] 3.62 TFA CH2Cl2 0 3.71 98 
5[b] 3.62 HCl EtOH 50 3.71 50 
 [a] mixture yield. [b] Isolated yield. 
 
Treatment of the N-Boc derivative 3.63 with TFA in EtOH for 4h at 80ºC 
rendered product 3.73 in a 60% yield as a result of removal of Boc group and formation 
of trifluoroacetamide group (Scheme 3.14).  
N
Boc
BzO
H
COOEt
OH
OH
3.73
NH
BzO
COOEt
OH
OH
EtOH, 80ºC, 60%
F3C
O
TFA
3.63  
Scheme 3.14. Synthesis of compound 3.73 
 
-  Phthalimido deprotection 
 Compound 3.66, bearing a phthalimido group, resulting from the efficient 
dihydroxylation of alkene 3.52, was initially protected by reaction with an excess of 
BnBr  with the previously formed alcoholate in the presence of TBAI, affording product 
3.74 in 80% yield. Removal of phthalimido was carried out by treatment with 1,2-
ethylenediamine in refluxing methanol to provide compound 3.75 in 86% yield. 
Deprotection of phthalimido group was also attempted in the unprotected compound 
3.66, by reaction with methyl amine affording 3.76 in 40% yield (Scheme 3.15).  
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N
OH
HO
O
O
OH
O O
 2h, rt, 80%
N
OBn
BnO
O
O
OBn
O O
NH2
OBn
BnO
O
O
OBn
H2NCH2CH2NH2
MeOH, reflux, 86%
NH2
OH O
O
OH
CH3NH2
1h, 40%
3.66
3.74 3.75
HO
3.76
TBAI, BnBr, 
NaH,
 
Scheme 3.15.  Removal of phthalimido group 
3.3.5. Dioxolane deprotection X87X, X112 
Acylation of product 3.69 in the presence of acetic anhydride and pyridine 
afforded the desired product 3.77 (Scheme 3.16). 
 
 
 
                                        Scheme 3.16. Synthesis of compound 3.77 
 
We envisaged that removal of dioxolane protecting group could directly afford 
monoprotected nectrisine by releasing the aldehyde group and concomitant formation of 
imine. Any attempt, however, of removing the dioxolane ring to induce the cyclization 
in 3.69, 3.75 and acetate 3.77 by treatment with HClX87 X and p-TsOHF112F in THF at 50ºC or 
rt in THF afforded degradation products.  
 
3.3.6. Cyclization and protection reactions 
         Due to the difficulty of hydrolysis of dioxolane ring we turned our attention to the 
ester derivative 3.62. In addition, we considered that benzoate moiety could be the 
responsible of the failure in cyclization of 3.71. Thus, we explored the deprotection of 
                                                 
112    Puls, R.; Al-Haras, A.; Rissig, H. U. Org. Lett. 2002, 4, 2353–2355. 
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benzoyl group in 3.62 with NaOEt in EtOH.F113F Unexpectedly, compound 3.78 resulting 
from the alcoholysis of benzoate group but also from the concomitant deprotection of 
the acetate group and hydrolysis of the ester group (Scheme 3.17). Formation of this 
compound, however, should not pose a problem, considering that the subsequent 
cleavage of the boc group by acid treatment could be followed by spontaneous 
cyclization to give the lactam 3.79.  
 
 
Scheme 3.17. Synthesis of compounds 3.79 
 
         With this purpose, 3.78 was submitted to hydrolysis conditions with TFA at 0ºC 
for 2h to give a reaction crude that was treated with TBDPSCl, imidazole in DMF at 
room temperature for 16h. This process sought to monosilylate lactam 3.79, presumably 
formed from acid treatement, at position 5 to render lactam 3.80 which had been 
previously synthesized throught another synthetic strategy.X87 X Therefore, synthesis of 
lactam 3.80 would constitue a formal synthesis of the nectrisine. However, the 
protection process rendered coumpond 3.81 (14 mg) as a result of disilylation at 
position 2 and 5.(Scheme 3.18). No change was observed when the protection was 
carefully monitored at 0ºC, observing that the disilylated product was formed very fast. 
In fact, the monosilylated product was practically not detected. The fact that the 
monosilylated product is more soluble in the reaction medium than the starting material 
can have influence in the outcome of the reaction. Anyway, it was demonstrated that by 
removing the benzoate at position 5 the cyclization took place 
 
                                                 
113    Bimalendu, R.;  Kausikisankar, P.; Balaram, M. Glycoconj. J . 2008, 25, 157–166.    
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Scheme 3.18. Synthesis and protection of lactam  3.79 
 
3.3.7. Final steps towards Nectrisine (3.2)X87 
 
We Next decided to explore the cyclization from compound 3.71 by first 
removing the benzoate group. Thus, hydrolysis of benzoate in 3.71 with LiOH afforded 
crude lactam 3.79, whose hydroxyl functionalities were fully protected by treatment 
with TBSCl to give 3.82 in 35% yield. Attempting to increase the silylation yield, 3.79 
was treated with TBSOTf and lutidine but no protected lactam was recovered after 
aqueous work-up of the reaction crude. Subsequent protection of 3.82 with di-t-butyl 
dicarbonate (Boc)2O and Et3N in CH2Cl2 gave imide 3.83 in 50% yield. The increased 
carbonyl electrophilicity resulting from NBoc protection should facilitate the smooth 
reduction of the lactam 3.83, which proceeded by reaction with Super Hydride® at 
−78°C to give 3.84 in (10 mg, 42% yield).  
The little amounts of synthetic itermediates 3.81 and 3.84 prevented to move 
forward in the synthetic route proposed and led the synthesis of nectrisine pending. In 
our hands, the silylation step has proven troublesome, either by lack of selective 
protection at the primary position or by unsatisfactory synthetic yield of the fully 
silylated intermediate, so that in the future a synthetic solution for the silylation step 
should be provided to assure completion of the synthesis proposed.  
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N
OTBS
TBSO
TBSO
H
ONH2
BzO
COOEt
OH
OH
1) LiOH, MeOH-THF
2) TBSCl, Imidazole, 
        DMF, 35%
N
OTBS
TBSO
TBSO
Boc
O
3.71 3.82
3.83
Boc2O, Et3N, DMAP (cat), 
   CH2Cl2, rt, 12h, 50%
N
OTBS
TBSO
TBSO
Boc
OH
LiEt3BH, THF, -78ºC
           42 %
3.84  
 
Scheme 3.19. Synthesis of Compond 3.84 
 
3.3.8. Structural elucidation of compounds 
 
Configuration assignment of acyclic diasteromeric products, like those obtained 
from dihydroxylation, is usually realised by comparison of the spectroscopical data of 
further advanced cyclic intermediates, like in this case would have been nectrisine. The 
impossibility of reaching the end of our synthetic route prevented us from confirming 
the configuration of the diastereomeric dihydroxylated products. On the other hand, the 
anomalous disilylation observed in our hands of a process that had been reported to lead 
to monosilylation, put in us some doubts whether the major dihydroxylated product 
obtained in our route could be different from that leading to the nectrisine. This fact 
prompted us to analyze in detail the configuration of the obtained products by NMR 
techniques. Thus, we compared the spectroscopical data of 3.81 with those of related 
compounds (Table 3.7). Data of compounds 3.80 and 3.85 correspond to those reported 
in the bibliography for these compounds. Furthermore, we conducted a NOE 
experiment of compound 3.81. 
In Table 3.7, NMR data of compounds 3.80 and 3.81, both without Boc protecting 
group at nitrogen, and 3.83 and 3.85 which have a protecting group in the nitrogen and 
are persilylated, are compared. The following observations can be deduced: 
• Chemical shift and coupling constants values in 3.80 and 3.81 are very close. 
• Chemical shift and coupling constants values in 3.83 and 3.85 are very close, 
and some differences can be attributed to the fact that spectra of 3.83 were 
recorded in a 400 MHz equipment while data of 3.85 were obtained in a 250 
MHz equipment. 
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• Coupling constant values of J2,3  and J3,4 in 3.80 and 3.81 are ca. 7.5 Hz, while 
the former is around 1.5 Hz for 3.83 and 3.85 and J3,4 is not provided, probably 
due to its low value. This is indicative of a diferent conformational bias of both 
groups of compounds, so that 3.80 and 3.81 exist in a 3E conformation whereas 
3.83 and 3.85 exist as a E3 conformation, with the silyloxy groups in a pseudo-
trans-diaxial conformation. (Scheme 3.20) This conformational change may be 
explained by the destabilization of the 3E conformation in 3.83 and 3.85 due to 
severe gauche interactions of the bulky neighboring silyl groups altogether with 
the presence of of N-Boc group. 
• The 13C NMR spectra of 3.80 and 3.81 are very similar, and the chemical shifts 
of C4 and C5 are virtually coincident. 13NMR Chemical shifts for 3.83 and 3.85 
are practically identical, except for C5, which is the position where the protecting 
groups are different. 
 
NBocNH
O
H4
OR'
H5H5'
OR
H2
H3
ROO
H3
H2
OR'H5'
H5
H4
HO
RO
3E E3
3.80 R'= TBDPS, R= H
3.81 R=R'= TBDPS
3.83 R=R'= TBS
3.85 R'= TBDPS, R= TBS  
 
Scheme 3.20. Conformations of lactams 3.80, 3.81, 3.83 and 3.85 
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Table 3.7. Selected 1H and 13C NMR data of compounds 3.80, 3.81, 3.83 and 3.85 (δ in 
ppm, J in Hz). 
 
(δ in 
ppm) 
H
N O
OHHO
TBDPSO
3.80  
H
N O
OTBDPSHO
TBDPSO
3.81
N O
OSBTTBSO
TBSO
3.83
Boc
N O
OSBTTBSO
TBDPSO
3.85
Boc
H2 4.28 (d, 1H) 
J = 7.5 Hz 
4.28(d ,1H) 
J = 6.8 Hz 
4.13 ( t, 1H) 
J = 1.6 Hz 
4.31 (t, 1H) 
J = 1.5 Hz 
C2 76.4 78.0 83.2 82.9 
H3 3.99 (t, 1H) 
J = 7.5 Hz 
3.94(t, 1H) 
J = 6.8 Hz 
3.95 (dd, 1H) 
J = 1.6, 0.8 Hz 
4.13-3.96 
(m, 2H) 
C3 75.9 77.2 71.8 72.0 
H4 3.52 (td, 1H) 
J = 7.5, 3 Hz 
3.32(td, 1H) 
J = 7.2, 3.6 Hz 
3.88-3.74 
(m, 3H) 
4.13-3.96 
(m, 2H) 
C4 58.2 57.6 67.0 66.7 
H5 3.89 (dd, 1H) 
J = 10.5, 3 Hz 
3.78 (dd, 1H) 
J = 10.8, 3.6 Hz 
3.88-3.74 
(m, 3H) 
3.88-3.74 
(m, 2H) 
C5 64.5 65.0 61.6 62.6 
H5’ 3.62 (dd, 1H) 
J=10.5, 7.5 Hz 
3.56 (dd, 1H) 
J = 10, 7.8 Hz 
3.88-3.74 
(m, 3H) 
3.88-3.74 
(m, 2H) 
C5’ 64.5 65.0 61.6 62.6 
 
 
The analysis of these data suggest that compounds 3.80 and 3.81 share the same 
configuration and similar conformation and the same applies to the pair of compounds 
3.83 and 3.85. Between these two groups of compounds, the configuration is identical 
but the conformation changes. 
On the other hand, the results of the NOE study on compound 3.81 are the 
following:  
Table 3.8. Selected NOE contacts in compound 3.81. 
Proton 
irradiated 
NOE effect  
H2 H4 (XXX)   
H3 H5 (XXX) H4 (X)  
H4 H2 (XXX) H5’ (XXX) H3 (X) 
H5 H3 (XXX) H4 (X)  
XXX= strong, X= weak 
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Relevant NOE correlsations are H2-H4 and H3-H5, which indicate that in 
compound 3.81 H2 and H4 are on the same face of the molecule, as well as H3 and H5.  
These facts together with the conclusions of the previous comparative study, 
suggest that the configuration for compounds 3.81 and 3.83 is D-arabino, in agreement 
with that in the natural product nectrisine. 
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3.4. Experimental Part 
3.4.1. General Methods 
All chemicals used were reagent grade and used as supplied unless otherwise 
specified. HPLC grade dichloromethane (CH2Cl2), tetrahydrofuran (THF) and 
dimethylformamide (DMF) were dried using a solvent purification system (Pure SOLV 
system-4®). Toluene was purified using standard procedure.  
1H and 13C NMR spectra were recorded on a Varian® Mercury VX 400 (400 
MHz and 100.6 MHz respectively) or Varian 400-MR spectrometer in CDCl3 as 
solvent, with chemical shifts (δ) referenced to internal standards CDCl3 (7.26 ppm 1H, 
77.23 ppm 13C) or Me4Si as an internal reference (0.00 ppm). 2D correlation spectra 
(gCOSY, NOESY, gHSQC, gHMBC) were visualized using VNMR program 
(Varian®). ESI MS were run on an Agilent® 1100 Series LC/MSD instrument. Optical 
rotations were measured at room temperature in a Perkin-Elmer® 241 MC apparatus 
with 10 cm cells. Elemental analysis (C, H, N, S) were performed on a Carlo Erba® EA 
1108 Analyser in the Servei de Recursos Científics (SRCiT-URV). IR spectra were 
recorded on a JASCO FT/IR-600 plus Fourier Transform Infrared Spectrometer ATR 
Specac Golden Gate. Melting points, determined with Reichert apparatus, are 
uncorrected.  
Reactions were monitored by TLC carried out on 0.25 mm E. Merck® silica gel 
60 F254 glass or aluminium plates. Developed TLC plates were visualized under a 
short-wave UV lamp (250 nm) and by heating plates that were dipped in ethanol/H2SO4 
(15:1) and basic solution of potassium permanganate. Flash column chromatography 
was carried out using forced flow of the indicated solvent on Fluka® or Merck® silica 
gel 60 (230-400 mesh). Radial chromatography was performed on 1 or 2 mm plates of 
Kieselgel 60 PF254 silica gel, depending on the amount of product. Flash column 
chromatography (FCC) was performed using flash silica gel (32–63 μm) and using a 
solvent polarity correlated with TLC mobility. 
 The enantiomeric excess (ee%) determined via chiral HPLC analysis (chiralpack 
OD column, heptane:iPrOH, flow rate 1 mlmin-1). 
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3.4.2. Compound characterization 
t-Butyl benzoylimido carboxylate (3.38). 
 
N
H
O
OtBu
O
3.38  
 
t-butyl alcohol (2.10 ml, 22.4 mmol) was added to a solution of 
benzoylisocyanate (2.56 ml, 20.4 mmol) in anhydrous dichlorometane 40 ml. The 
solution was stirred at room temperature for 18h. The evaporation of solvent provided 
the desired product 3.38 as a white solid in 96% yield (4.3 g).  
 
IR (neat): 3249, 1746, 1675,  1501, 1483, 1370, 1364, 1143, 1128, 1100  cm-1. 1H 
NMR (CDCl3, 400 MHz, δ in ppm): δ=  8.3 (br s, 1H, NH), 7.8 (dd, 2H, J = 7.2, 1.2 
Hz), 7.5 (tt, 1H, J = 14.8, 7.6 Hz), 7.4 (t, 2H, J = 7.6 Hz), 1.4 (s, 9H).  13C NMR 
(CDCl3, 100.6 MHz, δ in ppm): δ= 165.4, 149.7, 133.5, 132.9, 128.8, 127.6, 82.9, 28.2. 
ESI-HRMS  [M+1]+ calcd for C12H16NO3 : 222.113, Found 222.113. 
(2S)-2-((tert-Butoxycarbonyl)amino)but-3-1-yl benzoate (3.40). 
 
HN
Boc
BzO
3.40  
A 25 mL flamed-dried flask under vacuum, benzoylimido carboxylate 3.38 (0.4 
g, 1.88 mmol), [(η3-C3H5)PdCl]2 (0.011 g, 0.03 mmol) and R,R ligand (0.07 g, 0.09 
mmol) were added under argon and the flask was purged three times with argon. Then 
dry dichloromethane (40 mL) was added to the mixture and the solution was stirred 30 
min at rt. Butadiene monoepoxide (0.11 ml, 1.57 mmol) was added in one portion and 
the resulting mixture was stirred at 35 °C for 18h. The resulting mixture was 
concentrated and purified by flash chromatography using 10:1 hexanes:ethyl acetate as 
a solvent to afford compound 3.40 as a white solid (0.44 g, 98%). The enantiomeric 
excess was 97% ee determined by chiral HPLC (chiralpack OD, heptane:iPrOH 95:5, 1 
mlmin-1, tR(R) = 6.2 min and tR(S) = 7 min).   
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[α]D25 = -41.8 (c1, CHCl3). IR (neat): 3359, 3069, 2977, 1700, 1516, 1451, 1365, 1269, 
1163, 1113, 1069, 709 cm-1. 1H NMR (CDCl3, 400 MHz, δ in ppm): δ=  8 .02 (dd, 2H, 
J = 8, 1.6 Hz), 7.54 (tt, 1H, J = 7.2 ,  1.6 Hz),  7.42 (t, 2H, J = 8.4 Hz), 5.88 (ddd, 1H, J 
= 17.2, 10.4, 5.2 Hz) , 5.33 (dd, 1H, J =17.2, 2.8, 0.8 Hz), 5.23 (dd, 1H, J = 10.4, 2.8, 
1.6 Hz), 4.86 (br s, 1H), 4.6 (br s, 1H), 4.35 (d, 2H, J = 4.8 Hz), 1.4 (s, 9H). 13C NMR 
(CDCl3, 100.6 MHz, δ in ppm): δ=166.4, 155.3, 134.8, 133.2, 129.8, 129.7, 128.4, 
116.8, 79.8, 66.4, 51.8, 28.4. ESI-HRMS [M+23] calcd for C16H21NaNO4: 314.1368, 
Found: 314.1347. 
(2S)-2-((bis-tert-Butoxycarbonyl)amino)but-3-1-yl benzoate (3.41). 
 
BzO
N
Boc Boc
3.41  
To a solution of product 3.40 (0.3 g, 1.03 mmol) in 11ml Et3N were added DMAP 
(0.25 g, 2.06 mmol) and di-t-butyl dicarbonate (1.17 g, 5.36 mmol) at 0ºC, reaction 
stirred at 90ºC for 18h. Reaction quenched with NH4Cl, the aqueous layer was extracted 
with AcOEt tree times and the combined organic layer was washed with H2O, brine, 
dried (MgSO4) and concentred in vacuo. The residue was chromatographed over SiO2 
(Hexane/AcOEt 10:2) to give product 3.41 as yellow liquide in 92% yield (0.37 g). 
 
[α]D25 = +28.2 (c0.85, CHCl3). IR (neat): 3094, 2979, 2933, 1723, 1700, 1452, 1367, 1347, 
1267, 1112, 855, 710 cm-1. 1H NMR (CDCl3, 400 MHz, δ in ppm): δ=  7.88 (dd, 2H,  J 
=8.4, 1.2 Hz), 7.35 (tt, 1H, J = 7.6, 1.2 Hz) , 7.24 (t, 2H,  J = 7.6 Hz), 5.8 (ddd, 1H, J = 
17.2, 10.4, 6.4 Hz), 5.17 (dd, 1H, J =17.6, 1.2 Hz), 5.07 (dd, 1H, J =10.4, 1.2 Hz), 5.1 (m, 
1H), 4.51(dd, 1H, J =10.8, 9.2 Hz), 4.41(dd, 1H, J = 11.2, 6 Hz), 1.4(s, 18H). 13C NMR 
(CDCl3, 100.6 MHz, δ in ppm): δ=166.2, 152.8, 133.7, 133.1, 130.1, 129.8, 128.4, 118.4, 
82.8, 64.8, 57.2, 28.1. ESI-HRMS [M+23] calcd for C21H29NaNO6: 414.1893, Found: 
414.1892. 
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2-(S)-3-buten-2-phthalimido-1-ol (3.43). 
HO
NO O
3.43
 
In a 250 ml flamed-dried flask, Na2CO3 (53 mg, 0.05 mmol), phthalimide (3.42) 
(1.47 g, 10 mmol), [(η3-C3H5)PdCl]2 (14.6 mg, 0.04 mmol) and (R,R) ligand (3.39) 
(94.6 mg, 0.12 mmol) were added under argon being the flask purged three times with 
argon. Then dry dichloromethane (80 ml) was added to the mixture and the solution was 
stirred 15 min at rt. Butadiene monoepoxide (810 μl, 10 mmol) was added in one 
portion and the resulting mixture was stirred at rt for 14h. The resulting mixture was 
concentrated and purified by flash chromatography, using 1:1 hexanes:ethyl acetate as a 
solvent, to afford 2.16 g of compound 3.43 (2.1 g, 98%) as a white solid. An 
enantiomeric excess of 96% ee was determined by chiral HPLC (chiralpack OD, 
heptane:iPrOH 90:10, 1 mlmin-1, tR(S) = 14.1 min and tR(R) = 16.9 min).   
 [α]D25 =   -65.9 (c 1, CHCl3). Mp 60-63 ºC. IR (neat): 3527, 1763, 1702, 1656, 1609, 
1467 and 1388 cm-1. 1H NMR (CDCl3, 400 MHz, δ in ppm): δ= 7.73 (dd, 2H, J = 5.6, 
3.2 Hz), 7.62 (dd, 2H, J = 5.6, 3.2 Hz), 6.06 (ddd, 1H, J = 17.6, 10.4, 7.2 Hz), 5.19 
(ddd, 1H, J = 17.6, 1.2, 1.2 Hz), 5.18 (ddd, 1H, J = 10.0, 1.2, 1.2 Hz), 4.84 (m, 1H), 
4.07 (ddd, 1H, J = 11.4, 8.4, 8.0 Hz), 3.86 (ddd, 1H, J = 11.4, 7.6, 4.6 Hz), 2.98 (dd, 1H, 
J = 8.0, 4.6). 13C NMR (CDCl3, 100.6 MHz, δ in ppm): δ= 168.7, 134.3, 132.1, 131.9, 
123.5, 119.0, 62.8, 56.1. ESI-HRMS [M+1] calcd for C12H12NO3: 218.0817, Found: 
218.0813.  
(2E, 4S)-5-hydroxy-4-phthalimido-pent-2-en-1-al (3.46). 
HO H
O
NO O
3.46  
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Compound 3.43 (50 mg, 0.23 mmol) was dissolved in dichloromethane (15 mL) 
at reflux. Hoveyda-Grubbs catalyst (8 mg, 0.012 mmol, 5%) was added to the solution 
and then the reaction mixture was stirred under argon. Acrolein (0.05 mL, 0.7 mmol) 
was added at that temperature over 2h by slowly addition. After 11h the crude was 
cooled and it was concentrated under vacuum and purified by flash chromatography 
using hexanes: ethyl acetate (2:1) to give compound 3.46 as an yellow oil (50 mg, 
78%).  
IR (neat): 3462, 2926, 2706, 1772, 1707, 1467, 1383, 1063, 877, 796, 718 cm-1. 1H 
NMR (CDCl3, 400 MHz, δ in ppm): δ = 9.54 (d, 1H, J = 8.0 Hz), 7.83 (dd, 2H, J = 5.6, 
3.2 Hz), 7.72 (dd, 2H, J = 5.2, 3.6 Hz), 7.03 (dd, 1H, J = 16.0, 4.0 Hz), 6.12 (dd, 1H, J 
= 16.0, 8.0 Hz), 5.17 (m, 1H), 4.18 (m, 1H), 4.09-4.04 (m, 5H). 13C NMR (CDCl3, 
100.6 MHz, δ in ppm): δ = 193.1, 168.2, 149.9, 134.7, 133.8, 131.8, 62.1, 60.6, 54.1, 
21.2, 14. 3.  
(2S,3E)-2-{bis[(tert-butoxy)carbonyl]amino}-4-(1,3-dioxolan-2-yl)but-3-en-1-yl 
benzoate (3.51). 
 
N
Boc Boc
BzO
O
O
3.51  
 
To a solution of product 3.41 (0.1 g, 0.26 mmol)  and (0.011 g, 0.013 mmol) of II 
generation Grubbs catalyst in dichlorometane (6 ml) was added vinyldioxolane (0.13 
ml, 1.3 mmol) at 55ºC. Reaction stirred at 55ºC for 12h, evaporation of solvent and 
purification by silica chromatography (Hexan:AcOEt, 10:3) provided the desired 
product 3.51 in 82% conversion and 78% yield (0.094 g).  
 
IR (neat): 2979, 2933, 2888, 1721, 1701, 1367, 1348, 1267, 1147, 1113, 968, 712 cm-1. 
1H NMR (CDCl3, 400 MHz, δ in ppm): δ=  8.02 (d, 2H, J =8.4 Hz), 7.54 (t, 1H, J =7.6 
Hz), 7.41 (t, 2H, J = 7.6 Hz), 6.11 (dd, 1H, J = 16, 6.4 Hz), 5.74 (dd, 1H, J = 16, 6 Hz), 
5.28 (d, 1H, J = 6 Hz), 5.26 (m, 1H) , 4.59 (t, 1H, J = 10.8 Hz), 4.85 (dd, 1H, J = 6, 11.2 
Hz), 3.94 (m, 4H), 1.45(s, 18H); 13C NMR  (CDCl3, 100.6 MHz, δ in ppm): δ=  166.3, 
152.6, 133.3, 131.5, 130.1, 130.0, 128.5, 103.2, 83.1,65.2, 64.7, 55.9, 28.2. ESI-HRMS 
[M+23] calcd for C24H33NaNO8: 486.2104, Found: 486.2109. 
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(2S,3E)-4-(1,3-dioxalan-2-yl)-2-phthalimido-but-3-en-1-ol (3.52). 
HO
NO O
3.52
O
O
 
Compound 3.43 (50 mg, 0.23 mmol) was dissolved in dichloromethane (25 ml) at 
room temperature. Second generation Grubbs catalyst (5%) was added to the solution 
and then the reaction mixture was refluxed under argon. Compound 3.50 (0.1 ml, 0.92 
mmol) was added at that temperature over 2 h by slowly addition. After 10 h the crude 
was cooled and it was concentrated under vacuum and purified by flash chromatography 
using hexanes: ethyl acetate (3:1) to give compound 3.52 as an yellow oil (57 mg, 
81%).  
[α]D25= +34.0 (c 2.7, CH2Cl2). IR (neat): 3471, 2924, 2854, 1774, 1703, 1466, 1382, 
1312, 1273, 1180, 1123, 1029, 719 cm-1. 1H NMR (CDCl3, 400 MHz, δ in ppm): δ = 
7.85-7.81 (m, 2H), 7.77-7.72 (m, 2H), 6.28 (dd, 1H, J =16.0, 6.8 Hz), 5.72 (dd, 1H, J = 
16.0, 5.8 Hz), 5.25 (d, 1H, J = 5.8 Hz), 4.95 (m, 1H), 4.12 (m, 1H), 3.67 (m, 2H), 3.87 
(m, 1H), 3.74 (m, 1H), 3.6 (m, 1H), 3.01 (brs, 1H, OH).  13C NMR  (CDCl3, 100.6 
MHz, δ in ppm): δ = 168.6, 134.4, 131.9, 131.2, 129.9, 123.6, 102.9, 72.5, 65.2, 62.8, 
54.6. ESI-HMRS [M+1] calcd for C15H46NO5: 290.1028, Found: 290.1009.   
Ethyl (2E,4S)-5-benzoyloxy-4-((tert-butoxycarbonyl)amino)-pent-2-enoate (3.54). 
 
HN
Boc
O
O
BzO
3.54   
 
To a solution of product 3.40 (0.1 g, 0.34 mmol) and (0.011 g, 0.017 mmol) of 
Hoveyda-Grubbs catalyst in dichlorometane (9 ml) was added ethylacrylate (0.25 ml, 
2.38 mmol) at 55ºC. Reaction stirred at 55ºC for 12h, evaporation of solvent and 
purification by silica chromatography Hexan/AcOEt (15:1) provided the desired product 
3.55 in 96% yield (0.12 g).   
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[α]D25= -1.06 (c1.3, CHCl3). IR (neat): 3336, 2976, 2935, 1663, 1585, 1452, 1367, 
1312, 1072, 1025, 864, 734 cm-1. 1H NMR (CDCl3, 400 MHz, δ in ppm): δ= 7.95 (dd, 
2H, J = 8.4, 1.2 Hz), 7.50 (td, 1H, J = 7.2, 1.2 Hz), 7.37 (t, 2H, J = 7.2 Hz), 6.92 (dd, 
1H, J = 15.6, 5.2 Hz), 6.04 (dd, 1H, J = 15.6, 1.6 Hz), 5.24 (br d, 1H, J= 8.8 Hz), 4.37 
(d, 2H,  J = 4.4 Hz), 4.14(q, 2H, J = 7.2 Hz), 1.37 (s, 18H), 1.22 (t, 3H, J = 7.6 Hz); 13C 
NMR  (CDCl3, 100.6 MHz, δ in ppm): δ= 166.2, 165.8, 155.1, 144.2, 133.3, 129.7, 
129.6,129.4, 128.4, 128.3, 122.8, 80, 65.7, 60.7, 50.7, 28.2, 14.1. ESI-HRMS [M+23] 
calcld for C19H25NaO6:  386.1580, Found: 386.1594. 
 
Ethyl (2E,4S)-5-benzoyloxy-4-((bis-tert-butoxycarbonyl)amino)-pent-2-enoate (3.55). 
 
N
Boc
O
O
BzO
3.55
Boc
 
 
To a solution of product 3.42 (0.3 g, 0.77 mmol) and (0.024 g, 0.0385 mmol) of 
Hoveyda-Grubbs catalyst in dichlorometane (20 ml) was added ethylacrylate (0.41 ml, 
3.85 mmol) at 55ºC. Reaction stirred at 55ºC for 12h, evaporation of solvent and 
purification by silica chromatography Hexan/AcOEt (15:1) provided the desired product 
3.55 as yellow liquid in 98% yield (0.35 g).   
 
[α]D25= +13.8 (c1.1, CHCl3). IR (neat) : 2979, 1720, 1452, 1367, 1350, 1265, 1231, 
1149, 1112, 975, 854, 710 cm-1. 1H NMR (CDCl3, 400 MHz, δ in ppm): δ= 8 (d, 2H, J 
= 8.4 Hz), 7.52 (t, 1H, J = 7.6 Hz), 7.4 (t, 2H, J = 8 Hz), 7.02 (dd, 1H, J = 16, 5.2 Hz), 
6.97 (dd, 1H, J = 16, 1.6 Hz), 5.3 (m, 1H), 4.56 (dd, 2H,  J =8.4 4.8 Hz), 4.17(q, 2H, J = 
7.6 Hz), 1.43 (s, 18H), 1.25 (t, 3H, J = 7.2 Hz); 13C NMR  (CDCl3, 100.6 MHz, δ in 
ppm): δ=  166.0, 165.8, 152.1, 143.5, 133.6, 133.2, 129.7, 129.6, 128.3, 122.8, 83.3, 
64.2, 60.6, 55.3,27.9, 14.2. ESI-HRMS [M+23] calcld for C24H33NNaO8 : 486.2104, 
Found: 486.2123. 
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Ethyl (4S,2E)- 5-hydroxy-4-phthalimido-pent-2-enoate (3.56). 
HO
NO O
3.56
OEt
O
 
Compound 3.43 (50 mg, 0.23 mmol) and compound 3.54 (0.1 ml, 0.92 mmol) 
were dissolved in dichloromethane (25 ml) at room temperature. Second generation 
Grubbs catalyst (5%) was added to the solution and then the reaction mixture was 
refluxed under argon for 12h. After cooling the reaction mixture it was concentrated 
under vacuum and purified by flash chromatography using petroleum ether: ethyl 
acetate (3:2) to give compound 3.56 as a colorless oil (40 mg, 71%). 
IR (neat): 3470, 3102, 3083, 2924, 2854, 1774, 1703, 1384, 1314, 1273, 1180, 1027, 
719 cm-1.   1H NMR (CDCl3, 400 MHz, δ in ppm): δ= 7.92-7.85 (m, 2H), 7.79-7.71 (m, 
2H), 7.12 (dd, 1H, J = 15.9, 6.0 Hz), 5.92 (d, 1H, J = 15.9 Hz) 5.09 (m, 1H), 4.19 (q, 
2H, J = 6.9 Hz), 4.05 (m, 2H), 3.00 (brs, 1H), 1.27 (t, 3H, J = 6.9 Hz). 13C NMR  
(CDCl3, 100.6 MHz, δ in ppm): δ = 168.4, 165.7, 141.2, 134.7, 131.7, 124.2, 123.8, 
62.6, 61.0, 54.2, 14.4.  
(2R,3R,4S)-2-((bis-tert-butoxy)carbonyl)amino-4-(1,3-dioxolan-2-yl)-3,4-dihydroxybutyl 
benzoate (3.58).  
(2R,3S,4R)-2-((bis-tert-butoxy)carbonyl)amino-4-(1,3-dioxolan-2-yl)-3,4-dihydroxybutyl 
benzoate (3.59). 
O
O
HN
Boc
BzO
OH
OH
O
O
N
Boc
BzO
OH
OH
Boc
3.58 3.59  
 
To a solution of product 3.51 (0.28 g, 0.6 mmol) in 25ml dichlorometane were 
added (0.38 g, 1.5 mmol) NMO and (0.044 ml, 0.015 mmol) OsO4 in water at 0ºC, 
reaction stirred at room temperature for 24h. Reaction quenched by Na2S2O3 stirred for 
15min, the aqueous layer was extracted with AcOEt tree times and the combined 
organic layer was washed, brine, dried (MgSO4) and concentred in vacuo. Purification 
UNIVERSITAT ROVIRA I VIRGILI 
ENANTISELECTIVE SYNTHESIS OF NATURAL PRODUCTS 
Mariam Azzouz 
Enantioselective Synthesis of nectrisine 
 
73 
 
of product (Hexane/AcOEt) provided two products 3.58 (0.2 g, 70%) and 3.59 (0.06 g,  
25%) 
 
Compound (3.58). [α]D25= -3.6 (c0.7, CHCl3). IR (neat): 3481, 2978, 2924, 1720, 1702, 
1367, 1349, 1269, 1148, 1070, 852, 712 cm-1. 1H NMR (CDCl3, 400 MHz, δ in ppm): 
δ= 8.02 (dd, 2H, J = 8, 1.2 Hz), 7.54 (tt, 1H, J = 7.2,  Hz 1.6), 7.42 (t, 2H, J = 7.6   Hz), 
5.04 (d, 1H, J = 4 Hz), 4.8 (dd, 2H, J = 6.4, 2 Hz), 4.58 (ddd, 1H, J = 8.8,  4.8 Hz), 4.32 
(t, 1H, J = 8 Hz), 3.98 (m, 4H), 3.67 (t,1H, J = 4.8Hz), 3.07 (br s, 1H), 1.64 (brs, 1H), 
1.44 (s, 18H). 13C NMR  (CDCl3, 100.6 MHz, δ in ppm): δ= 166.3, 153.9, 133.1, 130.1, 
129.9, 128.4, 104.1, 83.5, 70.5, 69.8, 65.6, 65.4, 63.3, 58.1, 28.06. ESI-HRMS [M+23] 
calcld for C24H35NNaO10:  520.2159, Found: 520.2128.  
 
Compound (3.59). [α]D25= -9 (c0.18,CHCl3). IR (neat): 3339, 2972, 2899, 2357, 1717, 
1455, 1378, 1271, 1086, 1046, 880, 668 cm-1. 1H NMR (CDCl3, 400MHz, δ in ppm): 
δ= 8.01 (dd, 2H, J = 8.8, 1.2 Hz), 7.57 (tt, 1H, J = 7.2 1, 6 Hz), 7.44 (t, 2H, J = 7.2 Hz), 
5.04 (d, 1H, J = 5.2 Hz), 4.65 (m, 3H), 4.4 (dd,1H, J = 13.2, 3.6 Hz), 3.97 (m, 4H), 3.66 
(brs, 1H), 2.60 (brs, 1H), 1.64 (br s, 1H), 1.52 (s, 9H). 13C NMR  (CDCl3, 100.6MHz, δ 
in ppm): δ= 166.2, 149.1,  133.6, 129.9,  129.1,  128.7, 102.0,  84.6, 74.6 , 72.6, 65.6,  
65.4, 63.6,  55.6, 28.1. ESI-HRMS [M+23] calcld for C19H27NNaO8: 420.1634, Found: 
420.1582. 
 
 
 
 
Ethyl (2S,3R,4R)-5-(benzoyloxy)-4-((bis-tert-butoxycarbonyl)amino)-2,3-dihydroxy-  
penta noate  (3.62) and ethyl (2S,3S,4S)-5-(benzoyloxy)-4-((tert-butoxycarbonyl)amino)-
2,3-dihydroxy- pentanoate  (3.63).  
 
N
Boc
O
O
BzO
3.62
Boc
OH
OH
HN
Boc
O
O
BzO
3.63
OH
OH
 
Method A 
To a solution of product 3.55 (0.7 g, 1.5 mmol) in 50 ml dichlorometane were 
added (0.44 g, 3.75 mmol) NMO and (0.47 ml, 0.075 mmol) OsO4 in water at 0ºC, 
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reaction stirred at room temperature for 24h. Reaction quenched by Na2S2O3 stirred for 
15 min, the aqueous layer was extracted with AcOEt tree times and the combined organic 
layer was washed, brine, dried (MgSO4) and concentred in vacuo. Purification of product 
(Hexane/AcOEt) provided two products 3.62 (0. 447g, 60%) and 3.63 (0.214 g, 36%) as 
yellow liquid. 
 
Method B 
Compound 3.55 (0.1 g, 0.2 mmol) was dissolved in CH2Cl2 (14ml) at -78ºC under 
dry argon. TMEDA (0.033 ml, 0.22 mmol) was added and the reaction stirred for 5 
minutes before the rapid a addition of osmium tetraoxide (0.06 g, 0.22 mmol). The dark 
coloured solution was stirred for 1 hour at -78ºC before being warmed to room 
temperature and stirred for 5h . The  solvent was removed in vacuo and the black solide 
was resolved in methanol (5ml).Concentrated hydrochloric acid (3drop) was added and 
the reaction stirred for 2 hours.the solvent was removed in vacuo to afford a product 3.63 
in 90% yield. 
  
Compound (3.62). [α]D25 = -6.2 (c10, CHCl3). IR (cm-1): 3484, 2979, 2931, 1723, 1452, 
1367, 1348, 1268, 1227, 1149, 1114, 711. 1H NMR (CDCl3, 400 MHz, δ in ppm): δ= 
8.02 (dd, 2H, J = 7.6, 1.2 Hz), 7.5 (tt, 1H, J = 7.2, 1.2 Hz), 7.4 (t, 2H, J = 7.6 Hz), 4.79 
(m ,2H) , 4.66 (m,  1H), 4.48 (t, 1H, J = 9.2 Hz ), 4.3 (m, 3H), 3.50 (d, 1H, J =4.8 Hz), 
3.20 (d , 1H, J = 9.2 Hz), 1.42 (s, 18H), 1.28 (t, 3H, J = 7.2 Hz). 13C NMR  (CDCl3, 
100.6 MHz, δ in ppm): δ= 172.8, 166.3, 154.9, 133.1, 130.1, 129.8, 128.3, 83.5, 71.9, 
70.8, 62.3, 63.1, 58.0, 27.9, 14.2. ESI-HRMS [M+23] calcd for C24H35NNaO10: 
520.2159, Found: 520.2156. 
 
Compound (3.63). [α]D25 = + 23.1 (c6, CHCl3). IR (neat): 3472, 2981, 2935, 1804, 1722, 
1370, 1267, 1208,1154, 1115,  1066, 710 cm-1. 1H NMR (CDCl3, 400 MHz, δ in ppm): 
δ= 8.01 (dd, 2H, J = 8, 0.8 Hz), 7.95 (tt, 1H, J = 7.6, 1.2Hz), 7.45 (t, 2H,  J =7.6 Hz ), 
4.77 (t, 1H, J = 2.8 Hz) , 4.63 (m, 2H), 4.52 (dd , 1H, J = 10.8, 2 Hz), 4.31 (m, 3H) , 3.31 
(d, 1H, J = 4.8 Hz), 1.61 (brs, 1H),  1.55 (s, 9H), 1.32 (t, 3H, J = 6.8 Hz). 13C NMR  
(CDCl3, 100.6 MHz, δ in ppm): δ= 170.4, 166.1, 148.8, 133.7, 129.9, 129.0, 128.7, 84.8, 
75.6, 71.3, 63.7, 63.1, 55.5, 28.0, 14.1. ESI-HRMS [M+23] calcd for C19H28NO8: 
398.1815, Found: 398.1817. 
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(2R,3R,4S)-2-amino-4-(1,3-dioxolan-2-yl)-3,4-dihydroxybutyl benzoate (3.69) (2R,3S,4R)-2-
amino-4-(1,3-dioxolan-2-yl)-3,4-dihydroxybutyl benzoate (3.70). 
 
NH2
OH
OH
BzO
O
O
3.69
NH2
OH
OH
BzO
O
O
3.70  
 
To a solution of mixture 3.59, 3.60 (0.1 g, 0.2 mmol) in CH2Cl2 (1 ml) was treated 
with triftuoroacetic (1 ml). The mixture was then stirred for 2h at 0ºC. Removal of all 
volatiles under reduced pressure gave two products one soluble in MeOH (3.69, Maj, 
0.024 g, 40%) and other soluble in CDCl3 (3.70, Min, 0.018 g , 30%). 
Compound (3.69). [α]D25 = +8.7 (c0.8,CH3OH). IR (neat): 3343, 2922, 1719, 1668, 
1540, 1271, 1181, 1131, 1044, 974, 836, 708 cm-1. 1H NMR (CD3OD, 400 MHz, δ in 
ppm): δ=  8.13 (d, 2H, J = 7.2 Hz), 7.64 (t, 1H, J = 6.8 Hz), 7.51 (t, 2H, J = 8 Hz), 5.06 
(d, 1H, J = 4.4 Hz), 4.75 (dd, 1H, J = 12, 3.6 Hz), 4.56 (dd, 1H, J = 12, 7.2 Hz), 4.11 
(dd, 1H, J = 6, 3.6 Hz), 3.98 (m, 4H), 3.82 (m, 1H), 3.72 (t, 1H, J = 3.6 Hz). 13C NMR 
(CD3OD, 100.6 MHz, δ in ppm): δ= 158, 125.1, 121.3, 121.1, 120.1, 94.7, 63.6, 59.4, 
56.9, 56.8, 53.7, 45.1. ESI-HRMS [M+] calcd for C14H20NO6: 298,1291, Found: 
298.1288. 
Compound (3.70). [α]D25 = +13.8 (c1,CHCl3). IR (neat): 3343, 2922, 1750, 1718, 
1451, 1394, 1315, 1270, 1114, 1070, 1027, 712 cm-1. 1H NMR (CDCl3, 400 MHz, δ in 
ppm): δ=  8.01 (d, 2H, J = 7.6 Hz), 7.59 (t, 1H, J=6.8Hz), 7.46 (t, 2H, J = 7.6 Hz), 
5.37(brs, 1H), 5.06 (d, 1H, J = 4.8 Hz), 4.64 (dd, 1H, J = 4.8, 2.8 Hz), 4.51 (dd, 1H, J = 
10.8, 3.2 Hz), 4.30 (m, 2H), 3.98 (m, 4H), 3.68 (brs, 1H),  2.60 (brs, 1H). ESI-HRMS 
[M+23] calcd for C14H19NNaO6 : 320.111 , Found: 320.2526. 
 
Ethyl (2S,3R,4R)-4-amino-5-(benzoyloxy)-2,3-dihydroxypentanoate (3.71). 
 
NH2
O
O
BzO
3.71
OH
OH
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To a solution of 3.62 (0.8 g, 1.6 mmol) in CH2Cl2 (8 ml) was treated with 
triftuoroacetic (8 ml). The mixture was then stirred for 2h at 0ºC. Removal of all 
volatiles under reduced pressure gave a product 3.71 in 90% yield (0.42 g). 
 
[α]D25 = + 16.6 (c1.1, MeOH). IR (neat): 3244, 2968, 1717, 1601, 1451, 1375, 1268, 
1098, 1070, 1025, 862, 710 cm-1. 1H NMR  (CD3OD, 400 MHz, δ in ppm): δ= 8.04 (d, 
2H, J = 7.6 Hz), 7.56 (t, 1H, J = 7.2 Hz), 7.43 (t, 2H, J = 8 Hz), 4.68 (dd, 1H, J = 12, 
3.6 Hz), 4.51 (dd, 1H, J = 12, 6.4 Hz), 4.35 (d, 1H, J = 2.4 Hz), 4.25 (dd, 1H, J = 2.8, 6 
Hz), 4.18 (m, 2H), 3.77 (brs, 1H), 1.22 (t, 3H, J = 1.8 Hz).  13C NMR (CD3OD, 100.6 
MHz, δ in ppm ) δ= 171.7, 166.0, 133.2, 129.4, 129.1, 128.2, 71.4, 68.3, 61.7, 61.3, 
53.0, 13.0 . ESI-HRMS [M+1] calcd for C14H20NO6 m/z [M+H]+: 298.1291, Found: 
298.1253   
 
Ethyl (2R,3S,4R)-5-(benzoyloxy)-2-3-dihydroxy-4-(trifluoroacetamido)pentanoate (3.73). 
 
O
O
HN
BzO
OH
OH
O FF
F
3.73  
To a solution of compound 3.63 (0.05 g, 0.12 mmol) in EtOH (0.6 ml) was treated 
with triftuoroacetic (0.6 ml) at 0ºC. The mixture was then stirred for 4h30 min at8 0ºC. 
Removal of all volatiles under reduced pressure provided desired product 3.73 in 60% 
yield (0.028 g). 
 
[α]D25 = +32.3 (c1.8,CHCl3). IR (neat) : 3343, 2986, 1717, 1451, 1395, 1315, 1369, 
1116, 1070, 1025, 862, 711 cm-1. 1H NMR (CDCl3, 400 MHz, δ in ppm): δ= 8 (dd, 2H, 
J = 8, 1.2 Hz), 7.57 ( tt, 1H, J =7.2,  2.8 1.6 Hz), 7.43 ( t, 2H, J = 8Hz), 6.2 (s, 1H), 4.77 
( dd, 1H, J = 4.4, 1.6 Hz) , 4.47 (dd, 1H, J = 13, 6 Hz), 4.31 (m, 5H),  3.27 (brs, 2H),  
1.29 (t, 3H, J = 6.8 Hz). 13C NMR (CDCl3, 100.6 MHz, δ in ppm): δ= 170.8, 166.3, 
158.7,  133.7, 129.9, 129.2, 128.8,  128.7,  79.0,  71.2,  65.4, 62.9, 52.7, 14.2. ESI-
HRMS [M+] calcd for C16H18 F3NO7:  393.1035, Found: 392.0977. 
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(2S,3R,4R)-4-((tert-butoxycarbonyl)amino)-2,3,5-trihydroxypentanoic acid (3.78). 
 
HN
OH
O
HO
3.78
OH
OH
Boc
 
 
Product 3.62 (0.1 g, 0.2 mmol) was dissolved in dry ethanol (1 ml), and NaOEt 
(catalytic amount) was added. The reaction mixture was stirred at room temperature for 
4h. Removal of EtOH under reduced pressure provided desired product 3.78 which is 
soluble in MeOH (0.052 g , 99%). 
 
[α]D25= +19.36 (c1.57, CH3OH). 1H NMR  (CD3OD, 400 MHz, δ in ppm): δ= 3.96 
(s,1H) , 3.81 (m,1H), 3.65 (m, 3H), 1.4 (s, 9H), 13C NMR (CD3OD, 100.6 MHz, δ in 
ppm): δ= 177.6, 156.7, 78.5, 70.9, 70.5, 60.7, 53.2, 26.75. ESI-HRMS [M+23] calcd. 
for C10H19 N Na O7: 288.1059, Found: 288.1043.  
 
(3S,4R,5R)-3-(tert-butyldiphenylsilyloxy)-5-((tert-butyldiphenylsilyloxy)methyl)-4-
hydroxypyrrolidin-2-one (3.81). 
 
N
OTBDPS
TBDPSO
HO
H
O
3.81  
An ice-cooled solution of dihidroxy ester 3.79 (0.03g, 0.076 mmol) in CH2Cl2 
(0.4ml) was treated with trifluoroacetic acid (0.4ml).The mixture was than stirred for 2h 
at 0ºC .Removal of all volatiles under reduced pressure gave residue which was 
dissolved in dry DMF (1ml) and treated under argon with tert-butyldiphenyl chloride 
(0.022 ml, 0.085 mmol) and imidazole (0.015 g, 0.22 mmol).The mixture was then 
stirred for 16h at room temperature. Workup (extraction with Et2O) and column 
chromatography on silica gel (10:3) Hexan/EtOAC provided 3.81 in 30% yield (0.014 
g). 
 
[α]D25 = +6.3 (c0.3, CHCl3). IR (neat): 2928, 2324, 1698, 1428, 1264, 1111, 896, 820, 
702, 607 cm-1.  1H NMR  (CDCl3, 400 MHz, δ in ppm): δ= 7.86 (d, 2H, J = 7.6 Hz), 
UNIVERSITAT ROVIRA I VIRGILI 
ENANTISELECTIVE SYNTHESIS OF NATURAL PRODUCTS 
Mariam Azzouz 
Enantioselective Synthesis of nectrisine 
 
78 
 
7.75 (d, 2H, J = 7.6 Hz)  7.61 (m, 4H), 7.42 (m, 12H), 5.73 (s, 1H, NH), 4.28 (d, 1H, J = 
6.8 Hz),  3.94 (td, 1H, 6.8, 3.6 Hz), 3.78 (dd, 1H, J = 10.8, 3.6 Hz), 3.56 (dd, 1H, J = 
7.2, 10, 7.8 Hz), 3.32 (td, 1H, J = 7.2, 3.6 Hz), 1.11 (s, 9H), 1.05 (s. 9H). 13C NMR 
(CDCl3, 100.6 MHz, δ in ppm): δ= 172.2, 136.3, 135.9, 135.7 (2C), 134.5, 133.0, 132.9, 
132.3, 130.4, 130.2 (3C), 128.3, 128.1 (3C), 78.0, 77.2, 65.0, 57.6, 27, 19.4 (2C). ESI-
HRMS [M+46] calcd for  C37H45 Na2 NO7: 669.2683, Found: 669.2888. 
 
 
(3S,4R,5R)-3,4-bis-(tert-butyldimethylsilyloxy)-5-((tert-butyldimethyldimethylsilyl)oxy 
Methyl)pyrrolidin-2-one (3.82). 
H
N O
OSBTTBSO
TBSO
3.82  
Lactam 3.79 (0.029 g, 0.2 mmol)  was dissolved in dry DMF (1ml) and treated 
under argon with tert-Butyldimethylsilyl chloride (0.12 ml, 0.66 mmol) and imidazole 
(0.09g, 1.32 mmol).The mixture was then stirred for 16h at room temperature .workup 
(extraction with Et2O) and column chromatography on silica gel (30:1) Hexan/EtOAC 
provided 3.82 as oil (0.034 g,  35%). 
 
1H NMR (CDCl3, 400 MHz, δ in ppm): δ= 5.74 (brs, 1H), 4.11 (d, 1H, J = 5.6 Hz), 
3.88 (t, 1H, J = 5.6 Hz), 3.80 (dd, 1H, J = 9.6, 4 Hz), 3.48 (dd, 1H, J = 10 Hz), 3.38 (td, 
1H, J = 8.8 Hz, J = 4.8 Hz), 0.91 (s, 1H), 0.89 (s, 1H), 0.88 0.19 (s, 3H), 0.14 (s, 3H), 
0.10 (s, 3H), 0.07 (s, 3H),  0.05 (s, 6H). 13C NMR (CDCl3, 100.6 MHz, δ in ppm): δ= 
173.4, 77.9, 76.8, 64.4, 60.5, 25.9, 25.7 (2C), 18.3, 17.9, -4.0, -4.1, -4.5, -4.6, -5.3.  
 
tert-butyl (3S,4R,5R)-N-tert-butoxycarbonyl-3,4-bis[(tert-butyldimethylsilyl)oxy]-5-((tert-
butyldimethylsilyloxy)methyl)-2-pyrrolidin-2-one(3.87). 
N O
OSBTTBSO
TBSO
3.83
Boc
 
  
To stirred solution of 3.82 (0.045g, 0.1 mmol), Et3N (0.013 ml, 0.13 mmol) and 
DMAP (catalytic amount) in CH2Cl2 (4 ml) was added (Boc)2O (0.03g, 0.03 mmol) at 
room temperature. After being stirred for overnight, the solvents were removed under 
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reduced pressure. The residue was then partitioned with H2O and EtOAC. The aqueous 
layer was extracted with EtOAC (3 times) and the combined organic layers were 
washed with saturated aqueous NaHCO3, brine, dried (MgSO4) and concentrated in 
vacuo. The residue was chromatographed over SiO2 (Hexane:EtOAC, 99:1) To give 
3.83  as an oil (0.025 g,  50%). 
 
[α]D25 = -19.1 (c 0.2, CHCl3), IR(neat): 2928, 1791, 1718, 1263, 1110, 835, 781, 735, 
703 cm-1.  1H NMR (CDCl3, 400 MHz, δ in ppm): δ= 4.13 (t, 1H, J=1.6 Hz), 3.95 (d, 
1H, J = 1.6 Hz), 3.88-3.74 (m, 3H), 1.52 (s, 9H), 0.89 (s, 9H), 0.88 (s, 9H), 0.87 (s, 9H), 
0.15 (s, 3H), 0.14 (s, 3H), 0.10 (s, 6H),  0.053 (s, 3H),  0.042  (s, 3H). 13C NMR 
(CDCl3, 100.6 MHz, δ in ppm): δ= 172.3, 150.3, 83.2, 78.5, 71.8, 67.0, 61.6, 28.2, 26.0, 
25.9, 25.8, 18.4, 18.3(2C), 18.1, -4.2, -4.4 (2C), -4.9, -5.2 (2C). ESI-HRMS [M+Na] 
calcd for C28H59NNaO6Si3:  612.3548, Found: 612.3568. 
 
tert-butyl (3S,4R,5R)-N-tert-butoxycarbonyl-3,4-bis(tert-butyldimethylsilyloxy)-5-((tert-
butyldimethylsilyloxy)methyl)-2-hydroxypyrrolidine (3.84). 
 
N
OTBSTBSO
TBSO
3.84
Boc
OH
 
 
To a precooled (-78ºC) solution of 3.87 (0.024 g, 0.041 mmol) in THF (1 ml) 
under argon atmosphere LiEt3BH (0.06 ml of a 1M THF solution, 0.053 mmol) was 
slowly added. After being stirred at -78°C for 2h, the solution was quenched at this 
temperature with methanol (1ml) and subsequently with 2 ml of saturated aqueous 
NaHCO3 solution. The resulting foamy slurry was allowed to warm to room 
temperature and then it was vigorously extracted with EtOAc (3 times). The extracts 
were dried (MgSO4) and concentrated in vacuo. The residue was chromatographed over 
SiO2 (Hexane/ EtOAc, 50:1) to give (0.010 g,  42%) of 3.88 as an oil. 
 
[α]D25 = -15.2 (c0.1, CHCl3). IR(neat): 2955, 2928, 1700, 1471, 1390, 1255, 1090, 835, 
778, 738 cm-1.1H NMR (CDCl3, 400 MHz, δ in ppm) δ= 5.34 (brs, 0.5H), 5.15 (brs, 
0.5H), 4.17 (brs, 1H), 3.86 (t, 1H, J = 4 Hz), 3.63 (brs, 2H), 3.49 (brs, 1H), 3.26 (brs, 
1H), 1.47 (s, 18H), 0.92 (s, 9H), 0.89 (s, 9H), 0.86 (s, 9H), 0.13 (s, 1H), 0.08 (s, 1H), 
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0.07 (s, 1H), 0.06 (s, 1H), 0.05 (s, 1H). 13C NMR (CDCl3, 100.6 MHz, δ in ppm ) δ= 
157.9, 80.3, 76.1, 66.9, 65.8, 62.1, 28.6, 26.1, 26.0, 25.9, 18.4, 18.3, 18.0, -4.4, -4.6 
(2C), -4.8, -5.4(2C). 
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4.1. Introduction 
 
Over the past 35 years,114a antiviral drug discoveriesF114Fb,F115F have attracted the 
interest of both organic and medicinal chemists to propose new potential drugs for the 
treatment of viral infections, including DNA viruses and retroviruses. Among the 
various classes of antiviral drugs, acyclic nucleoside and nucleotide derivativesF116F,F117F 
have received considerable attention due to their ability to inhibit viral DNA 
polymerases and reverse transcriptases, which play key roles in the viral cycles. Acyclic 
nucleoside phosphonates (ANPs) belong to a family of modified nucleotide analogues, 
in which the sugar moiety has been replaced by a functionalized acyclic chain linking 
the nucleobase at one end and the phosphonic acid group at the other. Therefore, ANPs 
are metabolically stable due to the presence of a phosphonate linkage (P–C) instead of a 
phosphoester (P–O), making these compounds resistant towards phosphatases. 
Furthermore, they do not require the first intracellular phosphorylation step which is 
often considered as a limiting-step and essential for the antiviral effect. Indeed, ANPs 
share their mechanism of action with other nucleoside analogues. Briefly, after two 
subsequent phosphorylation steps the ANP is converted to its corresponding 
triphosphate derivative, which can then interfere with nucleic acid biosynthesis as a 
DNA chain terminator.F118 
 
Most of the antiviral compounds that are currently used in the treatment of 
herpesvirus (herpes simplex virus (HSV), varicella-zoster virus (VZV), and 
cytomegalovirus (CMV) infectionsF119F can be described as acyclic nucleoside analogues: 
acyclovir, penciclovir, and ganciclovir (Figure 4.1). To increase their oral 
bioavailability, acyclovir, ganciclovir, and penciclovir have been converted to their oral 
prodrug forms (termed valaciclovir, valganciclovir, and famciclovir, respectively). 
Following their absorption from the gut, these compounds are reconverted to the parent 
compounds before reaching their target organ(s).114c 
                                                 
114  a) Kasthuri, M.; Chaloin, L;. Perigaud, Christian.; Pyrottes, S. Tetrahedron : Asymmetry 2011, 1505-1511. b) 
De Clercq, E. Med. Res. Rev. 2008, 28, 929–953, c) De Clercq, Clin. Microbiol. Rev. 2003, 569-596. 
115   De Clercq, E. Rev. Med. Virol. 2009, 19, 287–299. 
116      De Clercq, E. Biochem. Pharmacol. 2011, 82, 99–109. 
117      De Clercq, E. Biochem. Pharmacol. 2007, 73, 911–922. 
118      De Clercq, E.; Holy, A. Nat. Rev. Drug Disc. 2005, 4, 928–940. 
119      De Clercq, E. Rev. Med. Virol. 1995, 5, 149–164. 
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Figure 4.1. Acyclic nucleoside analogues and acyclic nucleotide analogues (acyclic nucleoside 
phosphonates)114c 
 
        After the acyclic nucleoside analogues have been taken up by the cells, they have to 
be phosphorylated through three consecutive phosphorylation steps (Figure 4.2) before 
they can interact, in their triphosphate form, with their target enzyme, the viral DNA 
polymerase. Of crucial importance in this phosphorylation process is the first 
phosphorylation step which is ensured by a specific virus-encoded thymidine kinase 
(TK) (for HSV and VZV) or a specific virus-encoded (UL97) protein kinase (PK) (for 
CMV).F120F Once the compounds have been phosphorylated to the monophosphate, 
cellular kinases (i.e., GMP kinase and NDP kinase) will afford their further 
phosphorylation to the di- and triphosphate stages.F121F In their triphosphate form, the 
compounds then interact as competitive inhibitors or alternate substrates with the 
normal substrates [2'-deoxynucleoside 5'-triphosphates (dNTPs)], and if they are 
incorporated into the DNA chain, they may act as chain terminators, thus preventing 
further chain elongation. It should be noted that, as while acyclovir obligatorily acts as a 
                                                 
120   Field, A. K.; Biron. K. K. Clin. Microbiol. Rev. 1994, 7, 1–13. 
121     De Clercq, E. Biochem. Pharmacol. 1991, 42, 963–972. 
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chain terminator, ganciclovir and penciclovir may also be incorporated, via an 
internucleotide linkage, in the interior of the DNA chain.114c 
 
Among the acyclic nucleoside phosphonates that have been pursued as antiviral 
agents are cidofovir (HPMPC) [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) 
cytosine], adefovir (PMEA) [9-(2-phosphonylmethoxyethyl) adenine], and tenofovir 
(PMPA) [(R)-9-(2-phosphonylmethoxypropyl) adenine]. Because of their limited oral 
bioavailability, the last two compounds have been converted to their oral prodrug forms, 
adefovir dipivoxil or bis(pivaloyloxymethyl)- PMEA [bis(POM)-PMEA] and tenofovir 
disoproxil or bis(isopropyloxycarbonyloxymethyl)- PMPA [bis(POC)-PMPA], 
respectively (Figure 4.1).114c 
 
 
 Figure 4.2. Intracellular metabolism of acyclic nucleoside analogues and acyclic nucleotide 
analogues. The former need three phosphorylation steps whereas the latter only need two to be 
converted to their active metabolites (the dNTP analogues). Symbols: ●, phosphate; 〇, 
phosphonate.114c 
 
The story that would eventually lead to the successful commercialization of the 
acyclic nucleoside phosphonates as antiviral drugs started some 35 years ago,117 when 
Dr. Anthonin Holy decided to collaborate on the exploration of the antiviral activity of 
new nucleoside analogues, in particular acyclic nucleoside analogues, and the first 
compound he found active in this series was [9-(2,3-dihydroxypropyl)adenine] (DHPA) 
(Scheme 4.1).F122F  
 
                                                 
122    De Clercq, E.; Descamps,  J.; Somer. P. ;  Holy,  A. Science 1978, 200, 563–565. 
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This publication came just a few months after the acyclic guanosine analogue 
acyclovir had been described as a selective anti-herpes simplex virus (HSV) agentF123F 
that owed its selectivity to a specific phosphorylation by the HSV-induced thymidine 
kinase (TK).F124F Although less potent than acyclovir against HSV, DHPA was active 
against a broad range of both DNA and RNA viruses, and its antiviral effects, as shown 
later were due to interference with the S-adenosylhomocysteine (SAH) hydrolase, thus 
inhibiting viral RNA maturation. In the early eighties, they examined the antiviral 
potential of various other acyclic nucleoside analogues, i.e. (R,S)-3-adenin-9-yl-2-
hydroxy-propanoic acid (AHPA) derivatives.F125F Their antiviral activity spectrum was 
essentially similar to that of (S)-9-(2,3-dihydroxypropyl)adenine (DHPA) and so was 
their mechanism of action.117 
 
With (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine (HPMPA) a totally 
new concept was born.F126F This acyclic nucleoside phosphonate, which could be 
envisaged as hybrid molecule between DHPA and PFA (phosphonoformic acid) 
(Scheme 4.1) exhibited a remarkable broad-spectrum activity against virtually all DNA 
viruses, including those that did not induce a specific viral TK, such as human 
cytomegalovirus (HCMV). Although HPMPA itself was not further developed as an 
antiviral drug, it served as the prototype compound for a series of acyclic nucleoside 
phosphonates (cidofovir, adefovir and tenofovir).117 
 
 
 
Scheme 4.1. (S)-9-(3-Hydroxy-2-phosphonylmethoxypropyl)adenine (HPMPA), and its 
predecessors 9-(2,3-dihydroxypropyl)adenine (DHPA) and phosphonoformic acid (PFA)117 
                                                 
123      Schaeffer, H. J.; Beauchamp, L.; Miranda,  P.; Elion, G. B.; Bauer, D. J.; Collins, P. Nature 1978, 
 272, 583–585. 
124      Elion, G. B.; Furman, P. A.; Fyfe, J. A.;  Miranda,  P. ;  Beauchamp, L. ; Schaeffer,  H. J. Proc. Natl.  
 Acad. Sci. USA. 1977, 74, 5716–5720. 
125      De Clercq, E.; Holy, A. J Med Chem. 1985, 28, 282–287. 
126      De Clercq, E.; Holy, A.; Rosenberg, I.; Sakuma, T.; Balzarini, J.; Maudgal. P. C. Nature 1986,  323,  
 464–467. 
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4.1.1. Cidofovir117 
The antiviral properties of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) 
cytosine (HPMPC, cidofovir), now on the market as Vistide® (Figure 4.3) were first 
described in 1987.F127F The antiviral activity spectrum of cidofovir (HPMPC) is similar to 
that of HPMPA. It is active against virtually all DNA viruses, including polyoma-, 
papilloma-, adeno-, herpes-, and poxviruses. Among the family of herpesviridae, all 
eight human herpesviruses (HSV-1, HSV-2, VZV, EBV, HCMV, HHV-6, HHV-7 and 
HHV-8), and, among the poxviruses, vaccinia, variola, cowpox, monkeypox, camelpox, 
molluscumcontagiosum have proved to be susceptible to the inhibitory effects of 
cidofovir.  
 
Figure 4.3. (S)-1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC, cidofovir, 
Vistide®).117 
 
Its mechanism of action, as in the case of human cytomegalovirus (HCMV), has 
been clearly demonstrated (Scheme 4.2), it is based on DNA chain termination 
(following the intracellular conversion of cidofovir to its diphosphate and the successive 
incorporation of two cidofovir units into the growing DNA chain.F128 
 
                                                 
127      De Clercq, E. Sakuma, T.; Baba, M.; Pauwels, R.; Balzarini, J.; Rosenberg, I.; Holy, A. Antivir. Res.  
 1987, 8, 261–272. 
128    De Clercq, E. Nature Rev. Microbiol. 2004, 2, 704–720. 
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                                                  Scheme 4.2. Mechanism of action of cidofovir117 
 
From a clinical viewpoint, cidofovir has been licensed for use, upon intravenous 
administration at a dose of 5mg/kg once every other week, in the treatment of HCMV 
retinitis in AIDS patientsF129F. Its future, however, lies in the remarkable, albeit anecdotal, 
results which have been accumulated with cidofovir when used topically or systemically 
in the treatment of HPV-associated diseases such as hypopharyngeal papilloma,F130F 
laryngeal papilloma,F131F recurrent respiratory papillomatosisF132F or plantar warts,F133F or 
poxvirus-associated diseases, such as molluscum contagiosum in AIDS patientsF134F or 
Orf (ecthyma contagiosum) in immunosuppressed patients.F135F Clearly, cidofovir should 
be further pursued for its potential in the treatment of those virus infections (i.e. 
papilloma, pox) for which, at present, there are few, if any, therapeutic alternatives. 
 
 
 
 
                                                 
129    De Clercq, E.; Holy, A. Nat. Rev. Drug Discov. 2005, 4, 928–940. 
130    Van Cutsem, E.; Snoeck,  R.; Van Ranst, M.; Fiten, P.; Opdenakker , G.; Geboes, K.; Janssens J, Rutgeerts P,
 Vantrappen G, de Clercq, E.  J. Med. Virol. 1995, 4, 230–235. 
131  Snoeck, R.; Wellens, W.; Desloovere, C.; Van Ranst, M.;  Naesens, L. De Clercq, E. Feenstra, L. J.  
 Med. Virol. 1998, 54, 219–225. 
132    Pransky, S. M.; Magit, A. E.; Kearns, D. B.;  Kang, D. R.; Duncan, N.O. Arch. Otolaryngol. Head  
 Neck. Surg. 1999, 125, 1143–1148. 
133    Davis, M. D.; Gostout, B. S.; McGovern,  R. M.;  Persin, D. H.; Schut,  R. L.;  Pittelkow,  M. R.; J  
 Am. Acad. Dermatol. 2000, 43, 340–343. 
134    Meadows, K. P.; Tyring, S. K.; Pavia, A. T.;  Rallis, T. M. Arch. Dermatol. 1997, 133, 987–990. 
135    Geerinck, K.; Lukito,  G.; Snoeck, R.; De Vos, R.; De Clercq, E.; Vanrenterghem , Y.; Degreef, H.; Maes, B.  
 J. Med. Virol , 2001, 64, 543–549. 
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4.1.2. Adefovir117 
The antiviral activity  spectrum of 9-(2-phosphonylmethoxyethyl)adenine 
(PMEA, adefovir, now marketed as its oral prodrug form bis(pivaloyloxy methyl) ester 
of PMEA, adefovir dipivoxil, Hepsera®] (Figure 4.4),  is partially overlapping with that 
of cidofovir in that both are active against herpesviruses (i.e. HSV-1, HSV-2, VZV, 
EBV, HCMV), but, in addition, adefovir is also active against hepadnaviruses (i.e. 
human and duck hepatitis B viruses) and retroviruses (HIV-1, HIV-2, SIV, feline 
immunodeficiency virus (FIV), visna/maedi virus, feline leukemia virus, LP-BM5 
(murine AIDS) virus and Moloney (murine) sarcoma virus). 
 
 
 
Figure 4.4.  Adefovir dipivoxil (Hepsera®).117 
 
In its mechanism of action (Scheme. 4.3), adefovir follows a similar strategy as 
cidofovir. Once adefovir has penetrated into the cell, it needs two subsequent 
phosphorylations to be converted to its diphosphate, which, after removal of the 
pyrophosphate moiety, is incorporated into the viral DNA and acts as an obligatory 
DNA chain terminator.X128 
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Scheme 4.3. Mechanism of action of adefovir117 
 
From a clinical view point, adefovir was first pursued for its potentiall use in the 
treatment of HIV infections (AIDS) but was eventually licensed in its prodrug form 
(adefovir dipivoxil) for the treatment of HBV infections (chronic hepatitis B).X129 
          
4.1.3. Tenofovir117 
The antiviral activity of (R)-9-(2-phosphonylmethoxypropyl) adenine (PMPA, 
tenofovir, now marketed as its oral prodrug form [bis(isopropyloxycarbonyloxymethyl) 
ester of PMPA, tenofovir disoproxil fumarate, TDF, Viread®] (Figure 4.5) was first 
described in 1993 F136F in a paper also pertaining to the activity of its 2,6-diaminopurine 
counterpart. The anti-HIV effects of the (R)-enantiomers of PMPA and PMPDAP were 
demonstrated in several human cell systems, including peripheral blood lymphocytes 
and freshly isolated monocyte-macrophages.F137F The in vivo anti-HIV efficacy of the 
prodrug, bis(isopropyloxycarbonyloxymethyl)-(R)-9-(2-phosphonylmethoxypro-pyl)- 
adenine, and its cellular metabolism were reported by Naesens et al.F138F and Robbins et 
                                                 
136    Balzarini, J.; Holy, A.;  Jindrich, J.; Naesens, L.; Snoeck, R.;  Schols, D.; De Clercq, E.  Antimicrob.  
 Agents Chemother. 1993, 37, 332–338. 
137     Balzarini, J.;  Aquaro,  S.; Perno, C. F.;  Witvrouw , M.;  Holy,  A.; De Clercq,  E. Biochem. Biophys.  
 Res. Commun. 1996, 219, 337–341. 
138     Naesens, L.;  Bischofberger, N.; Augustijns, P.;  Annaert,  P.; Van den Mooter, G.; Arimilli, M. N.;  
 Antimicrob. Agents Chemother 1998, 42, 1568–1573. 
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al.F139F The antiviral activity spectrum of tenofovir is narrower than that of adefovir, in 
that it no longer extends to herpesviruses but is confined to hepadna- and retroviruses. 
In its mechanism of action, tenofovir is assumed to follow exactly the same strategy as 
that of adefovir.F140 
 
 
 
Figure 4.5. Tenofovir disoproxil fumarate (TDF, Viread®)117 
 
From a clinical viewpoint, tenofovir disoproxil fumarate (TDF) has been licensed 
for the treatment of HIV infections (AIDS), as either a single drug (Viread®) (Figure 
4.5) once daily. 
 
4.1.4. Synthesis of HPMPC (cidofovir) and HPMPA143a 
         
HPMPC (cidofovir) and its cyclic analogue (cHPMPC) exhibit an antiviral 
activity spectrum that is quite similar to that of HPMPA (and cHPMPA). 
 
Synthesis of (S)-HPMP derivatives mostly utilizes basically catalyzed 
nucleophilic opening of the oxirane ring in (2S)-2-[(trityloxy]methyl]oxirane or (R)-
glycidol butyrate with an appropriate nucleobase like N4-benzoylcytosine, N6-
benzoyladenine or 2,6-bis(benzoylamino)purine (Scheme 4.4)F141F,F142F This reaction 
proceeds regioselectively to N9 position of the purine or N1 position of the pyrimidine 
base. The intermediates 2,3-dihydroxypropyl derivatives formed are subsequently 
etherified with dialkyl (diethyl or diisopropyl) ester of tosyloxymethanephosphonate in 
the presence of sodium hydride. After removal of benzoyl and trityl groups, phosphonic 
                                                 
139    Robbins, B. L.;  Srinivas,  R. V.; Kim, C.; Bischof berger, N.; Fridland, A. Antimicrob. Agents  
 Chemother 1998, 42, 612–617. 
140    De Clercq,  E. Expert Rev. Anti-infect. Ther. 2003, 1, 21–43. 
141    Webb, R.R.; Wos, J.A.; Bronson, J.J; Martin, J.C.  Tetrahedron Lett. 1988,  29, 5475–5478, 
142    Brodfuehrer, P.R.; Howell, H.G.; Sapino, C.; Vemishetti, P. Tetrahedron Lett. 1994, 35, 3243–3246. 
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ester groups were deprotected by the treatment with bromotrimethylsilane followed by 
hydrolysis.F143b 
 
Scheme 4.4.  Synthesis of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] derivatives of adenine 
and cytosine (HPMPA and HPMPC) from glycidol143a 
 
4.1.5. Synthesis of some unsaturated HPMPC analogues156 
 
The key synthetic steps leading to HPMPC analogues, vinyl ANP and allyl ANP, 
involve the olefin cross-metathesis reaction and the palladium-mediated C5-alkylation 
of the uracil moiety. Thus, two series of vinyl ANP and their allyl analogues have been 
obtained from the same N1- crotyl-5-phenylthiouracil (Figure 4.6). 
 
                                                 
143         a) Nucleoside and Nucleotide Analogues for the Treatment of Herpesvirus Infections: Current Stage and New 
Prospects in the Field of Acyclic Nucleoside Phosphonates. b) Holy, A. Collect.Czech. Chem. Comm. 1993, 
58, 649–674. 
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          Figure 4.6. Some bioactive acyclic nucleoside phosphonates realted to cidofovir. 
 
 
Recently, Grubbs et al.X51X reported on a general model for selectivity in cross-
metathesis (CM), by ranking the olefin reactivity in CM by categorizing the olefins in 
their abilities to undergo homodimerization via CM and by the stability of those 
homodimers. Based on this model, H. Kumamoto et al began to explore the cross-
metathesis reaction of the reactive crotylated uracil 4.6 with vinyl diethylphosphonate, 
(Scheme 4.5). The desired cross-coupling heterodimer 4.7 was obtained in 67% yield as 
the E isomer. It is important to note that the reaction proceeded without the protection at 
the N3-position of the heterocycle. Compound 4.7 was deprotected with TMSBr to 
afford the desired ANP. 
 
 
 
                              Scheme 4.5. Synthesis of vinyl ANP 4.8 
 
The same procedure was successfully applied to the cross-metathesis involving 
dimethylallyl phosphonate. Starting from N3-benzoylated crotylated uracil 4.10 
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prepared from N3-benzoyluracil 4.9,F144F the CM reaction gave the desired allyl 
phosphonate 4.11, isolated as a mixture of major and thermodynamically stable E-
isomer (4.11a, 72%) with the minor Z-isomer present in small amounts (4.11b, 15%) 
(Scheme 4.6). Both isomers can be separated by liquid chromatography on silica gel. 
Compounds 4.11a and 4.11b were deprotected with TMSBr to afford the desired 
products 4.12a (98%) and 4.12b (66%). 
 
 
 
Scheme 4.6. Synthesis of allyls ANPs 4.12a and 4.12b 
 
           Based on those results, they extended this approach to several 5-substituted uracil 
derivatives, which were obtained using the 5-phenylsulfonyluracil derivative 4.13 and 
its 3-N-benzoyl derivative 4.14, as synthetic common intermediates for the construction 
of either the C5-halogeno- 4.16a-c or the C5-carbon-substituted 4.16d-f uracil 
analogues as well as their N3-protected analogues 4.17a-f (Scheme 4.7). Thus, the 5-
phenylthio derivative 4.13 was prepared from 4.9 by (i) introduction of phenylthio 
group at the C5-position, (ii) crotylation of the N1-position, and (iii) debenzoylation of 
N3-position in 65% over three steps. By treating 4.13 with tributyltin hydride, a sulfur-
extrusive stannylationF145F occurred and the desired tin derivative 4.15 was obtained in 
high yields. On the one hand, the Pd(0)-mediated Stille-coupling reactionF146F involving 
4.15 allowed the isolation of the desired C5-carbon substituted derivatives 4.16a-c. On 
the other hand, compound 4.15 was easily converted into the 5-chloro (4.16e), and 5-
                                                 
144  Cruickshank, K. A.; Jiricny, J.; Reese, C. B. Tetrahedron Lett. 1984, 25, 681–684. 
145  Tanaka, H.; Hayakawa, H.; Obi, K.; Miyasaka, T. Tetrahedron 1986, 42, 4187–4195. 
146  Agrofoglio, L. A.; Gillaizeau, I.; Saito, Y. Chem. Rev. 2003, 103, 1875–1916. 
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bromo derivatives (4.16f) by simple treatment with NCS or NBS, respectively. A final 
benzoylation of 4.16a-f afforded the desired protected analogues 4.17a-f.  
 
 
Scheme 4.7. Synthesis of vinyls ANPs 4.16a-f and 4.17a-f 
 
The C5-substituted N3-unprotected uracil derivatives 4.13, 4.16a-e were engaged 
in a cross-metathesis reaction with diethyl vinyl phosphonate. The desired cross-
metathesis products 4.18a-e were isolated in moderate to good yield. The 
stereochemistry of the olefin was confirmed by 1H NMR and 31P NMR spectroscopy.  A 
final deprotection by treatment with TMSBr in CH2Cl2 afforded the free phosphonates 
4.20a-f in good yields (Scheme 4.8).  
 
The cross-metathesis of N3-protected uracil analogues 4.14, 4.17a-e with allyl 
diethylphosphonate was also performed and the cross products 4.19a-f were isolated as 
a mixture of E and Z isomers (average E/Z ratio 8:2) separable by chromatography. The 
final deprotection of N3-benzoyl and diethylphosphonate was similarly performed by 
treatment with TMSBr in CH2Cl2, and the free phosphonates 4.21a-f were obtained in 
good yields, respectively. 
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Scheme 4.8. Synthesis of allyls ANPs 4.20 and 4.21 
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4.2. Retrosynthesis 
 
                Spurred by the yet unexplored synthetic possibilities of this family of 
nucleosides, we became interested in the search for a new enantioselective method for 
the synthesis of acyclic nucleoside phosphonate analogues, and in particular, Cidofovir 
(HPMPC) analogues. Figure 4.7 shows the structural modifications proposed in 
comparison with the structure of Cidofovir and the vinyl ANP and allyl ANP analogues 
already prepared. 
 
 
Figure 4.7. Structural relationship between cidofovir and the target compounds 
 
             Unlike Cidofovir, where cytosine is bonded to a methylene group, the target 
compound presents a structure where the nucleic base is directly connected to a 
sterocenter, whose stereochemistry was chosen according to that of the one present in 
Cidofovir. We envisaged that the target compounds could be easily accesed using a 
synthetic scheme similar to that used in the synthesis of the nectrisine, based on 
palladium catalyzed allylic amination and cross-metathesis. The strategy would afford 
unsaturated compounds related to that of the allyl ANP analogue (Figure 4.1). A further 
structural modification to be considered is the reduction of the double bond to afford 
saturated acyclic nucleotide phosphonate analogs. In comparison to the structure of 
Cidofovir, those of the saturated compounds proposed would result from formal 
migration of the hydroxymethyl moiety to the carbon atom directly connected to the 
nucleic base and replacement of the oxygen atom at position 3 by a methylene group. 
Besides cytosine, other nucleic bases would be also considered to afford a small library 
of acyclic nucleotide phosphonates. 
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In this context, the retrosynthetic proposal is shown in Scheme 4.9. Cidofovir 
(HPMPC) analogues could be obtained by double bond reduction of product 4.22 
followed by protecting group cleavage on compound 4.25. Compound 4.22 in turn can 
be synthesized from compound 4.23 via chain elongation mediated by cross-metathesis 
reaction. Lastly, chiral synthon 4.23 could be obtained by a palladium-catalyzed 
dynamic kinetic asymmetric transformation (DYKAT) from racemic butadiene 
monoepoxide (4.24). 
 
                 Scheme 4.9. Retrosynthetic approach for the synthesis of Codofovir  
(HPMPC)    analogues. 
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4.3. Results and discussion    
4.3.1. Synthesis of allyl amines by a Pd-catalyzed allylic aminationX33X,X34 X,F147 
As it was discussed in the introduction and in the previous chapter, Pd-catalyzed 
asymmetric allylic alkylation (Pd-AAA) has become a powerful tool for the 
construction of stereocenters and has engendered a number of versatile methods for the 
total synthesis of natural products and other biologically active targets.  
 
            In this regard, we decided to explore the viability of the Pd-catalyzed 
deracemization of vinyl epoxide with different nucleic bases as nucleophiles using 
Trost’s ligands in order to obtain enantiopure allyl nucleobases that could serve as 
intermediates for the synthesis of acyclic nucleotide phosphonates. 
 
           The use of nucleobasesF148F,F149F as nucleophiles in asymmetric Pd-catalyzed allylic 
alkylationF150F, is not trivial. They have been shown to behave differently to other simple 
nucleophilesF151F,F152F, such as malonates, sulfinates, azides and amines in 
desymmetrization processes, where the asymmetric induction should in priciple be 
independent of the nucleophile. Contrarily, they have shown a remarkable effect on the 
catalytic turnover and the enantioselectivity of desymmetrization reactions, probably as 
a result of their ability to serve as competitive ligands and thereby disrupt the normal 
coordination of the palladium. 
  
          We initially explored the feasibility of the process with pyrimidine bases such as 
uracil and thymine. In order to guarantee N1 alkylation and prevent N3-alkylation and/or 
bis-alkylation, the process imposes previous protection of the imino functionality at N3. 
Furthermore, protection of the N3 functionality increases the lipofilicity of the 
compounds, allowing for the use of common organic solvents in the Pd-catalyzed 
asymmetric allylic amination. Thus, 3-N-benzoyluracil 4.28F153F was prepared by treating 
                                                 
147   Trost, B. M.; Osipov , M.; Dong. G. J. Am. Chem. Soc. 2010, 132, 15800–15807. 
148    Trost, B. M.; Kuo, G. H.; Benneche, T. J. Am. Chem. Soc. 1988, 110, 621–622. 
149    Trost, B. M.; Madsen, R.; Guile, S, D. Tetrahedron Lett. 1997, 38, 1707–1710. 
150   Trost, B. M. Acc. Chem. Res. 1996, 29, 355–364 
151   Trost, B. M.; Madsen, R.;  Guile, S. D.; Brown, B. J. Am. Chem. Soc. 2000, 122, 5947-5956 
152  Trost, B.M.; Madsen, R.; Guile, S.G.; Elia, A.E.H. Angew. Chem. Int. Ed. Engl. 1996, 35, 1569-1572 
153   Hyunseok, A.; Tae,  H,  C.; Kathlia, C.; Kyo, C, L.; Byoungsoo, K.; Byung, S, M.; Su Hee, H.; Jong, C,  
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uracil with an excess of benzoyl chloride (4.27), in the presence of pyridine as base to 
afford the desired product 4.28 F154Fwith 65% yield (Scheme 4.10). 
 
 
                      Scheme 4.10. Synthesis of 3-N-benzoyluracil 4.28 
 
 
         3-N-Benzoylthymine 4.30X154X was similarly prepared from thymine by reaction 
with an excess benzoyl chloride (Scheme 4.11). The reaction afforded product 4.30 with 
60% yield. 
 
N
H
NH
O
O
Cl
O pyridine
acetonitrile
0ºC , 12h
60%
N
H
N
O
O
O
4.304.29 4.27  
                             Scheme 4.11. Synthesis of 3-N-benzoylthymine 4.30 
With the protected uracil and thymine in hand we explored the allylic amination 
reaction. Thus, when butadiene monoepoxide 4.22 was treated with protected uracil 
4.28 in the presence of a 2 mol % [(η3-C3H5)PdCl]2  and 6 mol % of ligand 4.35 in 
dichloromethane (DCM) at room temperature for 18h, the desired product 4.31 was 
obtained  in 81% yield and 82% ee (Table 4.1, Entry 1). Increasing the temperature at 
35ºC afforded the desired product 4.31 in 79% yield and 73% ee (Table 4.1, Entry 2). 
When the reaction was conducted at lower temperature, 0ºC, product 4.31 was obtained 
in 80% yield and 70% ee (Table 4.1, Entry 3). For high enantioselectivities to be 
obtained, in addition to a selective alkylation of one diastereomeric intermediate over 
the other (K1>>>>k2), a Curtin-Hammett condition must be established, wherein 
interconversion is rapid and successfully competes with nucleophilic addition. In this 
regard, heating can favor equilibration of the π-allyl intermediates, but at the same time, 
can also balance the rates of corresponding nucleophilic additions (k1 > k2), leading to 
                                                                                                                                               
 L.; Kwon, S, C.; Gi Jeong, C.; Sang Moo L.;  Gwang Il, A.; Hakjune, R. J. Med. Chem. 2007, 50, 6032–6038. 
154        Hyunseok, A.; Tae,  H,  C.; Kathlia, C.; Kyo, C, L.; Byoungsoo, K.; Byung, S, M.; Su Hee, H.;Jong, C,  
L.; Kwon, S, C.; Gi Jeong, C.; Sang Moo L.;  Gwang Il, A.; Hakjune, R. J. Med. Chem. 2007, 50, 6032–6038. 
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decreased enantioselectivities, as it happens to be the case. On the other hand, decreased 
enantioselectivities when performing the reaction at lower temperatures may be 
attributed to the rate of π-allyl complex equilibration being slower than the rate of 
nucleophilic attack. 
         Shorter reaction times (5h) led to similar results to those obtained in entry 2 (Table 
4.1, Entry 4). Additionally, the choice of solvent had a marginal effect on the course of 
this transformation, with virtually the same values of yield and enantioselectivity (Table 
4.1, entries 5 and 6) 
 
Table 4.1. Allylic amination of butadiene monoepoxide using 4.28 as nucleophile, and 
[(η3-C3H5)PdCl]2/(R,R)-DACH-naphthyl as catalytic system. 
 
 
Entry Temp.  
(ºC) 
Solvent Conv 
  (%)[b] 
Regioselec. 
4.31:4.32[c] 
Yield of  
4.31 (%)[d] 
ee 
(%)[e] 
1 rt CH2Cl2 >99 >99:1 81 82 
2 35 CH2Cl2 >99 >99:1 79 73 
3 0 CH2Cl2 >99 >99:1 80 70 
4[f] rt CH2Cl2 >99 >99:1 83 84 
5 rt THF >99 >99:1 80 84 
6 rt CH3CN >99 >99:1 85 86 
[a] Conditions: [(η3-C3H5)PdCl]2 (2 mol%),  (R,R)-naphtyl Trost ligand (6 mol%), butadiene 
monoepoxyde (1.1. equiv), nucleic base (1.1 equiv.), time= 18h. [b] Determined by 1H NMR. [c] 
Determined by 1H NMR as branched:linear ratio. [d] Isolated yield of branched compound. [e] 
Determined by chiral HPLC Column (hexanes:iPrOH 85:15, 0.4 ml/min, Column OD-H). [f]  
Reaction stirred for 5h. 
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        The reaction 3-N-benzoylthymine (4.30) with butadiene monoepoxide under the 
optimized conditions afforded the branched N-alkylated product 4.33 in lower yield 
50% and 66 % ee (Scheme 4.12). 
 
Scheme 4.12. Pd-AAA of butadiene monoepoxide using 4.30 as nucleophile. 
 
 
Under all the conditions evaluated, the branched. N-alkylated product was 
observed exclusively, demonstrating the profound chemo- and regioselectivity of the 
transformation. 
 
We next explored the reaction with cytosine, which also required protection in 
order to avoid selectivity problems. Reaction of cytosine with Boc anhydride in the 
presence of DMAP and THF at room temperature afforded product 4.37 in 99% yield, 
which was treated by NaHCO3 and  MeOH  at  50ºC for 1h  to give the desired product 
4.38 in 98% yield (Scheme 4.13).F155F  
 
                                  Scheme 4.13. Synthesis of protected cytosine 4.38 
        The Pd-catalyzed asymmetric allylic amination of protected cytosine 4.38 and 
butadiene monepoxide in the presence of 2 mol% Pd/6 mol% DACH naphthyl ligand in 
dichloromethane at rt for 18 h furnished 4.42 in good yield (82%) and moderate 
enantioselectivity (67%) (Table 4.2, Entry 1). Working at lower temperatures (0ºC) 
                                                 
155    Andrea, P.; Giampaolo, G.; Ivana, P.; Mariolino, C.; Giammario, N. Eur. J. Org. Chem. 2008,  
 5786-5797.  
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rendered the product 4.42 with slightly increased enantioselectivity, whereas gentle 
heating at 35ºC produced an erosion of the enantioselectivity of the process (36%ee). 
The temperature effect differs from uracil, where the best enantioselectivitiy was 
obtained at room temperature. In all cases, conversions are complete and yields do not 
vary substantially. Furthermore, yield and enantioselectivity remain unaltered regardless 
the reaction time inverted in the process (5h or 18h). 
        The study was extended to the use of purine nucleobases. Protected adenine 4.41 
was prepared by treatment with an excess of (BoC)2O to afford fully protected 
derivative 4.40, followed by partial hydrolysis with NaHCO3 and MeOH at 50ºC for 1h 
to give the desired product 4.41 in 96% yield (Scheme 4.14)X155X  
 
 
                                Scheme 4.14. Synthesis of  protected adenine 4.41 
 
     All AAA experiments with adenine, butadiene monoepoxide, 2 mol% Pd / 6 mol% 
DACH naphthyl ligand in dichloromethane led to full conversion, good yield (85-90%) 
and complete regioselectivity to give compound 4.44. In general, enantioselectivity 
values are superior to those obtained for cytosine. The temperature effect over 
enantioselectivity is similar to that of uracil, with maximum enantioselectivity (91%) at 
room temperature (Table 4.2, Entries 5, 6 and 9). As already seen in other cases, 
reaction time does not seem to affect either the yield or the enantioselectivity (Table 4.2, 
Entries 6, 8), and the same happens to apply to the solvent effect, where replacement of 
dichloromethane by THF resulted in a marginal erosion in yield and enantioselectivity. 
We also studied the reaction of butadiene monoepoxide with acetylcytosine 4.46 
in dichloromethane at 35ºC in the presence of 6 mol%(R,R)-DACH-naphtyl and 2 mol% 
[η3(-C3H5)PdCl]2 as a catalyst precursor obtaining the dialkylated product 4.47 in 40% 
yield (Scheme 4.15). Since it is clear that both NH present in the compound can react, 
no further studies were considered. 
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Table 4.2. Allylic amination of butadiene monoepoxide using 4.38 and 4.41 as 
nucleophiles, and Pd/ (R,R)-DACH- naphthyl Trost ligand as catalytic system. 
 
 
 
Entry Nu Temp. 
(ºC) 
Solvent Product Conversion 
(%)[b] 
Regioselec. 
Branched/linear[c] 
Yield of 
branched 
(%)[d] 
Ee 
(%)[e]
1 4.38 rt CH2Cl2 4.42 >99 >99:1 82 67 
2 4.38 0 CH2Cl2 4.42 >99 >99:1 85 72 
3 4.38 35 CH2Cl2 4.42 >99 >99:1 81 36 
4[f] 4.38 rt CH2Cl2 4.42 >99 >99:1 80 68 
5 4.41 35 CH2Cl2 4.44 >99 >99:1 87 77 
6 4.41 rt CH2Cl2 4.44 >99 >99:1 89 91 
7 4.41 rt THF 4.44 >99 >99:1 85 87 
8[f] 4.41 rt CH2Cl2 4.44 >99 >99:1 90 92 
9 4.41 0 CH2Cl2 4.44 >99 >99:1 85 70 
 [a] Conditions: catalyst (2 mol%),  (R,R)-naphtyl Trost ligand (6 mol%), 1 equiv of  butadiene monoepoxide and 1.1 
equiv of Nu, all reactions stirred for 18h. [b] Determined by 1H NMR. [c] Determined by 1H NMR as 
branched:linear ratio. [d] Isolated yield of branched compound. [e] determined by chiral HPLC Column 
(hexanes:iPrOH 90:10 , 0.5-0.6 ml/min, Column OD-H). [f] Reaction stirred for 5h.  
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Scheme 4.15. Reaction of butadiene monoepoxide with cytosine 4.47 
4.3.2. Synthesis of 1,2-disubstituted allyl amines by Ru-catalyzed cross-
metathesisF156 
 
          Next synthetic step in our synthetic plan aimed at elongating the hydrocarbon 
skeleton with an alkyl chain that incorporates the phosphonate moiety while 
maintaining the unsaturated function. Such a transformation can be carried out by 
means of a ruthenium-catalyzed cross metathesis. Reaction of the allyl cytosine 
derivative 4.42 with the reactant of choice, namely diethylallyl phosphonate (4.48), in 
the presence of 5 mol% of 2nd generation Grubbs catalyst in dichloromethane at 55 ºC 
for 16 h, followed by hydroxyl protection as a benzoate afforded the desired product 
4.50 in an excellent 90% yield as the E isomer (Scheme 4.16). 
 
 
 
 
Scheme 4.16. Synthesis of compound 4.50 
 
 
                                                 
156   Hiroki, k.; Topalis, D.; Broggi, J.; Pradere, U.; Roy, V.; Berteina-Raboin, S.; Nolan, P. S.; Deville-Bonne, D.;  
 Andrei, G.; Snoeck, R.; Garin, D.; Crance, J.M.; Agrofoglio L. A. Tetrahedron  2008, 64, 3517–3526. 
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We also attempted the cross-metathesis reaction over the silyl protected derivative 
4.51, which was obtained in 85% yield by reaction of compound 4.42 with TBDPSCl 
(Scheme 4.17).X88XCross metathesis reaction of 4.51 with diethylallylphosphonateX156X in 
presence of 5 mol% 2nd generation Grubbs catalyst and dichloromethane at 55ºC for 16h 
furnished  product 4.52  in 92% yield. 
 
 
Scheme 4.17. Synthesis of compound 4.52 
 
The adenine derivatives were also explored. Cross metathesis of compound 4.53, 
obtained by silylation of the primary alcohol in compound 4.44 by reaction with 
TBDPSCl, with diethylallyl phosphonate under the same conditions to those previously 
tested rendered E alkene 4.54 in 90% yield as a green oil (Scheme 4.18). 
 
 
Scheme 4.18. Synthesis of compound 4.54 
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4.3.3. Hydrogenation reaction by Pd/CF157 
 
With the protected forms of the acyclic nucleoside phosphonates in hand, the final 
steps in the synthetic plan involve on one hand double bond hydrogenation to give 
access to the saturated nucleoside analogues and on the other hand protecting group 
cleavage on the saturated and unsaturated derivatives to render the final products. 
 
Attempted hydrogenation reaction of the compound 4.52 with Pd/C in methanol at 
1 bar of hydrogen led to no conversion (Table 4.3, Entry 1). At higher hydrogen 
pressure (10 bar) the presence of two new products was observed by 1H NMR 
spectroscopy after 12h of reaction. One was assigned to the desired product 4.55 and the 
second one was attributed to a product in which the hydrogenation of double bonds in 
cytosine was also produced (Table 4.3, Entry 2). 
 
Table 4.3. Hydrogenation of compound 4.52   
 
 
 
Entry Allylamine solvent PH2  
(bar) 
Temp.
(ºC) 
Time 
(h) 
Product Conversion 
(%)[b] 
Yield 
(%)[c] 
1 4.52 MeOH 1 rt 12 4.52 >2 - 
2 4.52 MeOH 10 rt 12 4.55 50 - 
3 4.52 MeOH 3 rt 3 4.55 73 51 
4 4.52 MeOH 3 rt 5 4.55 >99 87 
[a] conditions: All reaction were stirred  at room temperature in MeOH in the presence of Pd/C. [b] Determined by 
1H NMR spectroscopy. [c] Isolated yield. 
 
In order to improve the conversion of hydrogenated product 4.55, we decided to 
decrease both hydrogen pressure (3 bar) and reaction time (3h). Under these conditions 
product 4.55 was exclusively obtained although the conversion (73%) was not complete 
                                                 
157   Tomioka, T.; Yabe,Y.; Takahashi, T.; Simmons, T. K. J. Org. Chem. 2011, 76, 4669–4674. 
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(Table 4.3, Entry 3). Full conversion and 87% yield of compound 4.55 were obtained 
when the reaction time was increased to 5 h (Table 4.3, Entry 4). 
 
4.3.4. Removal of protecting groups X156 
 
The unsaturated phosphonate esters derived from cytosine were deprotected by 
reaction with TMSBr in dichloromethane at room temperature for 60h. Under these 
conditions the phosphonate alkyl ester, the N-Boc groups and the silyl ether in 4.52 
were removed affording the fully deprotected target products 4.57 in 93 % yield. Under 
the same conditions, however, compound 4.50 rendered 4.58 in a 98% yield with the 
benzoate group unaltered (Scheme 4.19). 
 
 
 
Scheme 4.19. Removal of protecting groups 
 
Analogous deprotection in the unsaturated adenine derivative 4.54 (Scheme 4.20) 
and the saturated cytosine derivative 4.55 (Scheme 4.21) afforded the fully deprotected 
target products 4.58 and 4.59 in 89% and 80% yields, respectively 
 
 
 
Scheme 4.20. Synthesis of compound 4.58 
 
 
 
Scheme 4.21. Synthesis of compound 4.59 
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Biological evaluation of these nucleosides analogues as chemotherapeutic and 
anti-viral agents is currently in progress in the Laboratory of Virology and 
Chemotherapy of Prof. Jan Balzarini (University of Leuven, Belgium), and therefore 
due activity profiles of these compounds will be presented when provided. 
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4.4. Experimental Part 
4.4.1. General Methods 
 
 
All chemicals used were reagent grade and used as supplied unless otherwise 
specified. HPLC grade dichloromethane (CH2Cl2), tetrahydrofuran (THF) and 
dimethylformamide (DMF) were dried using a solvent purification system (Pure 
SOLVsystem-4®). Toluene was purified using standard procedure. 
 
1H and 13C NMR spectra were recorded on a Varian® Mercury VX 400 (400 MHz 
and 100.6 MHz respectively) or Varian 400-MR spectrometer in CDCl3 as solvent, with 
chemical shifts (δ) referenced to internal standards CDCl3 (7.26 ppm 1H, 77.23 ppm 13C) 
or Me4Si as an internal reference (0.00 ppm). 2D correlation spectra (gCOSY, NOESY, 
gHSQC, gHMBC) were visualized using VNMR program (Varian®). ESI MS were run 
on an Agilent® 1100 Series LC/MSD instrument. Optical rotations were measured at 
room temperature in a Perkin-Elmer® 241 MC apparatus with 10 cm cells. IR spectra 
were recorded on a JASCO FT/IR-600 plus Fourier Transform Infrared Spectrometer 
ATR Specac Golden Gate. Melting points, determined with Reichert apparatus, are 
uncorrected. Optical rotations were measured at 598 nm on a Jasco DIP-370 digital 
polarimeter using a 100 mm cell. 
 
Reactions were monitored by TLC carried out on 0.25 mm E. Merck® silica gel 
60F254 glass or aluminium plates. Developed TLC plates were visualized under a short-
wave UV lamp (250 nm) and by heating plates that were dipped in ethanol/H2SO4 
(15:1) and basic solution of potassium permanganate. Flash column chromatography 
was carried out using forced flow of the indicated solvent on Fluka® or Merck® silica 
gel 60 (230-400mesh). Radial chromatography was performed on 1 or 2 mm plates of 
Kieselgel 60 PF254 silica gel, depending on the amount of product. Flash column 
chromatography (FCC) was performed using flash silica gel (32–63 μm) and employed 
a solvent polarity correlated with TLC mobility. 
  
         The enantiomeric excess (ee%) determined via chiral HPLC analysis (chiralpack 
OD column, heptane:iPrOH, flow rate 0.5-1 mlmin-1). 
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 4.4.2. Compound characterization 
 
3-N-Benzoyluracil (4.28). 
N
H
N
O
O
O
4.28  
 
 
Benzoyl chloride (1.1 ml, 9 mmol) was added to a uracil solution (0.5 g, 4.5 
mmol) in anhydrous pyridine (8 ml) and anhydrous acetonitrile (19 ml). After stirring 
for 12 h, cold water (12 ml) was added to the reaction mixture. The solvent was 
removed by rotary-evaporation, and the residue was purified by silica gel column 
chromatography CH2Cl2/MeOH (30:1) (0.63 g, 65%).  
 
1H NMR (DMSO-d6, 400 MHz, δ in ppm) δ= 11.8 (br s, 1H), 7.94 (d, 2H, J = 8.4 Hz), 
7.77 (t, 1H, J = 7.6 Hz), 7.67 (dd, 1H, J = 7.6, 1.2 Hz,), 7.60 (t, 1H, J = 7.6Hz), 5.63 
(dd, 1H, J = 8, 1.2 Hz,). 13C NMR (DMSO-d6, 100.6 MHz, δ in ppm) δ= 170, 162.9, 
150.1, 143.4, 131.3, 130.2, 126.4, 100.1. 
 
3-N-Benzoylthymine (4.30). 
N
H
N
O
O
O
4.30  
 
Benzoyl chloride (1.85 ml, 16 mmol) was added to a thymine solution (1 g, 8 
mmol) in anhydrous pyridine (14 ml) and anhydrous acetonitrile (34 ml). After stirring 
for 12 h, cold water (21 ml) was added to the reaction mixture. The solvent was 
removed by rotary-evaporation, and the residue was purified by silica gel column 
chromatography CH2Cl2/MeOH (30:1) (1.1 g, 60%).  
 
1H NMR (400 MHz, DMSO-d6, δ in ppm ) δ= 7.92 (dd, 1H, J = 10, 2 Hz), 7.77 (tt, 1H, 
J = 7.6, 2.8 Hz.), 7.59 (t, 1H, J = 8.4 Hz), 7.53 (d, 1H, J = 1.2 Hz), 1.6 Z(s, 3H).  
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3-Benzoyl-1-[(2S)-1-hydroxybut-3-en-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione 
(4.31). 
 
N
N
O
O
O
HO
4.31  
 
Compound 4.31 was prepared from butadiene monoepoxide 0.06 ml, 3-N-
Benzoyluracil  (0.1 g, 0.46 mmol), (η3C3H5PdCl)2 (0.003 g, 0.0082 mmol) and (R,R)-  
ligand 4.35 (0.02 g,  0.025 mmol) in 10 ml of dichloromethane for 5h. Purification by 
silica chromatography (1:1 hexane/ACOEt) provided the desired prodauct 4.31 in 
(0.095 g, 83%) and 84 ee% determined by chiral HPLC (chiralpack OD, hexane:iPrOH 
85:15, 0.4 mlmin-1, tR(R) = 78 min and tR(S) = 92.2 min).   
 
[α]D25 = -3.7(c 1.8, CHCl3). IR (neat): 3400, 2921, 2851, 1742, 1698, 1645, 1438, 1361, 
1238, 941, 796, 682 cm-1. 1H NMR (CDCl3, 400MHz, δ in ppm): δ=  7.94 ( d, 2H, J = 
7.2 Hz), 7.65 (t, 1H, J = 7.2 Hz),  7.50 (t , 2H,  J = 7.6 Hz), 7.43 (d, 1H, J = 8.4 Hz), 
5.91 (ddd, 1H, J = 17.2,  10.4, 5.2 Hz)  , 5.78 (d, 1H, J = 7.6 Hz), 5.45(dd, 1H, J = 11.6, 
1.2 Hz), 5.37 (dd, 1H, J = 18, 1.6 Hz), 5.14 (m, 1H), 2.7 (brs, 1H). 13C NMR (CDCl3, 
100.6 MHz, δ in ppm): δ= 169.1, 162.5, 150.5, 142.9, 135.4, 131.8, 131.4, 130.6, 129.4, 
121.0, 101.9, 62.7, 59.15. ESI-HRMS [M+23] calcld for C15H14N2NaO4: 309.0851, 
Found: 309.0833. 
 
3-Benzoyl-1-[(2S)-1-hydroxybut-3-en-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-
-2,4-dione (4.33). 
N
N
O
O
O
HO
4.33  
 
Compound 4.33 was prepared from butadiene monoepoxide 0.014 ml, product 3-
N-Benzoylthymine (0.05 g, 0.2 mmol), (η3C3H5PdCl)2 (0.0013 g , 0.036 mmol) and 
(R,R)-ligand 4.35 (0.008 g, 0.0108 mmol) in 5 ml of dichloromethane for 18h. 
Purification by silica chromatography (1:1 hexane/ACOEt) provided the desired 
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product in (0.021 g, 40%) and 66 ee% determined by chiral HPLC (chiralpack OD, 
hexane:iPrOH 85:15, 0.4 mlmin-1).   
 
[α]D25 = -4.8 (c 0.2, CHCl3). IR (neat): 3088, 2921, 2851, 1742, 1698, 1632,1420, 1249, 
1221, 962, 763, 683 cm-1. 1H NMR (CDCl3, 400MHz, δ in ppm): δ = 8.10 (dd, 2H, J = 
8.4, 1.2 Hz), 7.59 (tt, 1H, J = 7.6, 2.8 Hz), 7.47 (t, 2H, J = 7.2 Hz), 5.94 (ddd, 1H, J = 
17.2, 10.4, 6 Hz), 5.63 (m, 1H), 5.47 (dt, 1H, J = 17.2, 2.8, 1.6 Hz), 5.35 (dt, 1H, J 
=10.8, 2.4, 1.2 Hz), 3.87 (m, 2H), 1.89 (brs, 1H), 1.56 (s, 1H). ESI-HRMS [M+1] 
calcld for C16H17N2O4 m/z: 301.1188, Found: 301.1214.  
 
1-tert-Butoxycarbonylamino-4-((bis(tert-butoxycarbonyl)amino)-1,2-
dihydropyrimidine-2-one (4.37). 
 
N
N
N
BocBoc
4.37
O
Boc
 
 
To a Ar-flushed flask equipped with a magnetic stiring bar and containing 
cytosine (0.5 g, 4.5 mmol) and DMAP (0.054 g, 0.45 mmol) was added dry THF 
(30ml). To the stirred suspension was added Boc2O (4 g, 18 mmol) under Ar 
atmosphere. The reaction mixture was stirred overnight at room temperature, at which 
point TLC analysis indicated the presence of single product. The excess amount of THF 
was removed to give 4.37 (1.83 g, 99%) as a yellow oil.  
 
1H NMR (400MHz, CDCl3) δ = 7.95 (d, 1H, J = 8 Hz), 7.05 (d, 1H, J = 8Hz), 1.57 (s, 
9H), 1.52 (s, 18H). 13CNMR (CDCl3, 100.6MHz, δ in ppm) δ = 162.4, 151.4, 150.3, 
149.2, 143.6, 97.0, 86.8, 85.4, 27.8, 27.7. 
 
4-((Bis-(tert-butoxycarbonyl)amino)-1,2-dihydropyrimidin-2-one (4.38).173 
N
H
N
N
BocBoc
O
4.38  
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To a solution of 4.37 (0.27 g, 0.7 mmol) dissolved in MeOH (8 ml) was added 
saturated NaHCO3aq (4 ml). The turbid solution was stirred at 50ºC for 1h, at which 
point clear conversion to bis-Boc protected adenine was observed by TLC. After 
evaporation of MeOH, water (4.5 ml) was added to the suspension, and the layer 
extracted with CH2Cl2 (3×100 ml). The organic layer was dried with Na2SO4, filtered 
and evaporated to give pure 4.38 (0.213 g , 98%) as a white solid. 
 
 1H NMR(CDCl3, 400MHz, δ in ppm ) δ =  13.18 (brs, 1H), 7.72 (d, 1H, J = 7.2 Hz), 
7.04 (d, 1H, J = 6.8 Hz), 1.5 (s, 18H).13C NMR(CDCl3, 100.6MHz, δ in ppm) δ = 
163.8, 158.6, 149.6, 146.1, 136.8, 96.8,  85.1, 27.8. 
 
9-tert-Butoxycarbonyl-6-bis-(tert-butoxycarbonyl)amino-9H-purine (4.40). 
 
To a Ar-flushed flask equipped with a magnetic stiring bar and containing adenine 
(0.5 g, 3.7 mmol) and DMAP (0.045g, 0.37 mmol) was added dry THF (25 ml). To the 
stirred suspension was added Boc2O (3.23 g, 14.8 mmol) under Ar atmosphere. The 
reaction mixture was stirred overnight at room temperature, at which point TLC 
analysis indicated the presence of single product. The excess amount of THF was 
removed to give 4.40 (1.6 g, 99%) as yellow oil.  
 
1H NMR (CDCl3, 400MHz, δ in ppm): δ = 8.94 (s, 1H), 8.46 (s, 1H),  1.64(s,9H), 1.35 
(s,18H). 13CNMR(CDCl3, 100.6 MHz, δ in ppm): δ = 154, 152.4, 151.2, 150.0, 145.6, 
143.2,  129.5, 87.5, 83.9, 27.8. 27.7. 
 
6-Bis-(tert-butoxycarbonyl)aminopurine (4.41). 
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To a solution of compound 4.40 (1.6 g, 3.7 mmol) dissolved in MeOH (40 ml) 
was added saturated NaHCO3aq (20 ml). The turbid solution was stirred at 50ºC for 1h, 
at which point clear conversion to bis-Boc  protected adenine was observed by TLC. 
After evaporation of MeOH, water (23 ml) was added to the suspension, and the layer 
extracted with CH2Cl2 (3×100 ml).The organic layer was dried with Na2SO4, filtered 
and evaporated to give pure 4.41 (1.2 g, 96%) as a white solid. 
 
 1H NMR (CDCl3, 400MHz, δ in ppm): δ =12.28 (brs, 1H) , 8.87 (s, 1H), 8.53 (s, 1H), 
1.42 (s, 18H). 13CNMR (CDCl3, 100.6 MHz, δ in ppm): δ = 154, 151.8, 150, 150, 145.5, 
145,  84.2, 27.7. 
 
4-((Bis(tert-butoxycarbonyl)amino)-1-((2S)-1-hydroxybut-3-en-2-yl)-1,2-
dihydropyrimidine-2-one(4.42). 
N
N
N
BocBoc
O
HO
4.42  
 
Compound 4.42 was prepared from butadiene monoepoxide (0.015 ml), product 
4.38 (0.06 g, 0.2 mmol), (η3C3H5PdCl)2 (0.0013 g, 0.0036 mmol) and  (R,R)-ligand 4.35 
(0.0085 g, 0.0108 mmol) in (5 ml) dichloromethane for 18h at 0ºC. Purification by silica 
gel chromatography (10:2 hexane/ACOEt) provided the desired product 4.42  in (0.058 
g, 85%) and 72 ee% determined by chiral HPLC (chiralpack OD, hexane:iPrOH 90:10, 
0.5 mlmin-1, tR(R) = 16.8 min and tR(S) = 19.2 min). 
  
[α]D25 = - 7.13 (c 1.06, CHCl3). IR (neat): 3354, 2980, 2924, 1772, 1742, 1643, 1613, 
1312, 1257, 1136, 1112, 787 cm-1. 1H NMR (CDCl3, 400MHz, δ in ppm): δ= 7.68 (d, 
1H, J = 7.2 Hz), 7.04 (d, 1H, J = 7.6 Hz), 5.94 (ddd, 1H, J = 17.2, 10.4, 6 Hz), 5.41 (dd, 
1H, J = 10, 1.2 Hz), 5.32 (dd, 1H, J = 17.2, 1.2 Hz), 5.26 (m, 1H), 4.98 (m, 2H), 2.83 
(brs, 1H), 1.59 (s, 18H). 13C NMR (CDCl3, 100.6 MHz, δ in ppm): δ= 161.9, 155.8, 
149.7, 147.2, 132.8, 120.5, 96.3, 85.1, 62.7, 61.2, 27.8. ESI-HRMS [M+1] calcld for 
C18H27N3O6 : 382.1978, Found: 382.1985. 
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6-(Bis-tert-butoxycarbonyl)amino)-9-((2S)-1-hydroxybut-3-en-2-yl)-9H-purine 
(4.44).  
 
 
 
Compound 4.44 were prepared from butadiene monoepoxide (0.02 ml), product 
4.41 (0.1 g, 0.3 mmol), (η3C3H5PdCl)2 (0.002 g, 0.0054 mmol) and (R,R)-ligand 4.35 
(0.013 g, 0.016 mmol ) in 6 ml dichloromethane at room temperature for 5h. 
Purification by silica chromatography (1:1 hexane/ACOEt) provided the desired product  
in (0.098 g 90%) and 92 ee% determined by chiral HPLC (chiralpack OD, 
hexane:iPrOH 90:10, 0.6 mlmin-1, tR(R) = 15.4 min and tR(S) = 18.2 min).  
 
[α]D25 = -15.80 (c0.92,CHCl3). IR (neat): 3324, 2978, 2932, 1786, 1750, 1600, 1575, 
1369, 1247, 1137, 1104, 848 cm-1. 1H NMR (CDCl3, 400 MHz, δ in ppm): δ= 8.83 (s, 
1H), 8.18 (s, 1H), 6.20 (ddd, 1H, J = 16.8, 10.4, 6 Hz) , 5.38 (d, 1H, J = 10.4 Hz), 5.23 
(m, 1H), 5.13 (d, 1H, J = 17.2 Hz), 5.18 (m, 2H), 3.96 (brs, 1H),1.46 (s, 18H).13C NMR 
(CDCl3, 100.6 MHz, δ in ppm): δ= 153.0, 151.8, 150.7 (2C), 145.2, 132.8, 129.2, 119.7, 
84.1, 63.8, 61.2, 28. ESI-HRMS [M+1] calcld for C19H28N5O4: 406.209, Found: 
406.2077, ESI-HRMS [M+23] calcld for C19H27N5NaO5: 428.1910, Found: 428.1994. 
  
4-(((2S)-1-hydroxybut-3-en-2-yl)-acetylamino)-1-((2S)-1-hydroxybut-3-en-2-yl)-1,2-
dihydropyrimidine-2-one (4.47).  
N
N
N
O
O
HO
OH
4.47  
          Compound 4.47 was prepared from butadiene monoepoxide 0.05 ml, 
Acetylcytosine 4.46 (0.1 g, 0.65 mmol), (η3C3H5PdCl)2 (0.0044g, 0.012mmol) and 
(R,R) ligand (0.03 g, 0.036 mmol)  in 12 ml dichloromethane for 18h. Purification by 
silica chromatography (hexanes/ACOEt) provided (0.07 g,  40%) of product 4.47.  
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1H NMR (CDCl3, 400 MHz, δ in ppm): δ = 7.29 ( d, 1H, J = 8.4 Hz), 6.19 (ddd, 1H, J 
=18, 10.8, 7.2 Hz), 5.90 (ddd, 1H, J = 17.2, 10.4, 5.2Hz), 5.54 (d, 1H, J = 8Hz), 5.62 
(m, 1H), 5.34 (m,5 H), 4.23 (m, 1H), 3.90 (m, 4H), 2 (s, 3H). 13CNMR (CDCl3, 100.6 
MHz, δ in ppm) 165.6, 164, 151.8, 141.1, 132.5, 132.2, 120.7, 119.1, 101.6, 62.4,59.5, 
57.4, 29.9. ESI-HRMS [M+1] calcld for C17H26N3O5 m/z: 294.1454,found: 294.1441. 
 
 (2S,3E)-2-[(4-bis-(tert-butoxycarbonyl)amino)-2-oxo-1,2-dihydropyrimidin-1-yl]-
5-(diethoxyphosphoryl)pent-3-en-1-yl benzoate (4.50). 
 
 
N
N
N
BocBoc
O
BzO P
OEt
O
OEt
4.50  
 
To a solution of compound 4.42 (0.3 g, 0.8 mmol) and diethylallylphosphonate 
(0.6 ml, 3.2 mmol) in CH2Cl2 (15 ml), II generation Grubbs catalyst (0.03 g, 0.04 mmol) 
was added. This solution was refluxed for 16h at 55ºC. After evaporation of all 
volatiles, the residue was dissolved in anhydrous dichloromethane (20 ml) and fresch 
distilled triethylamine (0.6 ml) was added. The solution was coled at 0ºC and benzoyl 
chloride (0.21 g, 1.5 mmol) was added dropwise, the resulting mixture was warmed at 
room temperature for 12h. The mixture was quenched by saturated NH4Cl aqueous 
solution and then the organic layer was washed with water and brine. The solvent was 
removed under vacum and the crude was purified by silica gel chromatography. This 
procedure provided 4.50 as an oil (0.46 g, 90%). 
 
 [α]D25 = - 18.7 (c 1.2, CHCl3). IR (neat): 3053, 2984, 1725, 1671, 1455, 1371, 1320, 
1264, 1138, 1110, 1025, 732 cm-1. 1H NMR (CDCl3, 400MHz, δ in ppm): δ= 7.94 (dd, 
2H, J = 8.4, 1.2 Hz), 7.66 (d, 1H, J = 7.2 Hz), 7.56 (t, 1H, J = 7.6 Hz), 7.44 (t, 2H, J = 
7.2 Hz), 7.06 (d, 1H, J = 7.6 Hz), 5.90 (m, 2H), 5.58 (m, 1H), 4.74 (dd, 1H, J = 12.4, 
5.2 Hz), 4.64 (dd, 1H, J = 11.6, 4.8 Hz),  4.06 (m, 4H) , 2.67 (m, 2H), 1.52 (s, 18H), 
1.25 (t, 6H, J= 6.8 Hz). 13C NMR (CDCl3, 100.6 MHz, δ in ppm): δ= 166.0, 162.3, 
154.9, 149.6, 146.1, 133.5, 130.2, 129.8, 129.4, 128.8, 128.6, 127.3, 96.5, 85.2, 63.8, 
62.4, 62.3, 58.1, 31.4, 30.1, 27.8, 16.6, 16.5. ESI-HRMS [M+1] calcld for C30H42N3O10 
P: 636.2686, Found: 636.2676. 
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2-[(4-bis-(tert-butoxycarbonyl)amino)-1-[(2S)-1-(tert-butyldiphenylsilyloxy)but-3-
en-2-yl]-1,2-dihydropyrimidin-2-one (4.51). 
 
N
N
N
BocBoc
O
TBDPSO
4.51  
 
Compound 4.42 (0.1 g, 0.26 mmol) was dissolved in dry DMF (3 ml) and treated 
under argon with tert-butyldiphenyl chloride (0.08 ml, 0.3 mmol) and imidazole (0.04 g, 
0.6 mmol).The mixture was then stirred for 16h at room temperature .workup 
(extraction with Et2O) and column chromatography on silica gel (10:2) Hexan/EtOAC 
provided 4.51 (0.136 g, 85%).  
 
[α]D25 = - 13.5 (c1.27,CHCl3). IR (neat): 2931, 2857, 1742, 1671, 1524, 1455, 1370, 
1319, 1256, 1137, 1110, 784, 701 cm-1. 1H NMR (CDCl3, 400MHz, δ in ppm): δ= 7.75 
(d, 1H, J = 8 Hz), 7.57 (ddd, 2H, J = 6, 3.2, 1.6  Hz), 7.48 (ddd, 2H, J = 6.4, 2.8, 1.2 
Hz),  7.38 (m, 6H), 6.98 (d, 1H, J = 7.2 Hz), 6.01 (ddd, 1H, J =17.6, 10.4, 6 Hz), 5.38 
(dd, 1H, J = 10.4, 0.8 Hz), 5.38 (m, 1H), 5.32 (dd, 1H, J = 17.6, 0.8 Hz), 3.97 (d, 2H, J 
= 3.6 Hz), 1.57 (s, 18H), 1.02 (s, 9H). 13C NMR (100.6 MHz,CDCl3): δ= 161.8, 154.9, 
149.7, 147.0, 135.6, 135.4, 132.9, 132.5,  130.1, 130.0, 127.9, 120.5, 95.5, 84.8, 63.8, 
59.5, 27.8, 26.9, 19.2. ESI-HRMS [M+1] calcld for C34H46N3O6Si: 620.3156, Found: 
620.3171. 
 
(2S, 3E)- 2-[((4-Bis-(tert-butoxycarbonyl)amino)-2-oxo-1,2-dihydropyrimidin-1-yl]-
1-(tert-butyldiphenylsilyloxy)-5-(diethoxyphosphoryl)pent-3-ene (4.52). 
N
N
N
BocBoc
O
TBDPSO P
OEt
O
OEt
4.52  
 
To a solution of product 4.51 (0.05 g, 0.08 mmol) and (0.004 g, 0.004 mmol) of II 
generation Grubbs catalyst in dichlorometane (4 ml) was added diethylallylphosphonate 
(0.06 ml, 0.32 mmol) at 55ºC. Reaction stirred at 55ºC for 16h, evaporation of solvent 
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and purification by silica chromatography AcOEt /Hexane (2:1) provided the desired 
product 4.52 as yellow liquid (0.057 g, 92%). 
 
[α]D25 = - 21.4 (c1.2,CHCl3). IR (neat) 2969, 2931, 1741, 1671, 1455, 1370, 1319, 
1255, 1111, 1024, 735, 701 cm-1.  1H NMR (CDCl3, 400 MHz, δ in ppm): δ= 7.68 (d, 
1H, J = 7.6 Hz), 7.56 (dd, 2H, J = 7.6, 1.6 Hz), 7.45 (dd, 2H, J = 8, 1.6 Hz), 7.38 (m, 
6H), 6.97 (d, 1H, J = 7.2 Hz), 5.83 (m, 2H), 5.29 (brs, 1H), 4.06 (m, 4H), 3.96 (d, 2H, J 
= 4Hz), 2.62 (d, 1H, J = 6.8 Hz),  2.58 (d, 1H, J = 6 Hz),  1.56 (s, 18H), 1.27 (t, 6H, J = 
6.8 Hz), 1.03 (s, 9H). 13C NMR  (CDCl3, 100.6 MHz, δ in ppm): δ=  161.7, 154.6, 
149.5, 146.9, 135.5, 135.3, 132.5, 132.4, 130.0, 129.9, 129.5, 129.4, 128.5, 127.8, 
126.5, 126.3, 95.4, 84.7, 63.6, 62.0, 61.9, 59.4, 31.3, 29.9, 27.7, 26.8, 19.1, 16.4. ESI-
HRMS [M+1] calcld for C39H57N3O9PSi: 770.3602, Found: 770.3797.  
 
 
6-(Bis-tert-butoxycarbonyl)amino)-9-((2S)-1-tert-butyldiphenylsilyloxy-but-3-en-2-
yl)-9H-purine (4.53). 
N
TBDPSO
4.53
N
N
N
N
Boc
Boc
 
 
Compound 4.44 (0.25 g, 0.6 mmol) was dissolved in dry DMF (7 ml) and treated 
under argon with tert-butyldiphenylsilyl chloride (0.18 ml,0.66 mmol) and imidazole 
(0.09 g, 1.32 mmol). The mixture was then stirred for 16h at room temperature. workup 
(extraction with Et2O) and column chromatography on silica gel (10:2) Hexan/EtOAC 
provided 4.53 (0.3 g, 80%).  
 
[α]D25 = -10.93 (c 1.13, CHCl3). IR(neat): 2987, 2362, 1733, 1716, 1558, 1540, 1507, 
1456, 1395, 1259, 1066, 749 cm-1. 1H NMR (CDCl3, 400 MHz, δ in ppm): δ= 8.79 (s, 
1H), 8.26 (s, 1H), 7.48 (td, 4H, J = 8, 1.6 Hz),  7.39 (tt, 2H, J = 9.6, 1.2 Hz), 7.32 (t, 4H, 
J = 7.2 Hz), 6.02 (ddd, 1H, J = 17.2, 10.4, 6.4 Hz), 5.34 (dd, 1H, J = 11.6, 0.8 Hz,), 5.30 
(m, 1H), 5.17 (dd, 1H, J = 17.2, 0.8 Hz), 4.16 (dd, 1H, J = 11.2, 6.8 Hz), 4.05 (dd, 1H, J 
= 10.8, 4 Hz), 1.43 (s, 18H), 0.94 (s, 9H). 13C NMR (CDCl3, 100.6 MHz, δ in ppm): δ=  
153.3, 151.8, 150.5, 150.3, 144.5, 135.5, 135.4, 132.5, 130.1, 127.9, 127.9, 119.8, 83.7, 
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64.8, 59.4, 27.9, 26.8, 19.1. ESI-HRMS [M+23] calcld for C35H45N5NaO5Si: 666.3088, 
Found: 666.3073. 
 
 (2S,3E)-2-[((6-Bis-(tert-butoxycarbonyl)amino)-purin-9-yl]-1-(tert-
butyldiphenylsilyloxy)-5-(diethoxyphosphoryl)pent-3-ene (4.54). 
N
TBDPSO P
OEt
O
OEt
4.54
N
N
N
N
Boc
Boc
 
To a solution of product 4.53 (0.14 g, 0.22 mmol) and (0.009 g, 0.011 mmol) of II 
generation Grubbs catalyst in dichlorometane (11 ml) was added 
diethylallylphosphonate (0.16 ml, 0.88 mmol ) at 55ºC. Reaction stirred at 55ºC for 16h, 
evaporation of solvent and purification by silica chromatography AcOEt /Hexan (2:1) 
provided the desired product 4.54 as green liquide (0.157 g , 90%). 
 
[α]D25 =  - 14.6 (c 1.36, CHCl3). IR (neat) 2929, 2856, 1788, 1599, 1452, 1369, 1252, 
1139, 1111, 1026, 704 cm-1. 1H NMR (CDCl3, 400 MHz, δ in ppm): δ=  8.77 (s, 1H), 
8.20 (s, 1H), 7.42-7.29 (m, 10H), 6.08 (m, 1H), 5.76 (ddd, 1H, J = 15.6, 14.4, 7.6 Hz), 
5.25 (bsr, 1H), 4.16 (dd, 2H, J = 10.4, 6.4 Hz), 4.03 (m, 4H), 3.61 (d, 2H, J = 7.2 Hz), 
2.56 (d, 1H, J = 7.6 Hz),  1.43 (s, 18H), 1.22 (t, 6H, J = 6.8 Hz), 0.93 (s, 9H). 13C NMR 
(CDCl3, 100.6 MHz, δ in ppm): δ= 153.2, 151.9, 150.6, 150.4, 144.5, 132.5, 135.5, 
132.4, 132.4, 130.1, 129.1, 129.0, 128.0, 126.2, 126.1, 83.8, 64.8, 62.2, 62.1, 59.2, 31.3, 
29.9, 28.0, 26.9, 19.2, 16.6. ESI-HRMS [M+1] calcld for C40H57N5O8 PSi: 794.3714, 
Found: 794.3694. 
 
 (2S)- 2-[((4-Bis-(tert-butoxycarbonyl)amino)-2-oxo-1,2-dihydropyrimidin-1-yl]-1-
(tert-butyldiphenylsilyloxy)-5-(diethoxyphosphoryl)pentane (4.55). 
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                To a solution of 4.52 (0.15 g, 0.2 mmol) in MeOH (6 mL) was added 5% 
palladium/carabon. The mixture was stirred under a hydrogen atomosphere (3 atm) at 
room temperature for 5 h. The reaction mixture was then filtered through Celite with 
MeOH and concentrated under reduced pressure. The crude product was purified by 
silicagel column chromatography (EtOAc) to give the compound 4.55 as colorless oil 
(0.134 g, 87%). 
 
[α]D25 = - 16 (c 2, CHCl3). IR (neat)  2930, 1743, 1669, 1456, 1320, 1264, 1137, 1113, 
733, 702 cm-1.. 1H NMR (CDCl3, 400MHz, δ in ppm): δ= 7.72 (d, 1H, J = 7.2 Hz), 7.55 
(dd, 2H, J = 8, 1.6 Hz), 7.47 (dd, 2H, J = 7.6, 1.6 Hz), 7.40 (m, 6H), 6.99 (d, 1H, J = 
7.2 Hz), 4.48 (brs, 1H), 4.03 (m, 4H), 3.84 (dd, 1H, J = 3.6, 11.2 Hz), 3.80 (dd, 1H, J = 
3.2, 11.2 Hz), 1.95-1.86 (m, 2H), 1.77-1.63 (m, 4H),1.55 (s, 18H), 1.26 (t, 6H, J = 6.8 
Hz), 1.01 (s, 9H). 13C NMR  (CDCl3, 400MHz, δ in ppm): δ=  161.8, 155.3, 149.8, 
146.2, 135.7, 135.5, 132.7, 132.5, 130.2, 130.1, 128.0, 95.7, 85, 64.4, 61.8, 61.7, 29.8, 
27.9, 27, 25.9, 24.5, 19.3, 16.7, 16.6. ESI-HRMS [M+1] calcld for C39H59N3O9PSi: 
772.3758, Found: 772.3730.  
 
 (2S,3E)-2-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-5-(diethoxyphosphoryl) 
pent-3-en-1-yl benzoate (4.56). 
 
 
 
Compound 4.50 (0.07 g, 0.16 mmol), was solubilized in CH2Cl2 (10 mL), and 
TMSBr (0.12 mL, 0.96 mmol) was added and stirred for 60 h at room temperature 
under positive pressure of dry Ar. MeOH (3 ml) was added and evaporated with heating 
(ca. 60 ºC). MeOH (3 mL) was added again, and this procedure was repeated three 
times more. The residue was extracted with H2O and CH2Cl2, and the inorganic phase 
was evaporated to dryness to afford the desired compound 4.56 as yellow liquid (0.06 
g, 98%). 
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 [ɑ]D25 =  +13.97 (c1.2, MeOH). IR (neat): 2968, 1716, 1670, 1451, 1382, 1268, 1112, 
1070, 1024, 973, 926, 713 cm-1.  1H NMR (D2O, 400 MHz, δ in ppm):  δ=  7.93 (d, 1H, 
J = 8 Hz), 7.85 (d, 2H, J = 7.2 Hz), 7.63 (t, 1H, J = 7.6 Hz), 7.46 (d, 2H, J = 7.6 Hz), 
6.16 (d, 1H, J = 7.6 Hz), 6 (ddd, 1H, J = 15.6, 13.6, 6.8 Hz), 5.88 (dt, 1H, J = 15.6, 
10.4, 5.6 Hz), 5.47 (m, 1H), 4.64 (m, 2H), 2.76 (d, 1H, J = 7.2 Hz), 2.71 (d, 1H, J = 7.6 
Hz). 13C NMR (D2O, 100.6 MHz, δ in ppm):  δ=  167.7, 158.8, 148.7, 147.0, 134.1, 
129.4, 129.2, 128.8, 128.4, 126.2, 94.92, 63.8, 57.3, 32.4, 31.0. ESI-HRMS [M+1] calcld 
for C16H19N3O6P :380.1011, Found: 380.1030. 
 
[(2E,4S)-4-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-5-hydroxypent-2-en-1-
yl]phosphonic acid (4.57). 
N
N
NH2
O
HO P
OH
O
OH
4.57  
 
Compound 4.52 (0.08 g, 0.1 mmol), was solubilized in CH2Cl2 (7 mL), and 
TMSBr (0.08 ml, 0.6 mmol) was added and stirred for 60 h at room temperature under 
positive pressure of dry Ar. MeOH (3 mL) was added and evaporated with heating (ca. 
60 ºC). MeOH (3 mL) was added again, and this procedure was repeated three times 
more. The residue was extracted with H2O and CH2Cl2, and the inorganic phase was 
evaporated. The crude product was purified by reverse phase chromatography on Silica 
C18 using (H2O, MeOH) as the eluent to give the compound 4.57 as a white solid 
(0.025 g, 93%). 
 
 [α]D25 = - 11.2 (c 2.89, MeOH). IR (neat): 2969, 1715, 1669, 1540, 1394, 1043, 973, 
872, 793, 762, 748, 702 cm-1. 1H NMR (D2O, 400 MHz, δ in ppm):  δ=  7.85 (d, 1H, J = 
7.6 Hz), 6.16 (d, 1H, J = 8 Hz), 5.77 (m, 2H), 5.16 (brs, 1H), 3.88 (d, 2H, J = 6 Hz), 
2.65 (d, 1H, J = 6 Hz), 2.61 (d, 1H, J = 7.2 Hz). 13C NMR (D2O, 100.6 MHz, δ in 
ppm):  158.8, 149.0, 147.0, 127.5, 127.4, 94.6, 60.9, 59.8, 31.8, 30.5. ESI-HRMS [M+1] 
calcld for C9H14N3O5P: 298.0569, Found: 298.0582. 
 
[(2E,4S)-4-(6-amino-9H-purin-9-yl)-5-hydroxypent-2-en-1-yl]phosphonic acid 
(4.58). 
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N
HO P
OH
O
OH
4.58
N
N
N
H2N
 
 
Compound 4.54 (0.05 g, 0.06 mmol), was solubilized in CH2Cl2 (4 ml), and 
TMSBr (0.64 ml, 0.36mmol) was added and stirred for 60 h at room temperature under 
positive pressure of dry Ar. MeOH (3 mL) was added and evaporated with heating (ca. 
60 ºC). MeOH (3 mL) was added again, and this procedure was repeated three times 
more. The residue was extracted with H2O and CH2Cl2, and the inorganic phase was 
evaporated. The crude was purified by reverse phase chromatography on Silica C18 
using (H2O, MeOH) as the eluent to give the compound 4.58 as a white solid (0.015 g, 
89%). 
 
[α]D25 =  - 12.4 (c1.93, MeOH). IR (neat): 3070, 2325, 1691, 1609, 1531, 1496, 1425, 
1387, 1224, 1107, 937, 770 cm-1. 1H NMR (D2O, 400 MHz, δ in ppm):  δ=  8.44 (s, 
1H), 8.40 (d, 1H), 6.02 (m, 1H), 5.76 (m, 1H), 5.35 (brs, 1H), 4.11 (dd, 1H, J = 12.4, 
8.4 Hz), 4.05 (dd, 1H, J = 11.6, 5.2 Hz), 2.65 (d, 1H, J = 7.2 Hz), 2.59 (d, 1H, J = 6.8 
Hz).13C NMR (D2O, 100.6 MHz, δ in ppm):  δ=  149.6, 148.3, 143.9, 143.6, 127.8, 
127.6, 127, 126.9, 118.1, 62.3, 59.2, 32, 30.7. ESI-HRMS [M+1] calcld for 
C10H15N5O4P: 300.0862, Found: 300.0825. 
 
[(4S)-4-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-5-hydroxypentyl]phosphonic 
acid (4.59). 
                                                                                                                                                                                          
 
 
Compound 4.55 (0.12 g, 0.15 mmol), was solubilized in CH2Cl2 (12 ml), and 
TMSBr (0.15 ml, 0.9 mmol) was added and stirred for 60 h at room temperature under 
positive pressure of dry Ar. MeOH (3 mL) was added and evaporated with heating (ca. 
60 ºC). MeOH (3 mL) was added again, and this procedure was repeated three times 
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more. The residue was extracted with H2O and CH2Cl2, and the inorganic phase was 
evaporated. The crude product was purified by reverse phase chromatography on Silica 
C18 using (H2O, MeOH) as the eluent to give the compound 4.59 as a whit solid (0.033 
g, 80%). 
 
[α]D25 = - 12 (c 0.2, MeOH). IR (neat): 3327, 2918, 1668, 1540, 1456, 1387, 1148, 
1050, 920, 785 cm-1.  1H NMR (D2O, 400MHz, δ in ppm):  δ= 7.87 (d, 1H, J = 8 Hz), 
6.19 (d, 1H, J = 8 Hz), 4.64 (m, 1H), 3.75 (m, 2H), 1.81-1.75 (m, 4H), 1.52(m, 2H). 13C 
NMR  (D2O, 100.6 MHz, δ in ppm):  δ=  158.7, 149.4, 146.2, 94.2, 61.7, 58.5, 28.8, 
26.1, 24.7, 18.3. ESI-HRMS [M+24] calcld for C9H17N3NaO5P: 301.0804, Found: 
301.1373. 
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APPROACHES TO THE 
ENANTIOSELECTIVE SYNTHESIS OF  
AT2433-A1 
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5.1. Introduction  
            
AT2433-A1, AT2433-A2, AT2433-B1 and AT2433-B2 are antitumor antibiotics 
which were isolated from the fermentation broth culture of Actinomadura melliaura 
(ATCC 39691). These compounds are closely related to the antitumor rebeccamycine 
(5.1)F158F,F159F (Figure 5.1), and were active against Gram-positive bacteria, such as 
Microcuccus luteus (ATCC 9341), Bacillus subtilus (ATCC 6633), Staphylococcus 
aureus (A 9537), Streptococus faecalis (A 20688) and Streptococcus faecium (ATCC 
9790). Furthermore, AT433-B2 has shown activity against the Gram-negative 
bacterium Escherichia coli (SS 1431). In addition, AT2433-A1, and AT2433-B1 
showed antitumor activity against the transplantable murine P-388 leukemia. 
 
There are two classes of indolocarbazole glycosides,165 differing both in structure 
and in mechanism of action. The straurosporine class is characterized by two bonds 
between the glycoside and indolocarbazole heterocycle. These fused structures exhibit 
potent inhibition of protein kinases.F160F In contrast, the rebeccamycinF161F class of 
indolocarbazole glycosides have a single glycosidic linkage and have shown 
remarkable activity in the poisoning of DNA topoisomerase I.F162F,F163F The only clinically 
used antitumor drugs that selectively target topoisomerase I are irinotecan and 
topotecan, derivatives of camptothecin. Both camptothecin and the indolocarbazole 
glycosides have been shown to stabilize the intermediate DNA-topoisomerase I 
complex, leading to cell death.F164F Currently, rebeccamycin derivatives are in phase II 
clinical trials for the treatment of a wide range of malignancies including refractory 
pediatric neuroblastoma, advanced renal cell carcinoma, metastatic or locally recurrent 
colorectal cancer, and stage IIIB or IV breast cancer.165 
 
                                                 
158    Bush, J. A.; Long, B. H.; Catino, J. J.; Bradner, W. T.; Tomita, K. J. Antibiotics. 1987, 40, 668–678. 
159    Kaneko, T.; Wong, H.; Okamoto, K. T.; Clardy, J. Tetrahedron Lett. 1985, 26, 4015–4018.  
160   Tamaoki, T.; Nomoto, H.; Takahashi, Y.; Kato, M.; Morimoto, M.; Tomita, F. Biochem. Biophys. Res.  
 Commun. 1986, 135, 397–402  
161    Nettleton, D. E.; Doyle, T. W.; Krishnan, B.; Matsumoto, G. K.; Clardy, J. Tetrahedron Lett. 1985, 26, 4011–
4014.  
162   Amashita, Y.; Fujii, N.; Murakata, C.; Ashizawa, T.; Okabe, M.;Nakano, H. Biochemistry. 1992, 31, 12069–
12075. 
163   Anizon, F.; Belin, L.; Moreau, P.; Sancelme, M.; Voldoire, A.; Prudhomme, M.; Ollier, M.; Severe, D.; Riou,  
 J. F.;  Bailly, C.; Fabbro, D.; Meyer, T. J. Med. Chem. 1997, 40, 3456–3465. 
164   D’Arpa, P.; Liu, L. F. Biochim. Biophys. Acta. 1989, 989, 163–177. 
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Interest in the indolo[2,3-a]carbazole glycosides comes from their potent 
antineoplasic properties. These glycosides are potent antitumor antibiotics currently 
undergoing clinical trials for the treatment of numerous types of cancer. AT2433-A1 is 
the most complex member of this family of compounds possessing a unique 
disaccharide with a sensitive aminodeoxysugar and an unsymmetric aglycon. The 
synthesis of this natural product requires a method for glycosylation that sets the 
stereochemistry of the anomeric center and the regiochemistry of the aglycon (Figure 
5.2).F165 
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Figure 5.1. Structure of rebecamycine (5.1), AT2433-A1 (5.2), AT2433-A2 (5.3), AT2433-B1 
(5.4) and AT2433-B2 (5.5).165 
The excellent antitumor activity of indolocarbazoleglycosides has led to a 
significant synthetic effort in this area.F166F,F167F The greatest challenge in the synthesis of 
the indolocarbazole glycosides is the formation of the N-glycosidic bond.  
 
Unlike other indolocarbazole natural products, AT2433-A1, AT2433-A2, 
AT2433-B1, and AT2433-B2 possess a unique disaccharide with a sensitive 2-deoxy 
aminosugar.F168F,F169F The complexity of these targets requires an efficient method for 
regioselective glycosylation in the presence of diverse functionality. While 
rebeccamycin has chlorine atoms at the 1 and 11 positions of the aromatic sector, 
                                                 
165     Chisholm, J. D.; Van Vranken, D. L. J. Org. Chem. 2000, 65, 7541–7553. 
166    Gribble, G. W.; Berthel, S. J. Tetrahedron 1992, 48, 8869–8880  
167    Prudhomme, M. Curr. Pharm. Des. 1997, 3, 265–290. 
168    Matson, J. A.; Claridge, C.; Bush, J. A.; Titus, J.; Bradner, W.T.; Doyle, T. W.; Horan, A. C.; Patel, M. J.
 Antibiot. 1989, 42, 1547–1555. 
169    Golik, J.; Doyle, T. W.; Krishnan, B.; Dubay, G.; Matson, J. A. J. Antibiot. 1989, 42, 1784–1789.  
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AT2433 A1 and A2 have chlorine atoms only at the 1 position. Thus, the disaccharide 
must be joined to the more hindered, less nucleophilic nitrogen atom. 
 
  The disaccharide of AT2433-A1 consists of a glucose and an aminosugar 
subunit, 2,4-dideoxy-4-amino-L-xylose (Figure 5.2). Derivatives of this aminosugar are 
present in the enediyne antitumor antibiotics calicheamicin and esperamicin.F170F,F171F,F172F  
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Figure 5.2. General structure of AT2433-A1 5.2165        
 
5.1.1. Synthesis of AT2433-A1165 
 
Following the procedure of Roush and Hunt,F173F homoallyl alcohol 5.6 was 
prepared from (R)-Garner’s aldehyde using an allyl dioxaborolane derived from (R,R)-
diisopropyl tartrate. Homoallyl alcohol 5.6 was formed as an 88:12 mixture of 
diastereomers differing in stereochemistry at the alcohol stereocenter. The mixture of 
diastereomers was then benzylated, and the latent aldehyde was revealed by 
dihydroxylation of the double bond with catalytic osmium tetroxide followed by 
cleavage of the diol with sodium metaperiodate. At the aldehyde stage the undesired 
diastereomer was separated chromatographically. Selective removal of the acetonideF174F 
led to the lactol 5.9, which was then converted to the glycosyl fluoride 5.10 by the 
action of DAST (Scheme 5.1). 
 
                                                 
170  Miniker, T. D.; Mukhanov, V. I.; Chkanikov, N. D.; Yartzeva,I. V.; Preobrazhenskaya, M. N. Carbohydr.  
 Res.  1978, 64, 17–31.  
171  Lee, M. D.; Dunne, T. S.; Chang, C. C.; Ellestad, G. A.; Siegel,M. M.; Morton, G. O.; McGahren, W. J.;  
 Borders, D. B. J. Am. Chem. Soc. 1987, 109, 3464–3466. 
172    Golik, J.; Clardy, J.; Dubay, G.; Groenewold, G.; Kawaguchi,H.; Konishi, M.; Krishnan, B.; Ohkuma, H.;  
 Saitoh, K.; Doyle, T. W. J. Am. Chem. Soc. 1987, 109, 3461–3462. 
173         Roush, W. R.; Hunt, J. A. J. Org. Chem. 1995, 60, 798–806. 
174    Garner, P. Tetrahedron Lett. 1984, 25, 5855–5858. 
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Scheme 5.1. Synthesis of glycosyl fluoride 5.10 
While 4-O-methylglucose had been previously prepared,F175F a strategy was needed 
for differential protection of the hydroxyl groups at the positions 1-3, 4 and 6. A 
suitable intermediate was prepared using the method of Samuelsson involving reductive 
opening of a 4,6-p-methoxybenzylidene acetal to give glucoside 5.11.F176F Methylation of 
the secondary alcohol using methyl iodide and sodium hydride provided the 4’-O-
methyl derivative. Selective removal of the 6-PMB protecting group under oxidative 
conditions led to glucoside 5.12, ready for glycosylation at the free 6-OH (Scheme 5.2). 
 
 
Scheme 5.2. Synthesis of compound partially protected 5.12 
Coupling of the primary alcohol 5.12 with glycosyl fluoride 5.10 was performed 
under Mukaiyama-NicolaouF177F conditions (Scheme 5.3). Within 15 min, the equatorial 
(β) and axial (α) glycosides were formed in a 2:1 ratio, consistent with results of 
DeslongshampsF178F and Woerpel.F179F  
 
                                                 
175    Bouveng, H. O.; Lindberg, B.; Theander, O. Acta Chem. Scand. 1957, 11, 1788–1789. 
176    Johansson, R.; Samuelsson, B.J. Chem. Soc. Perkin1 1984, 2371–2373. 
177    Mukaiyama, T.; Murai, Y.; Shoda, S. I. Chem. Lett. 1981, 10,  431–432. 
178    Miljkovic, M.; Yeagley, D.; Deslongchamps, P.; Dory, Y. L. J. Org. Chem. 1997, 62, 7597–7602. 
179   Romero, J. A. C.; Tabacco, S. A.; Woerpel, K. A. J. Am. Chem. Soc. 2000, 122, 168–169. 
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The equatorial and axial anomers were inseparable until the N-Boc group was 
reduced to the corresponding methylamino group. Reprotection of the methylamino 
group as the Boc derivative led to problems during deprotection due to the sensitivity of 
the 2-deoxypyranoside linkage.F180F Instead, the methylamino group of disaccharide 5.13 
was then protected as the N-trimethylsilylethyl carbamate (Teoc) derivative. 
 
Scheme 5.3. Coupling of the glycosyl fluoride 5.10 with primary alcohol 5.12  
Debenzylation with palladium and hydrogen provided the deprotected 
disaccharide 5.15, which was used in the synthesis of AT2433-A1 by condensation 
with 3 equiv of aglycon 5.16 in 35% yield. The dehydrohalogenation could be 
accomplished with DBU and iodine in methylene chloride in 52% yield to furnish the 
aromatic core of the aglycone. Finally, deprotection of the teoc group with TBAF 
provided material that matched AT2433-A1 (Scheme 5.4). 
 
Scheme 5.4. Synthesis of AT2433-A1 (5.2) 
                                                 
180   Chisholm, J. D.; Golik, J.; Krishnan, B.; Matson, J. A.; VanVranken, D. L. J. Am. Chem. Soc. 1999, 121, 
 3801–3802. 
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5.1.2. Synthesis of AT2433-B1165 
The disaccharide of AT2433-B1 5.4 consists of disaccharide 5.15 linked to 
aglycone 5.18, similar to 5.7, but lacking the chlorine atom. Refluxing of lactol 5.15 
with 3 equiv of 5.18 in methanol for 72 h gave 84% yield of glycosylated product. 
Oxidative aromatization of the mixture of diastereomers with DDQ led to the protected 
natural product 5.19 in 80% yield. Finally, deprotection of the Teoc carbamate with 
TBAF provided AT2433-B1 5.4 in good yield 86% (Scheme 5.5). 
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Scheme 5.5. Synthesis of AT2433-B1 5.4 
5.2. Retrosynthesis 
The objective of this work was to explore a new enantioselective method to 
obtain AT2433-A1 with special focus on the synthesis of the 2,4-dideoxy-4-amino-
xyloside moiety. The retrosynthetic proposal is shown in Scheme 5.6. The 
aminodeoxysugar (5.20) could be obtained from 5.21 by eletrophile-induced 
cyclization. A key point is the selection of group X, since it must control the 
regioselectivity of the cyclization to an endo-mode and eventually must behave as a 
leaving group in a future glycosylation reaction.  
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Amino alcohol 5.21 could be prepared from allylic amine 5.24 by 
dihydroxylation, sulphate formation and elimination. Compound 5.24 can be 
synthesized from allyl amine 5.25 via chain elongation mediated by cross-metathesis 
reaction. Lastly, chiral allyl amine 5.25 could be obtained, similarly to the previous 
chapters, by a palladium-catalyzed dynamic kinetic asymmetric transformation 
(DYKAT) from the racemic butadiene monoepoxide 5.26. 
On the other hand, the intermediate 5.21 could be also obtained by addition to the 
Garner aldehyde (5.28) followed by deprotection of the protecting groups in 5.27. 
 
               Scheme 5.6. Retrosynthetic approach for the synthesis of aminodeoxysugar 5.20 
  
The main steps of this approach will be the palladium-catalyzed asymmetric 
allylic amination of racemic butadiene monoepoxide (5.26),X33X,X34 X followed by chain 
elongation mediated by a ruthenium-catalyzed cross-metathesis reaction and a 
dihydroxylation reaction of the E-alkene intermediate. The stereoselectivity of the 
dihydroxylation reaction should be expected to be controlled by the stereocenter  
present in the molecule but if necessary, it could be enhanced by using the asymmetric 
method. Thus, the proposed approach relies on three metal-catalyzed reactions: i) 
palladium-catalyzed Dynamic Kinetic Asymmetric Transformation, ii) ruthenium-
catalyzed cross-metathesis and iii) osmium-catalyzed dihydroxylation.  
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5.3. Results and discussion 
5.3.1. Synthesis of the 2-deoxy-aminosugar from racemic monoepoxide butadiene 
5.3.1.1. Synthesis of allyl imides by DYKAT 
 
Based on our previous experience, compound 5.31 was obtained directly via 
palladium-catalyzed allylic substitution from butadiene monoepoxide (5.26) using 2 
mol% of [(η3-C3H5)PdCl]2, 6 mol% of (S,S)-DACH-Naphtyl (5.30)X34X and imide 5.29 to 
afford the desired compound in a 96% yield and 90% e.e. (Scheme 5.7). Deprotection 
of benzoyl group in 5.31 using LiOH in THFF181F afforded the desired compound 5.32 in 
96% yield. 
 
Scheme 5.7. Synthesis of compounds 5.31 and 5.32 
The synthesis of compound 2-(R)-N-phthalimido-3-buten-1-ol (5.34) was carried 
out, as reported in the previous chapters, under the conditions optimized by Trost. Thus, 
using 0.4 mol% of [(η3-C3H5)PdCl]2, 1.2 mol% of (S,S)-DACH-Naphtyl (5.30), and 
Na2CO3 in dichloromethane for 14h, allylic amine 5.34 was obtained in an excellent 
yield (99%) and 99% e.e. after recrystallization (Scheme 5.8).X33X  
                                                 
181    Julian, L.D.; Wang, Z.; Bostick, T.; Caille, S.; Choi, R. J. Med. Chem. 2008, 51, 3953–3960. 
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Scheme 5.8. Synthesis of compound 5.34 
 
Reaction of 5.34 with TIPSCl and imidazole in DMF in order to selectively 
protect the primary hydroxyl group rendered silylether 5.35 in a 99% yield, which was 
subsequently treated with hydrazine to remove the pthalimido group to furnish allyl 
amine 5.36 in 90% yield (Scheme 5.9). 
 
 
Scheme 5.9. Synthesis of compounds 5.35 and 5.36     
5.3.1.2. Cross metathesis reaction of allyl amines and C3-allyl derivatives 
 
Elongation of the hydrocarbon skeleton was next explored via a cross metathesis 
reaction. As already pointed out, the group X at the reacting alkene partner in the cross 
metathesis should first enable such a process, but should be also an electrodonating 
group to direct the electrophilic-promoted cyclization to an endo-mode to give the 
pyranose derivative. Furthermore, it should be able to act as a leaving group in the 
glycosylation step, or at least, should be an easily derivatizable group to be converted 
into such a group. The X groups initially chosen for that purpose were the hydroxyl and 
the acetate group.  
Thus, we studied the cross metathesis reaction of compound 5.31 with allyl 
acetate 5.37 and allyl alcohol 5.38. The metathesis reaction with compound 5.31 and 
allyl acetate 5.37 in presence of the second generation Grubbs 5.41 and Hoveyda-
Grubbs 5.42 catalysts in refluxing dichloromethane led to no conversion, as observed 
by TLC and 1H NMR after 12h of reaction (Table 5.1, Entries 1 and 2). No product was 
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observed either by TLC and 1H NMR after 12h of reaction when cross metathesis 
between compound 5.31 and allyl acohol 5.38 was carried out in the presence of the 
second generation Grubbs catalyst 5.41 (Table 5.1, Entry 4). A possible reason for these 
results could be the partial deactivation of the catalyst. For that reason the reaction was 
conducted using 10 mol/% of catalyst loading, but again no product was observed 
(Table 5.1, Entries 3, 5). 
Table 5.1. Ru-catalyzed cross-methatesis of compound 5.31 with alkenes 5.37, 5.38. 
 
Entry 
 
Reactant Catalyst Solvent Temp. 
(ºC) 
Product Conversion 
(%)[b] 
Yield 
(%)[c] 
1 3.37 5.42 CH2Cl2 reflux 5.39 < 2 - 
2 3.37 5.41 CH2Cl2 reflux 5.39 < 2 - 
3[d] 3.37 5.41 CH2Cl2 reflux 5.39 < 2 - 
4 3.38 5.41 CH2Cl2 reflux 5.40 < 2 - 
5[d] 3.38 5.41 CH2Cl2 reflux 5.40 < 2 - 
 [a] Reactions were stirred for 12h, 5 mol% catalyst loading, 0.5M in solvent. [b]  Determined 
by 1H NMR spectroscopy. [c] Isolated yield. [d] Reactions were stirred for 12h, 10 mol% 
catalyst loading, 0.5M in solvent. 
 
The cross metathesis reaction was then performed by reaction of compound 5.34 
and allyl acetate 5.37 in presence of the second generation Grubbs catalyst 5.41 in 
refluxing dichloromethane to afford 5.43 in a 43% yield (Table 5.2, Entry 1). When 
allyl acohol 5.38 was made to react with 5.34 in the presence of the second generation 
Grubbs catalyst 5.42 in refluxing dichloromethane, no crossed-product was obtained 
(Table 5.2, Entry 2). 
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5.2. Ru-catalyzed cross-methatesis betwen compound 5.34, allyl acetate 5.37 and allyl alcohol 
5.38. 
 
Entry 
 
Reactant Catalyst Solvent Temp 
T(ºC) 
Product Yield 
(%)[b] 
1 5.37 5.41 CH2Cl2 reflux 5.43 43 
2 5.38 5.41 CH2Cl2 reflux 5.44 - 
         [a] All reactions were stirred for 12h, 5 mol% catalyst  loading, (3equiv) of  substrate 5.38 and  
 5.39,  0.5M in solvent. [b] Isolated yield. 
 
Since the results of cross-metathesis starting from alkene 5.34 were somewhat 
disappointing, we decided to explore analogous reactions using as starting material 
alkenes 5.31 and 5.32, with a carbamoyl group at the nitrogen atom and with the 
hydroxyl group protected and unprotected, respectively. Moreover, together with 
alkene 5.37, which had provided the more promising results, we also explored other 
alkenes such allyl phenyl sulphide 5.45, which also fulfilled the requirements of the 
retrosynthesis. Indeed, the phenylsulphanyl group can control the regioselectivity of the 
cyclization reaction as well as being a good leaving group in glycosylation reactions. 
Besides, we also decided to perform these reactions in the presence of Ru- and Mo-
catalyst. 
Thus, when cross-metathesis reaction was performed between allyl acetate 5.37 
and compound 5.32 in the presence of second generation Grubbs catalyst 5.41 in 
refluxing dichloromethane, the desired product 5.46 was obtained in moderate 50% 
yield (Table 5.3, Entry 2), which decreased to 22% when the reaction was performed in 
toluene at 80ºC (Table 5.3, Entry 1). 
We then tried the reaction with allyl phenyl sulphide 5.45, which was initially 
treated with compound 5.31 in the presence of the second generation Grubbs catalyst 
5.41 in refluxing dichloromethane to afford compound 5.47 in low yield (17%) (Table 
5.3, Entry 3). The reaction with compound 5.32 under similar reaction conditions 
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afforded 5.48 in an improved 50% yield (Table 5.3, Entry 4). Slow addition of substrate 
5.32 over 10h maintaining the other reaction conditions did not allow to improve the 
yield and compound 5.48 was obtained in 28% yield (Table 5.3, Entry 5). 
 
Table 5.3. Ru-catalyzed cross-methatesis betwen allyl amines 5.31, 5.32 and alkenes  
5.37 and 5.45. 
 
Entry 
 
Allyl 
amine 
Reactant 
 
Catalyst Solvent Temp 
(ºC) 
Product Yield 
(%)[b] 
1 5.32 5.37 5.41 Toluene 80 5.46 22 
2 5.32 5.37 5.41 reflux 55 5.46 50 
3 5.31 5.45 5.41 reflux 55 5.47 17 
4 5.32 5.45 5.41 reflux 55 5.48 50 
5[c] 5.32 5.45 5.41 reflux 55 5.48 28 
6 5.32 5.45 5.42 reflux 55 5.48 80 
7[c] 5.32 5.45 5.42 reflux 55 5.48 25 
8 5.32 5.45 5.42 Toluene 80 5.48 < 2 
9 5.31 5.45 5.49 reflux 55 5.47 < 2 
[a] All reactions were stirred for 12h, 5 mol% catalyst loading, 0.5M in solvent. [b]  Isolated yield. [c] 
5.46 was  added dropwise for 10h. 
Yields significantly improved when the reaction between allyl phenyl sulphide 
5.45 and allyl amine 5.32 was carried out in the presence of Hoveyda–Grubbs catalyst 
5.42 in refluxing dichloromethane. In this case an excellent 80% yield of compound 
5.48 was obtained (Table 5.3, Entry 6). The slow addition of substrate 5.32 (Entry 7), or 
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the increase of temperature to 80ºC using toluene as the solvent (Table 5.3, Entry 8) did 
not improve the results. 
Unexpectedly, the reaction of phenyl sulphide 5.45 in the presence of Shrock 
catalyst 5.49 at refluxing dichloromethane did not give the expected cross-product 
(Table 5.3, Entry 9).  
Since the structure of the aminodeoxysugar (5.20) has a N-methyl substituent at 
position 4, we considered convenient to introduce this group in the initial steps, and in 
particular by methylation of compound 5.31 to afford compound 5.50. An initial test of 
methylation of 5.31 using dimethyl sulfate (CH3)2SO4 in THF/water as the solvent gave 
negative results (Table 5.4, Entry 1), although when the reaction was carried out in 
anhydrous THF the desired product 5.50 was obtained in 43% yield (Table 5.4, Entry 
2). When the reaction was heated to reflux no product was observed (Table 5.4, Entry 
3). Increasing dimethyl sulphate (CH3)2SO4 and sodium hydride (NaH) equivalents in 
THF at room temperature did not improve the results, and product 5.50 was obtained in 
30% yield (Table 5.4, Entry 4). 
Replacement of other agent dimethyl sulfate by MeOTf was not efficient (Table 
5.4, Entry 5). When methyl iodide (CH3I) was used as a methylating agent in the 
presence of pyridine as a base, the reaction did not evolve (Table 5.4, Entry 6). Reaction 
of 5.31 with CH3I and sodium hydride led to the formation of 5.50 in 44% yield (Table 
5.4, Entry 7).  
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Table 5.4. Methylation of compound 5.31 to give compound 5.50. Optimization of 
reaction conditions.F182 
 
Entry Reagents Solvent Temp 
(ºC) 
Time
(h) 
Yield 
(%)[b] 
1 (CH3)2SO4, NaH THF, H2O rt 7 - 
2 (CH3)2SO4, NaH THF rt 6 43 
3 (CH3)2SO4, NaH THF reflux - - 
4[c] (CH3)2SO4, NaH THF 6 rt 30 
5 TfOMe, py CH2Cl2 rt - - 
6 CH3I, Py THF rt - - 
7 CH3I, NaH THF rt 6 44 
[a] 1.8 equiv of (CH3)2SO4 loading and 2 equiv of NaH , [b] Isolated yield. [c] 
3.6 equiv of (CH3)2SO4 loading  and 4 equiv of NaH. 
 
In spite of the yield obtained in the methylation reaction being moderate, we 
decided to go on with the synthesis, and we tried the cross-metathesis reaction between 
5.50 and different alkene partners such as 5.37, 5.51 and 5.52. The reaction of 5.50 with 
allylacetates 5.37 and 5.51 in the presence of 5 mol% of the second generation of 
Grubbs catalyst 5.41 in refluxing dichloromethane did not afford the desired product 
5.53 (Table 5.5, Entries 1, 2). Cross experiment of 5.50 with 5.52 under the same 
reaction conditions led to the cross-product 5.54 in a 28% yield (Table 5.5, Entry 3).  
 
 
 
 
 
                                                 
182  Mahavir, P.; Denis,H.; Bin,H.; Hong-Yong, K.; Oljan, R.;Thomas J, B. Org. Lett. 2003, 5, 125–128. 
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Table 5.5. Ru-catalyzed cross-methatesis between of allyl amine 5.50 and alkenes 5.37, 
5.51 and 5.52. 
 
 
Entry 
 
Reactant Catalyst Solvent Temp 
(ºC) 
Product Conversion 
(%)[b] 
Yield 
(%)[c] 
1 5.37 5.41 CH2Cl2 reflux 5.53 < 2 - 
2 5.51 5.41 CH2Cl2 reflux 5.53 < 2 - 
3 5.52 5.41 CH2Cl2 reflux 5.54   30 28 
        [a] All reactions were stirred for 12h, 5 mol% catalyst loading, 0.5M in solvent, [b]  Determined 
        by   1H NMR spectroscopy, [c]  Isolated yield. 
To conclude, cross metathesis reaction allowed us to obtain the E-alkene 
necessary for the synthesis of a target molecule with complete control of the 
stereoselectivity. Although in general yields were between low and moderate, 
reasonably good synthetic yields (80%) were obtained by reaction of allyl carbamate 
5.32 and allyl phenyl sulphide. 
5.3.1.3. Dihydroxylation of allyl aminesX105X,F183F,F184 
Dihydroxylation reaction is one of the key steps in the synthesis of the target 
compound. From the two hydroxyl functions to be installed, the one adjacent to the 
amino moiety is that where control of the stereoselectivty is crucial, whereas the other 
one is of minor interest, considering that a subsequent elimination process will destroy 
the chirality of that center and generate a double bond. Among the numerous processes 
for installing a diol moiety, osmium-catalyzed dihydroxylation with catalytic OsO4 and 
NMO as a terminal oxidant is probably one of the most efficient methods, and a priori 
                                                 
183   a) Sammakia,T.; Hurley,T.B.; Sammond, D.M.; Smith, R. S. Tetrahedron Lett. 1996, 37, 4427–4430.  
 b) Walsh, P. J.; Tong Ho, P.; King, S. B.; Sharples, K, B. Tetrahedron Lett. 1994, 35, 5129–5132. 
184    Ritsuo, I.; Skurai, O.; Yamashita, T.; Horikawa, H. Tetrahedron 1998, 54, 10657–10670. 
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may well fit our purpose, producing syn-dihydroxylation of the E-alkene in a 
diastereoselective process controlled by the chirality of the substrate, that is, anti to the 
adjacent amino moiety. Furthermore, this method offers further possibilities for the 
transformation of chiral substrates when diastereoselectivities with achiral catalysts are 
not optimal, by using the asymmetric version, the so-called Sharpless dihydroxylation, 
in double stereodifferentiation processes, where usually the chiral catalyst can even 
override the inherent stereoselectivity bias of the substrate in mismatched processes. 
Compound 5.54, which was obtained with a low yield, was initially reacted at 
room temperature with 5 mol % of OsO4 and stoichometric amounts of oxidant NMO. 
Dihydroxylation products were obtained as a diastereomeric mixture of compounds 5.55 
and 5.56 in 16% and 12 % yields, respectively.  
 
Scheme 5.10. Dihydroxylation of alkene 5.54 to afford diols 5.55 and 5.56 
Given the low yield obtained in all the process involving methylation and 
reactivity of N-methylated compounds, we decided to explore other possibilities. 
Compound 5.48, which was obtained with the best yield and stereoselectivity in the Ru-
catalyzed cross-metathesis, was initially reacted at room temperature with 5 mol % of 
OsO4 and stoichometric amounts of NMO for 20h. The expected dihydroxylation 
products were not observed but instead products of sulfur oxidation were obtainedX183Xb 
(Table 5.6, Entry 1). Applying the reactions conditions described in the literature for the 
dihydroxylation of substrates containing sulphur moieties, that is, 5 mol % of OsO4, 
K2CO3 (3eq) and K3Fe(CN)6 (3eq) instead of NMO (Table 5.6, Entry 2) led to no 
conversion. The uses of other conventional methods of dihydroxylation using different 
oxidation agents for regenerating OsO4 afforded almost exclusively the oxidation of 
sulfur. X183 a 
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Table 5.6. Dihydroxylation of alkene 5.48. 
 
 
Entry Reagents Tem 
(ºC) 
Time 
 
Products Conversion 
(%)[a] 
1 OsO4/NMO rt 20h 5.57a:5.57b >2:<2 
2[b] OsO4 rt 10d 5.57a:5.57b >2:<2 
        [a] Determined by 1H NMR, [b] K2CO3 (3eq), K3Fe(CN)6 (3eq). 
 
Intending to search for systems able to produce synthetic yields of 
dihydroxylation products without oxidising the sulphur atom, asymmetric 
dihydroxylation reaction using commercially available AD-mix-α and β was also 
explored. Indeed, when compound 5.48 was treated with commercial AD-mix-α and β 
for 20-48h the selective formation dihydroxylation products was observed although in 
low conversions (28-37%) and low ratio a/b (Table 5.7, Entries 1-3). In order to 
improve the conversion, 1 equivalent of K3Fe(CN)6 was added to the reaction between 
compound 5.48 and AD-mix-β, which was stirred for 10 days. This modification gave 
the diastereomeric compounds 5.57a/b with moderate conversion 45% and 
unsatisfactory selectivity, 1.4:1, and sulfur oxidation was also observed (Table 5.7, 
Entry 5). Attempted dihydroxylation of compound 5.48 using the Sharpless 
procedureF185F  resulted in low to moderate yields of the desired products. The catalytic 
system OsO4/AD-mix gave poor results in this case, probably because the bulky 
osmium-ligand complex is sterically demanding and reacts slowly with the sterically 
hindered alkene.F186F  
These results indicate that there is a fine balance between olefin dihydroxylation 
and sulfur oxidation, and the factors influencing the rate of either reaction depend on the 
structure of the substrate. Moreover, the separation of diastereomeric compounds 
                                                 
185       Sharpless,  K. B.;  Amberg,W. Bennani, Y. L.;  Crispino, G. A.; Hartung, J.; Jeong, K.S.; Morikawa, K.; 
Wang, Z.  M.; Xu ,D.  Zhang, X. L. J. Org. Chem. 1992, 54, 2768–2771. 
186       Annuziata, R.; Cinquini, M.; Cozzi, F. Tetrahedron 1988, 44, 6897–6902. 
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5.57a/b proved unsuccessful, which prompted us to discard this approach towards AT-
2433-A1. 
Table 5.7. Dihydroxylation of alkene 5.48 using different conditions 
 
 
Entry Chiral ligand  Time 
 
Products Conversion 
(%)[a] 
Ratio 
5.57a/5.57b 
1 AD-MIX β 20h 5.57a-5.57b 28 1.1:1 
2 AD-MIX α 20h 5.57a-5.57b 30 1:1.2 
3 AD-MIX β 48h 5.57a-5.57b 37 1.1:1 
5[b] AD-MIX β 10d 5.57a-5.57b 45 1.4:1 
         [a] Determined by 1H NMR , [b]Ligand (0.03 eq), K3Fe(CN)6 (1eq). 
 
 
5.3.2. Attempts of synthesis of the 2-deoxyaminosugar from Garner aldehyde 
We decided to explore an alternative procedure based on the use of Garner 
aldehyde as starting material. This approach maintains the electrophilic cyclization from 
an acyclic precursor as a final step to produce the pyranose derivative, but avoids the 
dihydroxylation reaction which led to such disappointing results. Scheme 5.1 shows the 
synthetic scheme proposed. We expect that reaction of Garner aldehyde 5.28 with a 
metal phenylthioacetylide, followed by triple bond reduction will afford compound 
5.59. Deprotection and protection steps will give access to 5.60, from which 2-
deoxyaminosugar 5.61 can be obtained by a electrophile induced cyclization reaction 
(Scheme 5.11). 
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Scheme 5.11. Synthetic approach for the synthesis of 2-deoxyaminosugar 5.61 from 
Garner aldehyde  
 
The first objective was the synthesis of phenylthioacetylene. Parhan and StrightF187F 
described a synthesis of phenylthioacetylene (I) by reaction of cis- or trans-1,1-bis-
(phenylthio)ethylene (IIa) with buthyllithium. The reaction is quite general for the 
synthesis of alkyl or arylmercaptoacetylenes, with little preference in elimination of 
normal alkyl or aromatic mercaptide. The reaction is, however, subject to steric and 
electronic effects and the product of reaction is consistent with β-elimination 
mechanism (Scheme 5.12). 
 
Scheme 5.12. Synthesis of phenylthioacetylene and mechanism  
Synthesis of bis(tiophenil)ethene 5.63 was carried out from cis-1,2-
dichloroethylene 5.62 in 76% yield in the presence of thiophenol and KOH in 
                                                 
187      Parham,W. E. P.;  Stright, P. L. J. Am. Chem. Soc, 1956, 78, 4783–4787.    
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EthanolF188F,F189F  (Scheme 5.13). Treatment of compound 5.63 with n-BuLi or Sec-BuLi in 
ether did not afford the desired product 5.65. 
 
Scheme 5.13. Synthesis of cis-1,2-bis (tiophenol) ethyl 5.63 
Proven the difficulties for obtaining the phenylthioacetilene, we decided to 
attempt the addition of an acetylide donor to the Garner aldehyde and leave for 
subsequent steps the installation of the sulphide moiety. Thus, we attempted the 
addition of lithium silylacetylide 5.66 to the the Garner aldehyde 5.28 under chelating 
conditions (ZnBr2) (Table 5.8, Entry 1). However, the formation of the desired product 
5.67 was not observed. The same result was observed in the absence of ZnBr2 (Table 
5.8, Entry 2). 
Table 5.8. Synthesis of compound 5.67 F190 
 
 
 
Entry  Substrate Reagents Solvent Temp(ºC) Product 
1 5.66 n-BuLi, ZnBr2 Et2O -78- rt - 
2 5.66 n-BuLi Et2O -78- rt - 
 [a] All reactions were stirred for 12h 
 
                                                 
188    Parham,W. E. P.;  Heberling, P. J. Am. Chem. Soc, 1955, 77, 1175–1177.  
189   a) Truce, W. E.; Simms, J. A.; Boudakian, M. M.  J. Am. Chem. Soc. 1956 , 78 ,695–696. b) Parham,W. E. P.;   
 Motter, R. F.; Mayo, G. L. O. J. Am. Chem. Soc, 1959, 81, 3386–3391. 
190   Hillaert, U.; Boldin-Adamsky, S.; Rozenski, J.; Busson, R.; Futermanand, A. H.;  Van Calenbergh, Serge.  
 Bioog. Med. Chem. 2006, 14, 5273–5284. 
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To check wheter the absence of results was due to the particular reactivity of the 
substrate we treated benzaldehyde under similar conditions observing that compound 
5.68 was not formed either (Scheme 5.14). 
 
 
 Scheme 5.14. Synthesis of compound 5.68 
 
In the light of the unsuccessful results obtained either in dihydroxylation reaction 
or in the addition of acetylide synthons to the Garner aldehyde we decided to abandon  
this synthesis.  
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5.4. Experimental Part: 
5.4.1. General Methods 
All chemicals used were reagent grade and used as supplied unless otherwise 
specified. HPLC grade dichloromethane (CH2Cl2), tetrahydrofuran (THF) and 
dimethylformamide (DMF) were dried using a solvent purification system (Pure SOLV 
system-4®). Toluene was purified using standard procedure. 
 
1H and 13C NMR spectra were recorded on a Varian® Mercury VX 400 (400 MHz 
and 100.6 MHz respectively) or Varian 400-MR spectrometer in CDCl3 as solvent, with 
chemical shifts (δ) referenced to internal standards CDCl3 (7.26 ppm 1H, 77.23 ppm 
13C) or Me4Si as an internal reference (0.00 ppm). 2D correlation spectra (gCOSY, 
NOESY, gHSQC, gHMBC) were visualized using VNMR program (Varian®). ESI MS 
were run on an Agilent® 1100 Series LC/MSD instrument. Optical rotations were 
measured at room temperature in a Perkin-Elmer® 241 MC apparatus with 10 cm cells. 
Elemental analysis (C, H, N, S) were performed on a Carlo Erba® EA 1108 Analyser in 
the Servei de Recursos Científics (SRCiT-URV). IR spectra were recorded on a JASCO 
FT/IR-600 plus Fourier Transform Infrared Spectrometer ATR Specac Golden Gate. 
Melting points, determined with Reichert apparatus, are uncorrected.  
 
Reactions were monitored by TLC carried out on 0.25 mm E. Merck® silica gel 60 
F254 glass or aluminium plates. Developed TLC plates were visualized under a short-
wave UV lamp (250 nm) and by heating plates that were dipped in ethanol/H2SO4 
(15:1) and basic solution of potassium permanganate. Flash column chromatography 
was carried out using forced flow of the indicated solvent on Fluka® or Merck® silica 
gel 60 (230-400 mesh). Radial chromatography was performed on 1 or 2 mm plates of 
Kieselgel 60 PF254 silica gel, depending on the amount of product. Flash column 
chromatography (FCC) was performed using flash silica gel (32–63 μm) and using a 
solvent polarity correlated with TLC mobility. The enantiomeric excess (ee%) 
determined via chiral HPLC analysis (chiralpack OD column, heptane:iPrOH, flow rate 
1 mlmin-1). 
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5.4.2.Compound characterization 
(R)-tert-Butyl-1-benzoyloxybut-3-ene-2-ylcarbamate (5.31). 
 
In a 25 mL flamed-dried flask under vacuum, t-butyl benzoyl imido carboxylate 
5.30 (0.4 g, 1.88 mmol), [(η3-C3H5)PdCl]2 (0.011 g, 0.03 mmol) and (S,S)-ligand 5.30 
(0.07 g, 0.09 mmol) were added under argon and the flask was purged three times with 
argon. Then dry dichloromethane (40 mL) was added to the mixture and the solution 
was stirred 30 min at rt. Butadiene monoepoxide (0.11 ml, 1.57 mmol) was added in 
one portion and the resulting mixture was stirred at 35 °C for 18h. The resulting mixture 
was concentrated and purified by flash chromatography using 10:1 hexanes:ethyl 
acetate as a solvent to afford compound 5.31 as a white solid in  (0.483 g. 96%) and 
90% ee.  
[α]D25 = +37.2 (c 1, CHCl3). IR (neat): 3359, 3069, 2977,1700, 1516, 1451, 1365, 1269, 
1163, 1113, 1069, 709 cm-1. 1H NMR (CDCl3, 400 MHz, δ in ppm): δ=  8 .02 (dd, 2H, 
J = 8, 1.2Hz), 7.54 (tt, 1H, J = 7.6 ,  1.2 Hz),  7.42 (t, 2H, J = 8 Hz), 5.88 (ddd, 1H, J = 
17.2, 10.4, 5.2 Hz) , 5.33 (ddd, 1H, J =17.2, 1.6, 0.8 Hz), 5.23 (ddd, 1H, J = 10.4, 1.6, 
0.8 Hz), 4.86 (br s, 1H), 4.6 (br s, 1H), 4.35 (d, 2H, J = 5.2 Hz), 1.4 (s, 9H). 13C NMR 
(CDCl3, 100.6 MHz, δ in ppm): δ=166.4, 155.3, 134.8, 133.2, 129.8, 129.7, 128.4, 
116.8, 79.8, 66.4, 51.8, 28.4. ESI-HRMS [M+23] calcd for C16H21NaNO4: 314.1368, 
Found: 314.1347. 
(2R)-tert-Butyl-1-hydroxybut-3-en-2-ylcarbamate (5.32). 
HO
HN O
O
5.32
 
To a solution of  product  5.31 (0.05 g, 0.17 mmol) in 1:1 THF/MeOH (2 ml) was 
added LiOH (0.0048g, 0.204 mmol). After being stirred for 3h, After being stirred for 
3h the reaction mixture was diluted with water, extracted with 10% MeOH/CH2Cl2 (x5), 
dried with Na2SO4 and concentrated in vacuo. Purification by silica gel chromatography 
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using (10:4 hexane/ACOEt) as solvent afforded 5.32 product as colorless oil (0.03 g, 
96%). 
[α]D25 = +21.6 (c 1, CHCl3). IR (neat): 3329, 2978, 2931, 1687, 1456, 1392, 1367, 
1167, 1071, 1051, 922 cm-1 . 1H NMR (CDCl3, 400 MHz, δ in ppm): δ=  5.79 (ddd, 1H, 
J = 16.4, 10.4, 5.6 Hz), 5.25-5.17 (m, 2H), 5.06 (brs, 1H), 4.19 (brs, 1H), 3.66 (dd, 1H, 
J = 11.2, 4.4 Hz), 3.58 (dd, 1H, J = 11.2, 5.6 Hz), 2.96 (brs, 1H), 1.42 (s, 9H). 13C 
NMR  (CDCl3, 100.6 MHz, δ in ppm): δ= 156.3, 135.8, 116.5, 80.0, 65.2, 54.8, 28.5. 
ESI-HRMS [M+1] calcd for C9H18NO3 : 388.1287, Found: 388.1821.  
(2R)-Phthalimido-3-buten-1-ol (5.34). 
 
In a 250 mL flamed-dried flask, Na2CO3 (53 mg, 0.05 mmol), phthalimide 5.33 
(1.47 g, 10 mmol), [(η3-C3H5)PdCl]2 (14.6 mg, 0.04 mmol) and S,S-ligand 5.30 (94.6 
mg, 0.12 mmol) were added under argon being the flask purged three times with argon. 
Then dry dichloromethane (80 mL) was added to the mixture and the solution was 
stirred 15 min at rt. Butadiene monoepoxide (810 μl, 10 mmol) was added in one 
portion and the resulting mixture was stirred at rt for 14h. The resulting mixture was 
concentrated and purified by flash chromatography, using 1:1 hexanes:ethyl acetate as a 
solvent, to afford 2.16 g of compound 5.34 (99%) as a white solid. An enantiomeric 
excess of 99% ee was determined by chiral HPLC (chiralpack OD, heptane:iPrOH 
90:10, 1 mlmin-1, tR(R) = 14.1 min and tR(S) = 16.9 min).   
[α]D25 =  +65.9 (c 1, CHCl3). Mp 60-63 ºC. IR (neat): 3527, 1763, 1702, 1656, 1609, 
1467 and 1388 cm-1. 1H NMR (CDCl3, 400 MHz, δ in ppm): δ 7.73 (dd, 2H, J = 5.6, 
3.2 Hz), 7.62 (dd, 2H, J = 5.6, 3.2 Hz), 6.06 (ddd, 1H, J = 17.6, 10.4, 7.2 Hz), 5.19 
(ddd, 1H, J = 17.6, 1.2, 1.2 Hz), 5.18 (ddd, 1H, J = 10.0, 1.2, 1.2 Hz), 4.84 (m, 1H), 
4.07 (ddd, 1H, J = 11.4, 8.4, 8.0 Hz), 3.86 (ddd, 1H, J = 11.4, 7.6, 4.6 Hz), 2.98 (dd, 1H, 
J = 8.0, 4.6). 13C NMR (CDCl3, 100.6 MHz, δ in ppm): δ 168.7, 134.3, 132.1, 131.9, 
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123.5, 119.0, 62.8, 56.1. ESI-HRMS [M+1] calcd for C12H12NO3: 218.0817, Found: 
218.0813.  
(2R)-1-tri-Isopropylsilyloxy-2-phthalimido-3-butene (5.35). 
 
TiPSO
N OO
5.35
 
To a solution  of product 5.34 (0.1 g, 0.465 mmol) and imidazole (0.93ml, 
0.93mmol)  in 1.5 ml of  DMF was added TiPSCl at 0ºC. The mixture was stirred for 3h 
at room temperature, evaporation of solvent and purification by silica gel 
chromatography hexane: ethyl acetate (3:1) provided the desired compound 5.35 as a 
white solid (0.149 g , 99%).   
 
[α]D25 =  +9.4 (c 1.2, CHCl3). IR (neat) 3110, 2942, 2865, 1767, 1704, 1466, 1385, 
1361, 1109, 1083   cm-1.  1H NMR (CDCl3, 400 MHz, δ in ppm): δ=  7.79 (dd, 1H, J = 
5.2, 3.2 Hz), 7.68 (dd, 2H, J = 5.6, 3.2 Hz), 6.32 (ddd, 1H, J = 17.2, 10, 7.6 Hz), 5.26 
(ddd, 1H, J = 17.6, 1.2, 1.2 Hz) , 5.22 (ddd, 1H, J = 10.4, 1.2, 1.2 Hz), 4.92(m, 1H), 
4.23(dd, 1H, J = 10 Hz) , 3.94 (dd , 1H, J = 10, 6 Hz),  1.04(s, 3H), 0.96 (s, 18H). 13C 
NMR  (CDCl3, 100.6 MHz, δ in ppm): δ=  168.1, 133.8, 132.4, 132.02, 123.07, 118.9, 
62.6, 55.9, 17.8, 11.8 . ESI-HRMS [M+1] calcd for C21H32NO3Si : 374.2151, Found: 
374.2138. 
 
(2R)-1-tri-Isopropylsilyloxy-2-phthalimido-3-butene (5.36). 
 
 
To a solution of product 5.35 (0.17g , 0.46 mmol) in MeOH (2 ml) was added 
hydrazine (0.024 ml, 0.68 mmol) the mixture stirred at 70ºC for 18hThe reaction crude 
was concentrated, dissolved in CHCl3, and was filtered over Celite, and the filtrate was 
concentrated in vacuo. The residue was purified by column chromatography hexane: 
ethyl acetate (3:1) to afford the desired compound 5.36 as a yellow liquid (0.09 g, 90%).  
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1H NMR (CDCl3, 400MHz, δ in ppm): δ= 5.83 (ddd , 1H, J= 17.2, 10, 6 Hz),  5.22 
(ddd, 1H , J = 17.2, 1.2, 1.2 Hz)  , 5.08 (ddd, 1H , J = 10.4, 1.6, 0.8 Hz), 3.71 (m , 1H) ,  
3.48(m, 2H), 1.64 (brs, 2H), 1.26 (s, 3H), 1.08 (s, 18H).  
Methyl (2R,2E)-5-phthalimido-6-hydroxyhex-3-enoate (5.43). 
 
To a solution of product  5.34 (0.02 g, 0.09 mmol) and (0.0038 g, 0.0045 mmol) 
of 2nd generation Grubbs catalyst in dichlorometane (1 ml) was added dropwise allyl 
acetate (0.027 ml, 0.27 mmol) at 55ºC. Reaction was stirred at 55ºC for 12h, 
evaporation of solvent and purification by silicagel chromatography using 
hexanes/AcOEt (3:2) provided the desired product 5.43 as a colorless oil (0.011 g 43%). 
 
IR (neat): 3405, 2926, 1772, 1705, 1386, 1058, 721 cm-1. 1H NMR (CDCl3, 400MHz, δ 
in ppm): δ = 7.80 (dd, 2H, J = 5.6, 2.8  Hz), 7.70 (dd, 2H, J = 5.2, 3.2 Hz), 6.1 (ddt, 1H, 
J = 15.6, 7.4, 1.8), 5.82 (dtd, 1H, J = 16.8, 5.6, 1.2 Hz), 4.96 (m, 1H), 4.56 (dd, 2H, J = 
6, 0.8 Hz ), 4.11(ddd, 1H, J = 11.6, 6 Hz), 3.95(ddd, 1H, J = 11.6, 4Hz ), 2.69 (dd, 1H, J 
= 8.4, 4Hz  ), 2.04(s, 1H). 13C NMR (CDCl3, 100.6 MHz, δ in ppm): δ= 171.8, 168.8, 
134.4, 131.9, 128.9, 127.9, 123.6, 64.1, 63.1, 60.6, 55.3, 21.2.  
Methyl (3E,5R)-5-tert-butoxycarbonylamino-6-hydroxy-hex-3-enoate (5.46). 
 
 
To a solution of product 5.32 (0.07 g, 0.37 mmol) and  2nd generation Grubbs 
catalyst (0.016 g, 0.013 mmol)  in dichlorometane (5 ml) was added allyl phenyl acetate 
(0.11 ml, 1.29 mmol). Reaction stirred at 55ºC for 12h, evaporation of solvent and 
purification by silica chromatography using hexanes/AcOEt (1:1) solvent provided 
0.048 g of  the desired product 5.48  as yellow liquid (50%). 
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[α]D25 = -4.2 (c 1, CHCl3). IR (neat): 3271, 1734, 1674, 1506, 1367, 1265, 1168, 966, 
732, 701 cm-1. 1H NMR (CDCl3, 400 MHz, δ in ppm): δ=  5.77 (m, 2H) , 4.91(brs, 1H), 
4.75 (brs, 1H), 4.56 (dd, 2H, J= 4.4, 1.2 Hz), 4.26 (brs, 1H), 3.68 (m, 2H), 2.301 (brs, 
1H), 2.06 (s,3H) 1.4 (s, 9H). 13C NMR  (CDCl3, 100.6 MHz, δ in ppm): δ= 155.7, 
135.2, 131.1, 130.5, 128.9, 127.7, 126.7, .79.6, 65.4, 53.6, 36.4, 28.2. ESI-HRMS 
[M+23] calcd for C12H21NNaO5: 282.1317, Found: 282.1325 
(2R,3E)-2-(tert-Butoxycarbonyl)amino-1-hydroxy-5-(phenylsulfanyl)pent-3-ene 
(5.48). 
 
To a solution of product 5.32 (0.04 g, 0.21mmol) and (0.007 g, 0.011 mmol) of 
Grubbs-Hoveyda catalyst in dichlorometane (3 ml)  allyl phenyl sulphide (0.16 ml, 1.05 
mmol) was added. Reaction was stirred at 55ºC for 12h. Evaporation of solvent and 
purification by silica gel chromatography using hexan/AcOEt (3:2) as eluent provided 
the desired product 5.47  as yellow liquid (0.052 g, 80%) .  
 
[α]D25 =  +11.4 (c 2, CHCl3). IR (neat): 3433, 3053, 2359, 1684, 1506, 1366, 1165, 898, 
877, 734, 701 cm-1.  1H NMR (CDCl3, 400 MHz, δ in ppm): δ=  7.32-7.7.28 (m, 4H), 
7.2 (tt, 1H, J = 7.2, 1.2 Hz), 5.69 (dtd, 1H , J = 15.6, 7.2, 1.6 Hz) , 5.35 (ddt, 1H, J = 
15.2, 5.6, 1.2 Hz), 4.75 (brs, 1H), 4.12 (brs, 1H), 3.52 (m, 2H), 3.42 (m, 2H), 1.82 
(brs,1H) 1.39 (s, 9H). 13C NMR (CDCl3, 100.6 MHz, δ in ppm): δ= 155.7, 135.2, 
131.1, 130.5, 128.9, 127.7, 126.7, .79.6, 65.4, 53.6, 36.4, 28.2. ESI-HRMS [M+23] 
calcd for C16H23NNaO3S: 332.1296, Found: 332.1266. 
 
(2R)-2-(tert-butoxycarbonyl-methyl)-amine-but-3-en-1-yl benzoate (5.50). 
 
BzO
N O
O
5.50
Me
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To a solution of NaH (0.008 g, 0.34 mmol)  in THF ( 1ml) was added product 
5.31 drop wise (0.05g, 0.17 mmol)  in THF, the mixture was stirred for 10 min at room 
temperature, after was added dimethylsulphate (0.029 ml, 0.306 mmol). The mixture 
was stirred at this temperature until the starting material was not observed by TLC.then 
the  reaction was quenched with NH3, stirred for 1h, and  after toluene and water was 
added. The aqueous layer was extracted with water, the combined organic layer was 
dried by MgSO4 and concentred in vacuo. Purification by silica gel chromatography 
using 10:1 hexanes:ethylacetate  provided the desired  product 5.50 as a yellow liquid 
(0.024 g, 43%).  
 
[α]D25 = -7.5 (c1.1, CHCl3).  IR  (neat) 3400, 2926, 2853, 2600, 1638, 1648, 1100, 
1150, 1030, 1230 cm-1. 1H NMR (CDCl3, 400MHz, δ in ppm): δ=  8.01 ( dd  , 2H , J = 
8.4, 1.6 Hz), 7.55 (t, 1H, J =  7.6Hz), 7.42 (t , 2H, 7.6 Hz), 5.82 (ddd, 1H, J = 17.2, 
10.4, 4.8 Hz), 5.29 (dd, 1H, J = 10.8, 1.2 Hz), 5.23 (dd, 1H, J = 17.6, 1.2 Hz), 4.9(brs, 
1H) , 4.44(m, 2H),  2.8 (brs, 3H), 1.4 (s, 9H). 13C NMR (CDCl3, 100.6 MHz, δ in ppm): 
δ=  166.4, 133.6, 133.2, 130.0 129.9, 128.5, 118.1, 80, 63.6, 29.9, 28.6. ESI-HRMS 
[M+1] calcd for C17H24NO4 :306.1705, Found: 306.1766.   
 
3-Methylbut-2-en-1-yl acetate(5.51). 
 
 
A solution of 3-methyl-2-buten-1-ol (3 ml, 29.98 mmol) and pyridine (24.12 ml, 
299.8 mmol) was stirred for 5 min at room temperature, and after acetic anhydride was 
added. The mixture was stirred for 20h. The organic layer was extracted with HCl, 
diluted with ethylacetate, neutralized with bicarbonate and wached with water and  
brine. The resulting solution  was dried over anhydrous MgSO4 and the solvent was 
removed under vacuum to afford (3 g , 93%) of compound 5.51 as a colorless oil.  
 
IR (neat):  1734, 1434, 1375, 1228, 1046, 1021, 962, 819, 773 cm-1. 1H NMR (CDCl3, 
400MHz, δ in ppm): δ= 5.4 (t, 1H), 4.6 (d, 2H),  2 (s, 3H), 1.76 (s, 3H), 1.7 (s, 3H). 
ESI-HRMS [M+23] calcd for C7H13NNaO3 : 151.0724, Found: 151.0735.  
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(2R,3E)-5-bromo-2-(tert-butoxycarbonyl-methyl)-amino-pent-3-en-2-yl benzoate 
(5.54). 
   
 
 
To a solution of product 5.50 (0.058 g, 0.19 mmol) and (0.016g, 0.019 mmol) of 
2nd generation Grubbs catalyst in dichloromethane (2 ml), allyl bromide (0.054 ml, 
0.501 mmol) was added. The Reaction was stirred at 55ºC for 12h. Evaporation of 
solvent and purification by silica gel  chromatography hexanes/AcOEt (10:1) provided 
0.021 g (28%) of product 5.54 as a yellow liquid .  
 
1H NMR (CDCl3, 400MHz, δ in ppm): δ= 8 ( dd, 2H, J =6.8, 1.6 Hz), 7.55 (t, 1H, J = 
14.8, 7.6 Hz), 7.4 (t, 2H, J = 14.8, 7.6 Hz ), 5.9 (dt, 1H, J = 15.2, 7.2 Hz ) , 5.76 (dd, 
1H, J = 15.2, 5.2 Hz), 5 (m, 1H), 4.2 (m, 2H), 4(d, 2H, J = 7.2 Hz), 2.8 (s, 3H), 1.4 (s, 
9H); 13C NMR (CDCl3, 100.6 MHz, δ in ppm): δ= 133.3, 133.2, 129.94, 129.9,128.5, 
63.4, 31.4, 30.2, 29.8, 28.52. 
  
(2S,3S,4R)-5-bromo-2-(bis-tert-butoxycarbonyl)amino-3,4-dihydroxypent-3-en-2-yl 
benzoate (5.55), and (2S,3R,4S)-5-bromo-2-(bis-tert-butoxycarbonyl)amino-3,4-
dihydroxypent-3-en-2-yl benzoate (5.56). 
      
 
In a 10 ml round bottomed flask NMO (0.006 g, 0.053 mmol) was dissolved in 
water (1 ml), OsO4, acetone (1 ml) and tBuOH (1 ml) were added. The mixture was 
stirred for 5 minutes at 0 ºC and then, a solution of compound 5.54 (0.0177 g, 0.044 
mmols) in acetone (1 ml) was added in one portion. The mixture was stirred for 20 
hours at room temperature. When the reaction had finished a solution of Na2SO3 was 
added and the resulting clear mixture was stirred for 15 minutes. The reaction mixture 
was diluted with ethyl acetate and the organic layer was washed with brine, dried over 
MgSO4 and concentrated. The reaction mixture was purified by column 
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chromatography with hexane:ethyl acetate (5:2) to obtain 5.55 (0.003 g, 16%)  and 5.56 
(0.002 g, 12%) . 
 
Compound 5.56: [α]D25 = +4.2 (c 0.2, CHCl3). IR (neat): 3413,  2359, 1720, 1451, 
1276, 1153, 900, 873, 755, 710 cm-1. 1H NMR (CDCl3, 400 MHz, δ in ppm): δ= 8.01 
(d, 2H, J = 7.2 Hz), 7.57 (t, 1H, J = 7.2 Hz), 7.44 (t, 1H, J = 7.6 Hz), 4.74 (m, 2H), 4.39 
(m, 2H), 3.91 (m, 2H), 3.76 (brs, 1H), 3.52 (d, 2H, J = 5.6 Hz), 2.84 (s, 3H), 2.57 (brs, 
1H), 1.45 (s, 9H). 13C NMR (CDCl3, 100.6 MHz, δ in ppm): δ= 166.3, 163.5, 133.1, 
131.1, 129.6, 128.4, 75.76, 74.0, 71.7, 62.6, 54.1, 36.4, 28.2. ESI-HRMS [M+1] calcd 
for C18H27 Br NO6: 432.1022, Found: 432.0912. 
 
Compound 5.56: [α]D25 = -13 (c 0.27, CHCl3). IR (neat):  3431, 2359, 1720, 1684, 
1366, 1272, 1151, 864, 739, 710 cm-1. 1H NMR (CDCl3, 400 MHz, δ in ppm): δ=   8.01 
(d, 2H, J = 7.2 Hz), 7.57 (t, 1H, J = 8 Hz), 7.44 (t, 1H, J = 7.6 Hz), 4.65 (m, 2H), 4.30 
(brs, 1H), 3.82 (m, 2H), 3.66 (dt, 1H, J = 16.4, 4.8 Hz),  3.54 (dd, 1H, J = 10.4, 6.4 Hz), 
2.97(s, 3H), 2.80 (brs, 1H), 1.45 (s, 9H). 13C NMR (CDCl3, 100.6 MHz, δ in ppm): δ=  
166.4, 163.0, 133.4, 131.1, 129,8, 128.6, 71.7, 70.9, 69.5, 62.5, 53.3, 35.2, 28.4. ESI-
HRMS [M+23] calcd for C18H26 Br N Na O6: 454.0821, Found: 454.0708. 
 
(2R,3R,4R)-2-(tert-Butoxycarbonyl)amino-1,3,4-tri-hydroxy-5-(phenylsulfanyl)pentane 
(5.57a) and (2R,3S,4S)-2-(tert-Butoxycarbonyl)amino-1,3,4-trihydroxy-5-(phenylsulfanyl) 
pentane (5.57b). 
 
HN
Boc
HO SPh
OH
OH
5.57a
HN
Boc
HO SPh
OH
OH
5.57b  
 
In a 10 ml flask were weighted 0.45 g AD-mix-β and (0.011 g, 0.32 mmol) of 
methansulfanamide. Over this mixture, 4 ml of a solution of tBuoH/H2O were injected 
and the orange red solution was coled at 0ºC. This mixture was added in one portion at 
the corresponding olefine 5.48 (0.1 g, 0.32 mmol). The mixture was stirred for 48h at 
room temperature. A solution of Na2S2O3 was added over the yellow suspension and the 
resulting claear solution was stirred for additional 15 min. The reaction mixture was 
extracted with EtOAC, and the combined organic layer were washed with 1N KOH, 
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H2O and brine, the organic phase was dried over MgSO4, filtration and evaporation of 
solvent  provided (37%, 31 mg)  products 5.57a/b as a yellow paste. 
 
Compound (5.57a) : 1H NMR (CDCl3, 400 MHz, δ in ppm): δ =  7.39 (dd, 2H, J = 8, 
1.6 Hz), 7.29  (t, 2H, J = 6.8), 7.20 (t, 1H, J = 7.2 Hz), 5.18 (brs, 1H), 4.05 (brs, 2H), 
3.74 (m, 4H), 3.52 (brs, 1H), 3.14 (m, 2H), 2.39 (brs,1H), 1.38 (s, 9H). 
 
Compound (5.57b) : 1H NMR (CDCl3, 400 MHz, δ in ppm): δ =  7.39 (dd, 2H, J = 8, 
1.6 Hz), 7.28  (t, 2H, J = 7.2), 7.20 (t, 1H, J = 7.6Hz), 5.28 (brs, 1H), 3.84-3.68 (m, 6H), 
3.24 (brs, 2H), 3.04 (dd, 1H, J = 14, 4.6 Hz), 2.88 (brs,1H), 1.42 (s, 9H). 
 
 (Z)-1,2-bis-(phenilthio)ethene (5.63). 
 
 
 
Compounds KOH (1.907 g, 33.99 mmol) and thiophenol (2.108 ml, 20.6 mmol) 
were dissolved in ethanol (27 ml) and after cis-1,2-dichloroethylene (1g, 10.3 mmol) 
was added dropwise. The resulting solution was refluxed  for 5 hours, evaporated and 
then  water  was added. The aqueous layer was extracted with ether 3 times, the 
combined organic layer were wached with NaOH, water, and was dried over anhydrous 
MgSO4. Removal of solvent provided 1.9 g (76%) of compound  5.63 as yellow-orange 
liquid product.  
 
IR (neat): 3058, 1581, 1539, 1437, 1293, 1091, 1070, 1023 cm-1. 1H NMR (CDCl3, 400 
MHz, δ in ppm): δ= 7.54 (dd, 2H, J =7.2 , 1.6 Hz), 7.44 (dddd, 4H, J =14.8, 7.6, 2.4, 0.8 
Hz), 7.36 (dddd, 2H, J =14.4, 6, 2.4, 1.2 Hz), 6.65(s, 2H). 13C NMR (CDCl3, 100.6 
MHz, δ in ppm): δ= 135.3, 129.6, 129.2, 127.0, 125.1. ESI-HRMS [M+1] calcd for 
C14H13S2: 245.0459, Found: 245.0420. 
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CONCLUSIONS 
 
 
Chapter 3: Enantioselective synthesis of nectrisine 
The asymmetric allylic amination from racemic butadiene monoepoxide using (η3-
C3H5)PdCl/DACH-naphtyl system and t-Butyl-benzoyl-imido carboxylate as a N-
nucleophile proceeded with excellent yield (98%) and enantioselectivity (97%) to obtain 
the chiral allylic amine synthon.  
Elongation of the chain of the key chiral allylic imides 3.40, 3.41 and 3.43 with ethyl 
acrylate through cross metathesis using Hoveyda-Grubbs catalyst (5 mol%), proceeded 
quatitatively to obtain the trans alkene intermediates 3.54, 3.55 and 3.56, respectively. 
 
The installation of the syn diol moiety via dihydroxylation of the alkene proceeded with 
high yield and moderately good diastereoselectivity with OsO4/TMEDA. 
 
Hydrolysis of benzoate group in 3.71 with LiOH and in situ cyclization led to the 
lactam 3.79. 
 
Chapter 4: Enantioselective synthesis of Cidofovir analogues 
The asymmetric allylic amination of racemic butadiene monoepoxide with cytosine 4.38 
as N-nucleophile was carried out with (η3-C3H5)PdCl/DACH-naphtyl system to obtain 
chiral allylic cytosine 4.42 in 85% yield and 72% ee. The reaction was successfully 
expanded to other pyrimidine and purine bases, among which adenine 4.41 afforded 
chiral allyl adenine 4.44 in 90% yield and 92% ee.  
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Chain elongation via Ru-cross metathesis of key allylic nucleobases 4.51, 4.53 and 
diethyl allylphosphonate with second generation Grubbs catalyst (5 mol%), produced 
4.52 and 4.54 in 92% and 90% yield, respectively. 
 
Deprotection of all protecting groups with TMSBr afforded the desired unsaturated 
acyclic nucleosides 4.57 and 4.58 in good yields. 
 
Hydrogenation with (H2, /Pd/C) at 3 bar rendered the saturated Cidifovir analogues 
4.59.  
 
Chapter 5: Approaches to the Enantioselective Synthesis of AT2433-A1 
 
The asymmetric allylic amination from racemic butadiene monoepoxide using (η3-
C3H5)PdCl/DACH-naphtyl system and imide 5.29 as a nitrogen nucleophile proceeded 
with good yield (96%) and enantioselectivity (90%).  
Chain elongation of key chiral allylic amine 5.32 was carried out by cross metathesis 
with allyl phenyl sulphide with Hoveyda-Grubbs catalyst (5 mol%) to obtain the 
corresponding trans alkene 5.48 in 80% yield. 
The installation of the diol moiety with OsO4 was unsuccesful, due to the competitive 
oxidation of sulfur, preventing the completion of the synthesis. 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of (2S)-2-((tert-Butoxycarbonyl)amino)but-3-1-yl benzoate (3.40). 
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of  (2S)-2-((tert-Butoxycarbonyl)amino)but-3-1-yl benzoate (3.40). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of (2S)-2-((bis-tert-Butoxycarbonyl)amino)but-3-1-yl benzoate (3.41). 
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of (2S)-2-((bis-tert-Butoxycarbonyl)amino)but-3-1-yl benzoate (3.41). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of (2S,3E)-2-{bis[(tert-butoxy)carbonyl]amino}-4-(1,3-dioxolan-2-yl)but 
-3-en-1-yl benzoate (3.51). 
 
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of (2S,3E)-2-{bis[(tert-butoxy)carbonyl]amino}-4-(1,3-dioxolan-2-yl)but 
-3-en-1-yl benzoate (3.51). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of Ethyl (2E,4S)-5-benzoyloxy-4-((bis-tert-butoxycarbonyl)amino)-pent-2-
enoate (3.55). 
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of Ethyl (2E,4S)-5-benzoyloxy-4-((bis-tert-butoxycarbonyl)amino)- 
pent-2-enoate (3.55). 
 
 
 
N
Boc Boc
BzO O
O
N
Boc Boc
BzO O
O
UNIVERSITAT ROVIRA I VIRGILI 
ENANTISELECTIVE SYNTHESIS OF NATURAL PRODUCTS 
Mariam Azzouz 
Annex 
169 
 
1H NMR (CDCl3, 400 MHz, δ in ppm) of (2R,3R,4S)-2-((bis-tert-butoxy)carbonyl)amino-4-(1,3-dioxolan-2-yl)-
3,4-dihydroxybutyl benzoate (3.58).  
 
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of (2R,3R,4S)-2-((bis-tert-butoxy)carbonyl)amino-4-(1,3-dioxolan-2-
yl)-3,4-dihydroxybutyl benzoate (3.58).  
 
0.00.5 1.0 1.5 2.02.53.03.54.04.55.05.56.0 6.5 7.0 7.5 8.0 8.5 9.0 
f1 (ppm)
17
. 93
1. 141.091.084.170.941.101.991.001. 911. 092. 12
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1H NMR (CDCl3, 400 MHz, δ in ppm) of (2R,3S,4R)-2-((bis-tert-butoxy)carbonyl)amino-4-(1,3-dioxolan-2-yl)-
3,4-dihydroxybutyl benzoate (3.59). 
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of (2R,3S,4R)-2-((bis-tert-butoxy)carbonyl)amino-4-(1,3-dioxolan-2-
yl)-3,4-dihydroxybutyl benzoate (3.59). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of Ethy (2S,3R,4R)-5-(benzoyloxy)-4-((bis-tert-butoxycarbonyl)amino)-
2,3-dihydroxypentanoate (3.62).  
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm)of Ethy (2S,3R,4R)-5-(benzoyloxy)-4-((bis-tert-butoxycarbonyl)amino)-
2,3-dihydroxypentanoate (3.62). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of Ethyl (2S,3S,4S)-5-(benzoyloxy)-4-((tert-butoxycarbonyl)amino)-2,3-
dihydroxypentanoate  (3.63).  
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of Ethyl (2S,3S,4S)-5-(benzoyloxy)-4-((tert-butoxycarbonyl)amino)-
2,3-dihydroxypentanoate  (3.63). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of Ethyl (2R,3S,4R)-5-(benzoyloxy)-2-3-dihydroxy-4-
(trifluoroacetamido)pentanoate (3.73). 
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of Ethyl (2R,3S,4R)-5-(benzoyloxy)-2-3-dihydroxy-4-
(trifluoroacetamido)pentanoate (3.73). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of (3S,4R,5R)-3-(tert-butyldiphenylsilyloxy)-5-((tert-
butyldiphenylsilyloxy)methyl)-4-hydroxypyrrolidin-2-one (3.81). 
 
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of (3S,4R,5R)-3-(tert-butyldiphenylsilyloxy)-5-((tert-
butyldiphenylsilyloxy)methyl)-4-hydroxypyrrolidin-2-one (3.81). 
 
 
 
UNIVERSITAT ROVIRA I VIRGILI 
ENANTISELECTIVE SYNTHESIS OF NATURAL PRODUCTS 
Mariam Azzouz 
Annex 
175 
 
1H NMR (CDCl3, 400 MHz, δ in ppm) of (3S,4R,5R)-3,4-bis-(tert-butyldimethylsilyloxy)-5-((tert-
butyldimethyldimethylsilyl)oxyMethyl)pyrrolidin-2-one (3.82). 
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of (3S,4R,5R)-3,4-bis-(tert-butyldimethylsilyloxy)-5-((tert-
butyldimethyldimethylsilyl)oxyMethyl)pyrrolidin-2-one (3.82).  
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1H NMR (CDCl3, 400 MHz, δ in ppm) of tert-butyl (3S,4R,5R)-N-tert-butoxycarbonyl-3,4-bis[(tert-
butyldimethylsilyl)oxy]-5-((tert-butyldimethylsilyloxy)methyl)-2-pyrrolidin-2-one (3.83). 
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of tert-butyl (3S,4R,5R)-N-tert-butoxycarbonyl-3,4-bis[(tert-
butyldimethylsilyl)oxy]-5-((tert-butyldimethylsilyloxy)methyl)-2-pyrrolidin-2-one (3.83). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of 3-Benzoyl-1-[(2S)-1-hydroxybut-3-en-2-yl]-1,2,3,4-
tetrahydropyrimidine-2,4-dione (4.31).  
 
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of 3-Benzoyl-1-[(2S)-1-hydroxybut-3-en-2-yl]-1,2,3,4-
tetrahydropyrimidine-2,4-dione (4.31). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of 4-((Bis(tert-butoxycarbonyl)amino)-1-((2S)-1-hydroxybut-3-en-2-yl)-
1,2-dihydropyrimidine-2-one(4.42). 
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of of 4-((Bis(tert-butoxycarbonyl)amino)-1-((2S)-1-hydroxybut-3-en-2-
yl)-1,2-dihydropyrimidine-2-one(4.42). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of 6-(Bis-tert-butoxycarbonyl)amino)-9-((2S)-1-hydroxybut-3-en-2-yl)-
9H-purine (4.44).   
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of 6-(Bis-tert-butoxycarbonyl)amino)-9-((2S)-1-hydroxybut-3-en-2-
yl)-9H-purine (4.44).   
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1H NMR (CDCl3, 400 MHz, δ in ppm) of (2S,3E)-2-[(4-bis-(tert-butoxycarbonyl)amino)-2-oxo-1,2-
dihydropyrimidin-1-yl]-5-(diethoxyphosphoryl)pent-3-en-1-yl benzoate (4.50). 
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of (2S,3E)-2-[(4-bis-(tert-butoxycarbonyl)amino)-2-oxo-1,2-
dihydropyrimidin-1-yl]-5-(diethoxyphosphoryl)pent-3-en-1-yl benzoate (4.50). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of 2-[(4-bis-(tert-butoxycarbonyl)amino)-1-[(2S)-1-(tert-
butyldiphenylsilyloxy)but-3-en-2-yl]-1,2-dihydropyrimidin-2-one (4.51). 
 
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of 2-[(4-bis-(tert-butoxycarbonyl)amino)-1-[(2S)-1-(tert-
butyldiphenylsilyloxy)but-3-en-2-yl]-1,2-dihydropyrimidin-2-one (4.51). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of (2S, 3E)- 2-[((4-Bis-(tert-butoxycarbonyl)amino)-2-oxo-1,2-
dihydropyrimidin-1-yl]-1-(tert-butyldiphenylsilyloxy)-5-(diethoxyphosphoryl)pent-3-ene (4.52). 
 
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of (2S, 3E)- 2-[((4-Bis-(tert-butoxycarbonyl)amino)-2-oxo-1,2-
dihydropyrimidin-1-yl]-1-(tert-butyldiphenylsilyloxy)-5-(diethoxyphosphoryl)pent-3-ene (4.52). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of 6-(Bis-tert-butoxycarbonyl)amino)-9-((2S)-1-tert-
butyldiphenylsilyloxy-but-3-en-2-yl)-9H-purine (4.53). 
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of 6-(Bis-tert-butoxycarbonyl)amino)-9-((2S)-1-tert-
butyldiphenylsilyloxy-but-3-en-2-yl)-9H-purine (4.53). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of (2S,3E)-2-[((6-Bis-(tert-butoxycarbonyl)amino)-purin-9-yl]-1-(tert-
butyldiphenylsilyloxy)-5-(diethoxyphosphoryl)pent-3-ene (4.54). 
 
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of (2S,3E)-2-[((6-Bis-(tert-butoxycarbonyl)amino)-purin-9-yl]-1-(tert-
butyldiphenylsilyloxy)-5-(diethoxyphosphoryl)pent-3-ene (4.54). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of (2S)- 2-[((4-Bis-(tert-butoxycarbonyl)amino)-2-oxo-1,2-
dihydropyrimidin-1-yl]-1-(tert-butyldiphenylsilyloxy)-5-(diethoxyphosphoryl)pentane (4.55). 
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm)  of of (2S)- 2-[((4-Bis-(tert-butoxycarbonyl)amino)-2-oxo-1,2-
dihydropyrimidin-1-yl]-1-(tert-butyldiphenylsilyloxy)-5-(diethoxyphosphoryl)pentane (4.55). 
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1H NMR (D2O, 400 MHz, δ in ppm) of (2S,3E)-2-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-5-
(diethoxyphosphoryl) pent-3-en-1-yl benzoate (4.56). 
 
 
13C NMR (D2O, 100.6 MHz, δ in ppm)  of (2S,3E)-2-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-5-
(diethoxyphosphoryl) pent-3-en-1-yl benzoate (4.56). 
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1H NMR (D2O, 400 MHz, δ in ppm) of [(2E,4S)-4-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-5-hydroxypent-
2-en-1-yl]phosphonic acid (4.57). 
 
 
13C NMR (D2O, 100.6 MHz, δ in ppm)  of [(2E,4S)-4-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-5-
hydroxypent-2-en-1-yl]phosphonic acid (4.57). 
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1H NMR (D2O, 400 MHz, δ in ppm) of [(2E,4S)-4-(6-amino-9H-purin-9-yl)-5-hydroxypent-2-en-1-
yl]phosphonic acid (4.58). 
 
 
13C NMR (D2O, 100.6 MHz, δ in ppm) of [(2E,4S)-4-(6-amino-9H-purin-9-yl)-5-hydroxypent-2-en-1-
yl]phosphonic acid (4.58). 
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1H NMR (D2O, 400 MHz, δ in ppm) of [(4S)-4-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-5-
hydroxypentyl]phosphonic acid (4.59). 
 
 
13C NMR (D2O, 100.6 MHz, δ in ppm) of [(4S)-4-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-5-
hydroxypentyl]phosphonic acid (4.59). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of (2R)-Phthalimido-3-buten-1-ol (5.34) 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of (2R)-Phthalimido-3-buten-1-ol (5.34) 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of (2R)-1-tri-Isopropylsilyloxy-2-phthalimido-3-butene (5.35). 
 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of (2R)-1-tri-Isopropylsilyloxy-2-phthalimido-3-butene (5.35). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of Methyl (2R,2E)-5-phthalimido-6-hydroxyhex-3-enoate (5.43). 
 
13C NMR (CDCl3, 100.6 MHz, δ in ppm) of Methyl (2R,2E)-5-phthalimido-6-hydroxyhex-3-enoate (5.43). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of Methyl (3E,5R)-5-tert-butoxycarbonylamino-6-hydroxy-hex-3-enoate 
(5.46). 
 
 
13C NMR (CDCl3, 400 MHz, δ in ppm) of Methyl (3E,5R)-5-tert-butoxycarbonylamino-6-hydroxy-hex-3-enoate 
(5.46). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of (2R,3E)-2-(tert-Butoxycarbonyl)amino-1-hydroxy-5-
(phenylsulfanyl)pent-3-ene (5.48). 
 
1H NMR (CDCl3, 400 MHz, δ in ppm) of (2R,3E)-2-(tert-Butoxycarbonyl)amino-1-hydroxy-5-
(phenylsulfanyl)pent-3-ene (5.48) 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of (2R)-2-(tert-butoxycarbonyl-methyl)-amine-but-3-en-1-yl benzoate 
(5.50). 
 
 
13C NMR (CDCl3, 400 MHz, δ in ppm) of (2R)-2-(tert-butoxycarbonyl-methyl)-amine-but-3-en-1-yl benzoate 
(5.50). 
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1H NMR (CDCl3, 400 MHz, δ in ppm) of (Z)-1,2-bis-(phenilthio)ethene (5.63). 
 
 
13C NMR (CDCl3, 400 MHz, δ in ppm) of (Z)-1,2-bis-(phenilthio)ethene (5.63). 
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